var title_f37_27_38320="Ivermectin: Patient drug information";
var content_f37_27_38320=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ivermectin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F13856122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F13856123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?12/43/12980?source=see_link\">",
"       Ivermectin (systemic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/34/9764?source=see_link\">",
"       Ivermectin (topical): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12181 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-60.18.131.125-10F4DE3033-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38320=[""].join("\n");
var outline_f37_27_38320=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?12/43/12980?source=related_link\">",
"      Ivermectin (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/34/9764?source=related_link\">",
"      Ivermectin (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_27_38321="Erythrasma fluorescence";
var content_f37_27_38321=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythrasma under light from a Wood's lamp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFFAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD51hkC9ema17MFzuTIrCQEuOa6XRxwA+OfWvvZSbiYUIpzsMvNPdoC/wB72rFEJWXDCu8uYlMGMAHbyK4m9UpeuCc/N60Um3ua4ynGGsRyHJ5xx0qQjAzn8KZGMDBzn27U8rla747HkS3GMelJtH0p2MnvStwAO5qwuVJB1xUJBqzIPTvURGMd6wmrm0SKmlfmNTbaQr6Vi4Fp2ICMUbealK+tJt5GeKz9nZlcwwL+B96kjUd+tSLHuqYRFecVpGn1IlMjPQ00ckZ6+tPk9fbFKqj3+la2JuIR60nbJ6UpU/57UirkkihgGOCQaTaTz3qUIM9DTiOP8apoXMV8D86PUYzT3z29aFTI461Nh3IyMDNKB279ql8o+o9aQKec8Z/SjlDmRHtyBTtoJp+PUnrQcdBTsJsbtwwA6U4AdB0x1peOcUvbHTFUrIm5Gfu5HWgcmnkHnd+FIAQRxxQO4057jn2pMZPB/IVJtBHJwKaAAw4NAJiKOccD6VIF+tIo54qRAfwNNK4pMQcUowcZ4NSlOMZ4oUAMBwfwquUi4wKcDINKeTUsg+Un1PaoJDhT61TVhLUfOyFVGeaq7D1UfSpAMkk96d90cd6l+9qyl7pCqckZPNPC1IF9OtSKmfcURgJyI1TPegpjpUhXHpgUEAn0q+XQVyuw7Ec+tRbeR71bZCeMe9N2ZIqHBlKRXxyacq8nP4VMI8ZyTUix8Y64pqAOZXCDg/ypHXrwamZCvSmsCwJPFS1YOYoueDTB8uc9atKmWIx0prQfPxXJODlqjdTS0GQplsEVt6eX3cYAHUmsqJOC3Q1pWzpFECSCT60raG9KVndmqZ5Jj5YIBHrWDrcYjuchsk9TWw0U5i85B69K5+8LyNubJz3NCjbY1rz5lqhYHJHT8atDGOapYMaj3q3GS3bmuum+h500twJGPl79aQr2z0qQAA/rkUr54wa1tczuUyMnApm3npU7qevP4UgGMEj25rJrU0UiIoTnGenGac8Zxz36YqQYJz3qQgbc45p8twcisy8cH8ajIIweuasDgEkDjsfWm7N+Ox9ahxRSkPtlBPT2qxKNoz3xUlpFhc0XQywxWkYWjqYuV5WKYQk5zkn1pAnHPf8AWrAUYPbPFGwYx0pWLbK5XihVHfrU23p0NKSPp2osLmIgPUH3FI6nJx+tTAAmhlPTNHKK5W2cHjmpVTLc5zipNo6HoO1Lt5OOeKOXUfMN2lsVFIMZ4qxy3THTrUbjg5zgdqpxEiLYBkDGPWk28c59c0/AI6GlxwQOnWpsVdkQGaXb9DTz2xnB/Sgg4yaLBcawPB6kUwjB4qQn07Dmjvkjg0MLkbZHTH5UgHIzzTmBB46VIozzSG3YYFORVmNCVx1pI0ByT1qcv5eR1Pt0xWkY21M5S6IhPoQeeKcqbRk9Bzx6U5IyzbiQfX2oumWPKgjkc02upKfQhY5c/wCNQO+W4zSM/oKai+/NZuVzRRtqO3GnocmmqoJzmp0TuCacUwbHJ0x3zTsc88U+GM7hn9e1STxjGV6962S0MXLWxWUZIAxzTygHpnvU0CfORgetSvEeAw+b2pqInMpp1A/nVhIcjcTU0MI6t69KkeLPAz9apR7kuVyuIO/PtUUkJU4weelX0RhjHJNSOgI4x1+tDWg43RkpGXAGM47GmtGFkA7ehq8zxxNhiM9/es57gPd/J09K56kktDRXexNPGsafdHI64rMVm3nAz71sX5aS2Xackenasu3Usw3cc1lNe8kh0X7rbEQlVIB/GpkDKqnNQAYAB6n2q3bqZBsLAe9QjpuakOpubYxMo544rL1FOF2rj1rR0y38yRhgccZFWL+zJyVXdtFWqa6FyrSlHU5zyyVA71ZjBVcEcYqPIEnI6dRVpCX+ZRwBwK0hE5py6MijHOQOakeMnGen61Mu1U4qFpG+YcE9q1SsZKTexE8ZlkCr9OKJIDE5VhhqcuVIK/eB6+lSvKNx3Ludu57VLirFXadioByM9KkP3eOadsJPShhyQw5qLWKvchHzDjBPrUkaFnwKAAPTj2qxBtA5UeozTjG4SdkOPyJ/TNR4LMDtPTNTMys3GMCpVwQdvUjr61pYzWmpUYnrg0Kdx5xUvlky+/XJpsqFDwM45yaVrFXuBUGPr3546VEyZbI/WnIGz2C/TNWBHxk46cf40WuGxXAOe3v70pXnjHH61LtyR6DtikIHIC9OT2ppWFuyPG5cYGfakKDJ6mpF5z+nvS7eMj6cHihoaIgpx0GB29ajlAJwOn0q5EvysWGeOfaq8/3+vy44pNaDuQcelG3HTH4UoXnofzoIIb1FSxjASOuc+tJjrk5HrTnpmcZOOnpUDFPCgj86anJJ70v3hyRimscdP0pXAeeB6k9qVVA5OPoKaueADnHJqaNfnA/h96aB6D4Y94OOnrUyKGBAHSmIwydvBPFSIyW7ZmyDjPH8q1TsjKzkxlyywr8pwT1FUNwZSSeafdymdy4BCE4FQqny55rGUm2bKKSE2E5PpUyxfMMU6KP5ec1ahQAgkZqoQuTOdtBscDfjUvkuG5zUpyq+h9KsqVZAABn27j3rdRMHNsqquT06+tPCHow96mQbWKgn6d60hbI0RJ9B9RVpCUXLYpWtsj54x/npVyaw2RFyBjHWpIYjGTtHT1qeednjEYAYH1FO9jRQ01MgKA5Cqc9z6VIE3EZHIOTVkwhQDjJPPHaqlxPHbbVlY7j6dalytqwjB9SV1jiQs5AA5yTjFY9/qQ5WEYJ4z61BPqAkkdGJ8vPT+tUVIlm5Uhc1yVK9/hN1Cz1JJZCAuc5PNWbG3IO9l4PTJqIwtv3EHripZLwKuxcAjgVnFK92TNtrliTpOPuk8Cqzusbk9B7U3IKEjriklUOvA59q0bM4wSZFGuTznBq7aW5aUDkZ4z6VBZ/OBg/MO9WoJXMhWMEnpmpTijoUJS0NsRpYqgBU7h83saklvI3hYAEsBj0rF855bnZIckcCrK2kiiQoc98Z7VpB31ZVRtO0DFJCysTjnOau2kqeW0ajr+dU7iItvJIUDnmiwygL9+gog/esYTV43JpHO/pgdMChmLHHH5Yp0se9RKBkdwKanTIGcdPStFuQrWHQR5k54xz9aWaNUk3AkgUsQJORj3xVm4hJjG0cHrTsrEydmJgSRDauABk+uaqyqC4zn6VfhUiH5zjZ79apNkyYYgDrxTlsTDciYDcOaTkNgZNaIt4njx0btnjNVEhKy7GH1PSs2mjZNNDUU8ZPHrVm3h3EDBz2OandIxtVNpPfFERVScfNVJdxskNtt2nHqTz1qrdLk4GPp0rQDnYcnnGahkTceOnfmqFy7GYhKNz64qZGOR0I9jUzW6qASOc8+/0pYoCDnGR344pLQGKqErkd6QxnPQ/XjpVtImwML8vTFWDanZnAIByD6VVkRymSsOWAY8/XNSyxBQdvpgVbjjIG7j8RUbc8EcdelFh2aRnsDuJbIU80zy92MNyec1PcLuTK4AJ4pgkCDnBX16VIirIhU4PWm8n6Y4FWJpgxPHU/jUSuNrZ6Y4NS7FX0IG+7nHIqNwW5qQ5zgAYP60kgXHyg471nuWmM6Abhn2FGCw+YgHtTgWxgrmnIuTnsfakkAQxsTubOOhxVrKmQEjPY0+CJ3AEY46k5wKkdVsykshPrgr+laW5UR8TGtF5S+ZngdT6VnXUxuHCgDnoc9qmvLwXED7VCncCB6iq9vEwQvxvH6VnKXM7ItK2rF8s4VM885qRAN4DfdHbFJH8oLcszcCpQrBMnqeKpIUmD4DHH3R6etSLwBtxjqadFAAMAZUcmlMQGSW+Zv5Vol1Mm0Sgh42buBxRbdSMnrk571KqJsVQCOxPrSxSIm7PIrSxnctIobG0jcfarK7kBGRwOT2qvbspXdyDycVLvGflOCf1qjSJIJcYwTgdvWl3l5D5fJUfWlieONT5iZGMjNZuo6olsH+zYViMbu9TJ2V2aLcmv9US2iYOD5+PlUd/rXPSPJcuZp+cds1WWR7q4LueSe9dVY6QksAkLYxzn/GuJylWemxv8O+5zItmkJKDrzWtpOmNKC7ABE7mrwitrdnYvu6gAGtSKa2j0kkkAnsD0rSFKMdzFzc1oc3dAR78dBwP/ANVYzfM/NXdQud0pKZ2jpkVUUF2HGaibTdkVTi4q7JEPOPxqaMhcEnJ+lQOPmyBQHIXBoTsJq5LpwwGJztro9EhBRvLQl8kc9vpWDpeElO/nHOO1dJp90UUzuQsYHAqHbS520NyjdWpjvXZwFYdq07aycWhl34z1+lZf2hrzUN/OzJP0rVmlktrQMx+QngGtIyXQrkV3JnN6ogWRl4571TSSONdp5/pWxqto8sS3Many2Nc8wPmMMDIqpOzuji5Le6zWsw2FLqdj5GfWnwWoeRl6Y/Km6eAFIlYqCuUUjIJ/pUSPIkoPQE8CtlayuYO/M7F6G1AbaCc54xWs1oI7RsDJXr71ji58qTeCB69+a1ftwe2w+M5wc1qrbE97mWzLKGXKpIehY8fTNUvujdkZB6etSzOgu1Z1LxI2Sp/iHpRPm6uS6Rqm45Cg4AFZy1HBcqFE4IDdc9M81aS4E1uyKgZhzux0qhCqx3CpKTGAeTtyR+FTxzqsUuc7icjA4qUyuUQxlT3PHUcVPCrSOtRw3LPtMuAnIGBjmtH/AEZ1VrdirHjD8ULXqWiX7MqRK+7Ddwe9RsoYY64psZaTgSDPT2FKEZZG34YA5P8A9amUhGQt2+Xtx2qwNqj147UrQiT5gc8fSrEFvuYNIpyO2KZSi0MgjDMuTx69qmZx935fpSSxBASgAwDxUVpE8rMxDHngdTTvYai10HEKw5HB7+tUJYt33Tle+OMVqXERSLcw2gccjgVmRuCx3nCE9KV7smrpoylcEIBuwfQCqTkMwyTk9fQVcv3jaY+Sd4Bx71VuHVl3LgMe3oKls5+pFIBkjPbJI7VE2ScA8GozKqud5HPtTPM/2uaylNM2UWKVbfgcnsKcODgAdKlSQPH0/ejgEUq2UzjzCuxT3Y4pegub+bQhVjuAJAOOMVo28SFV2D5gDuLdqlh0Rn2F57dEYZJDjpVO/uII2aGzjZgp5dj1p83J8RXLzl6S5sba3LiV3lVgyxAYHvk1iXV9Ldvuk6Dge1QZMhJYgkdBTlUk9eFFYyqSntoi1GMQiUH52Bx2FaMYwjNJxlccd6htocrv54/Sp1QylVC8noK2hCxlUlcLfHlOzbQD04pEyWDAfKvHPepry1a02wPt8wnJA6ikciDZgBsDJA7fWtbNaMzvfVEi3B8gxY5PJPSljBKEk4ZuAMdKghkLbtwwSeSRUzuGwV5J4Aq07ohq2g5mGFTBJ9fenuqoRv5BBNOUmNNoTDk+uSakjhMjBpjlm9OOaoSWgHcsG4EL/wDWoil+brleuTSmMCQRp8zd/QVdeCKO2GP3s78CMdRQUkU7y6M0O4gbUHSuavSZpgFOQB1FXNSNzDhZkKFum4YwKzlZljKr36n19q4sTUv7p1UY9RUUmRFUEE8Vt3bXFnZ+UZPmPv0rPsLVnljccruAxnvWhrzNJebJVx5YAwves4RcVdGrS3ZmrLIxXk9eee9aDZnAA+XYOcVXtLc+YCOSe3pWvY2sbpKSRuUdTVxXci2uhiS2wXncOeCKcsag8EelS3A/esAxz3qsh/eE8Yz1NNWuRNNoVkJJBzjtUflgHGeKtlhjBPTtUJIyOKtxRmpMLZtrnoxPFalsyskcMx4BzWZbpv39Mjnn0ra06GA2vmSvlifu96xlY7sOpcxegjjt3dggKEcDOTUou0eAtcxgIh4XNS2FvDfSyeU5VVXHPeqOoxRwSSpuLKOFxULex6TuoX6Fhrg+VIyxbEI+QEVy820zMwAIPBOK6uaZbq0WDAUAcsBXJ30Ztbt1VicHuOtdCldWZ5eJp2d0JDIBIC56c81NcSh1+QH8e1RtEHUvCcg4yD1oiG4lcYwMj2rWN9jifK9R6BpI+PTg9qmtj91SuW6YPT61HBiMvHIoHPU9fwpfmjnO1sZ5U+hqlsJq+hNBZy3c4ihUtJyQCRyB71HBbkXLQtgBeSWOAtLHvCsyEkd+cVHHMYbhJCu51PIYZBHoabS3Eru6J7+1xbJPDIJQPlb2P/16pkqEXjrzjGMGtiC4hjMkghY2rAkKxB2k96yLly07M2HLncD0qZ2WqKjd6DouP9ZyuOuOlXBI0UpaIBUz3IINVyZUtwrDajruX6U0yec4TIAHGM4A96nSw02aSZt7lJIBGxHzYJyppftZuZXYW4Q9/KOV/AVWhgkaRdqtIg646N7VpWEtsJFinRreNmzx6+lUkS5O9jRsraQ2pkycdeTU0krRxoWVQCcZY8VX1tJWljWF08lsc5x+dLFaySKBgyNjswG6iU1F2OqlGpNaIkEsZcLuRiemDV+3mW3YFdozj7wzgeuKyksmjfDsgyclR1Brad7VbNGlZh8uBnjBHvWaqXOmNOa1loUNZvmIdRGJR2Kr0rlLuOXy/NcbI2JwRjr6VqXurwbpIxIQDwQv8Vc1ql2kkmI228cAnNDkoxvc4qrc52Fu5VtwxRvmx69RWU9w8hG5sKOwqG58wN85+lRpyeRXmVcS5S5bWNoUVFX3Lq7WIzwccGpreIySBEXcT61UjcKMnnHStLBTTUaNfmkPzEeldFOSl8iKl42S6k25IXCW7ZI5aQevtTRqaW6yB4hK7ZwW6iqLMI1IY81SkZnYntRUxDh8O4qdJN3ZNNeSyMcE7P7o6VJAzJgAHPc4qGMYXGBz3qwgO4BR3rGmpN8zZtKyVkKqN1YMM9cDFTIAVzj5R+tSBS6hVGGHU07yjuCjOehArsjHsYOQ2NWZBtBI74qysboAQfu8lgehpgjZZjGvGO9SSrtkCYxjlsetbRVkYyd3oWIY2nm86Ygu+WG5sA/U0yUKrLnBycnb3PpQFLxtIeEi4/GkONqDHzv39B61r0M/NiKBJzjCYwCe9X7dY8KXGD1Zh2FV8tMFjBzHH0UdvarPlMoKBP8AabnoPSqQpdxJgvMinjOF/wAae8vlxxrnfM33VJzt+tVxKrHzZeUX5UUGrNnA3kmWYqDnr3FUVEsWyC2G5gPm49zVW71I211cSkMJEwqAdAcd/wDCqN3dGeQhSRGp6+9ZkrtLJ5Y+Ye/rWNSry7GkYc2jFubm61CRTPI8mOF3dhT7SBWuUjl+QMeWHOBUsJAKRIFDL1bvk1s6TaW9jdebeMku4HhT93NcN3KXc74Ulp0RBNHb2aQPC6kF+fXjvVLVJJJruWYhsnkEjtRqrRyXji3BMYbgYq5duDYWwK/MwwRjpWy2aMptSemxDpWAkkjjJYYHersyiHy0RuX5IFLbSJBaJGFBkbnNVb5ZFnGQR6UIbXLB+Yy8jjUGQNg8AiqBj+YlenWtNYPMh3seD/OqJGCQScj1rSyZzSulZjGHBHGKj+9ntU4UbMnOaNmFOKbiZ8xFZgNwSFycEitu0tk87bGS23t6msizhDzIGz1weeldAIWtpQEwBuGMck1zHpUY+7qOUS2gcuQqnPC9qz9MuYnvW8/dtzgGuluEieBFZeSfmBFYV/YCHEkIxubpTWp01IyhZx2RsJFBcOzbwIwOPesbWtJc2z3IUhlOWHUYP8qtW85sYkZsuGH3cdDTpnkucoztskPzBT0FDQ5tVFZrU5WIugBQ4Iq6R9oRZECpJ90gd/epdSt/JmZkTCADINZyllyvPTIraE7aM8qdNp+ZbvYXgkCOVZgMhlOQakaNTEHXjHzD6VJDKs8MaTgAq2Ay1eNhIYlCgFEHBXnINbpXRi99CraJ5sgUYGep7VWvbcmabJ+YZJ/xrR0y3c3ATYQY89qj8QIsFxGw6NweacldCStqZVvI7sIVwPbikukOQSTv9hQUCfvV+Yg8H2qzNHu2kgqpGay3VmaKOt0VjISsabsp6ntTrmAwMcADnOT3q/ZwJ5E0EqABjw2O/bBrbTToGsIpJG3yjhlPU1jzvZnXDCuSunoVNGLMFO0KI/mJ9afcWKalIXhDIOv41o6HdQrK0TxbWAwAecipLq4htiyrgN1AFHt5SXK0dEcFSUVNyMW6tZfIaKWUkx/dJP61zEl9d2krCGdwCf4TW5q2pZDLgEtmuYuZtzfdwfpWFXXVswcop2pl9NTnA3mVt/rmtHSb2S+glspXy5IePcfveq/jXL78H5v0pyztC4dflPY5pQxPK7synSc00aOo/JdPHIrK4OCCMVENLkng88TJtzjBPOasNqsWpGKLU0VJB8ouR1x/tVVvrWbT7jy3ztb5kdTlXHqKmUoT956oiKlFKOz/ADG3NgVgDM+WAzntVKOJjjr9auAM2VkY/NzjrTZl8sYUfiTUSpwb57WNIzaXK3cZ5SgnfjOOAKklvHEQjTpVWSUsMd+5qLq2azdbl0iX7O/xCsWZvm5NPUeuMd6FXilUZbGAKUY2ZTZYiTDZwPzrQsIWklAjwc+386isot5Cnp3rqfDNukTvMzeyjFdkY2RFNc8rGTbW6LPJ5mflHJHc0str5MBn5xn5Qa177Tpp7t5YWX1rCkjmaV/OcgJwB1x9K6OZLYzqU2t0JEQkXmjjuAepNRHcsZZicueM1KY/NkymfKTnmo5pQ53A542qKu5zWsyQssgRFB2xj5vc01nbO8D524A9qjx5abOckcmrFnA0jb34U/L6VcXfQTtHUeitbgMScnkYpyM8rlEZuPvkd6lvGHmeUqmR1HzYPA+lEaAqIVby5jjLH7oHetPJEb6sEgEs2UXdEn3c8A+9N1i5dFW3QgqRlscZzVq7MNkfLtnLDACkjqe5+lVIoVu5RIrfO54yOnHJqZ6KyNILWxQnYxwBU5PAHpmkjHlMohJBf5Q2Oc1eXS0lE8stysEMQOCQfmPpj1NJpM6Q38UioxQNhR1OO9ccnzNnZCHLZPqMbS2e6t7ZRhsZldjwfWr2tz24giitgyGNdpyclq3LJ7SK5vZrgyK5bEUbYPy+9c5rqxjUAYVIjPzHJyRSgranTWjyQdnuVIo+UVgNxOTxWyIIpLGLJwd2B7VStIzcz7shegPPQV0KacrXUNsrfIpBPvVp6WMqdNvVIyfKK3zJuJ2DIz3qG9nLOik/dGCw9a2L+wIvHZSd3t0wKgezWS3aQAq6nk4oVy3TcVyorNKTbLHsx7+tZl3GiuvNaM6OSjNwBxjFQz226IOBgrzg+lbQ20OKvzN6lVYicEjj3psoZmxgYznirEi/KCDkYx0qJyQSBgj1rQ4ru422DMMnAYEH61uW+5ZEbhpM4PGKzNN2tbNJJENykfhW9ayxLcEupYEfK2OhrjSue5SS2Fy9zKIHBGBkMBitK90/fZiJGXzCMhs9arXc6CRPLJGeCwHSnWzeWyYkDq3Qn0FGjd0dkWleMle5mTWp/s+IMyiTdtbPYZ71asoBFFIiL8uOMHrUniGXy4v3AJyefT/69Raa7zhBt3Kilm29TmiVrWJhpUskRJp8k0kwnXdBjKv1I9j7VjXmkypdlYoyE4wOvFdJbiSEII5AvmnDAk4GTjmr+p2b2TZkMLbsFWjb5cHjNQpxvYqWDdSPN2OMSxeOZ4ZSAobgZ5Jqeyu5orxmQEBuDGelW5LUrdyecfLkxlQTnPeoLuMyYdciRSCcda6ozseVUw7WpdTUxCwuDCB82xjnFZOvE3EjkjA6j1FXjALy3WNhtB53AcZ9avXOm+XbRT+akjEYbb2I6g1cpJ6ExoSaucvaFiglXkDhga1tFjhuoPKZVMyMcqf7tO0+0to7+S3upCkMw+U7c4+vrWtpNmmmaiJj+8hf5d5HH19qwqT5Vc6cNh3N+RVntFaFyMLsGBj17GoNJlmku5EuQx3DAJ4Fb2qwny5LmKPeF5IXgYrG1DVrZ0toreF1deScYrnemsT0JwjBpS/4cpaoLjTr3zovu/Tiob8vNbiZmBbHI963b2RL3SxsXJA5zXJySP5bRMeByOauF3q+p5+LlGDsndGXcSEnPU9MVVlwuWOSfQGrUzDBHp1xVG4IwcGs6zsmc8EV9+4njA9qGUHkU1evtQX28DpXlOpp750W10EIGQM81r6dfySQfYLjbJGeY93UH0B96xyQT06UqZ8wMCcjuKmlWdOV4f0gnBTVmagSOaUNCee8b8EGpGtn8thIhyASD2qnqbB3imAw7rl8f3hUYu7lI9gkbbXd9YjGTjNGHs5NJpleU4zg96dEemRwafjd1TOelPiTbjKrXNCDc+ZbGzdkSqgKEjgdaktlQSLuAKk9KavTHPNSpHySvHFejFX1sYN9zas7ZAUdiFHoP51dWVtxEcmAD0zWNBIzqAWOCMH2rTKiKMbT81dGjRmnZmul2I1WJQRKwxk9PxrOvIP3gRCC8h+bnmorueRYlYuOOoH9aq2chCvcyMQegOaE2zaU01ZkupQpbwRQqfmwN59Kzs5w45A4HFW1ja4jMjNnnc2T2FV23Of3YYKK1v2OdobDGZXwTggZbJq3PIIohGhBJ49wKEhS1t2lkHzMMKD1NVUBeXDck/ewapXirdWZSjd36E8aYi86Rieyr71YgRoiJZeD94n0FQqpkYbFIij4U46mrBHmt5cjYij5fv07Va0CzbKzEzSSMFPI4PXAq7BKLa2ZEb55MqPRa6Hw9dQ6ZZzTtaiSeU7RuAIVSOoHtVe2tYbu6jn2BYwp3HPYHH61zznJano0cMmo2epmLaGaL7OzGTBwNhyMkdalj0XZcIyOUQEfMw4Ht9a6Kwt7eOEmFFVCzfO3VF9agsrUtepEspCM24u54VexrLmT0R2/VLWk9Sg6xxAGViqFss3H5YrGlSN3YqQUdtwJ6gVt6zZhZyI28xGb8D60kNgsksBmOGbBAI/hp3M6lGTk4pEOjWrSTsVhLKxBA9BWxqG6Bi8IKsq4981fsrKaCRZYGyit0xnFTXkbNNMsK7sc7mHU+1ON73N3SUIcl9UYNgZDEdwJfqSTmnRp5ysqMB7DpWkkEi2xZ4ipbIzjpWbFG9rPIy5PerjqZSTjy3Mm6jmDr8vCn8KlkRFgU4+ZuCta87iSDG0bj7VmSKI5QJM5AzWlNWZw4mKS0M6ZMZA5I7VBdQRx+QYJTK7JmVTGV8p8n5eevGDn3rroozqnh6ztNNurKGSCaR7qCeVYndyfkkDN1AXjGeKoeM7mOe7sy1zBeXsdusd5cQYKSy5PcfeIGAW70KpzS5fX+vmea4WVzGaX50EajyWGMr1Na+lOk0MyXBOUGENVGs0iERHPyA8etWvIZJ92zG6PJ2+tc6a3PdUJRkXbK2ZYcMAxbJ5qXylijQiLzGA4WprVJjHFHDneATgVbbMDxyNIvnKu4kjioTtc9KNNcqMmOzE9ifPMvmEnairkZqhbFoJ1jK7QRtY9OK3ZZbhlS8Vs+W2No6c1VurVpraV40w6kl+em6qUu5lOirqUehZtLOGZzHJky7cxNnAb61U1O9e+SFLmNY1gTy8x5Gec8+9XIIpbewCvH5krgAbDl0x3AptiiSRTQ3wwjsRuxgrjvistFK50uLceXbv+lzIhtkuLuNokk82T5QBzk9uPeo7q2ewvh9oiILfK6sMEexrf+zyW5laKbKQndFInBDYpuq/a57IXV0yyTZ3ZA6kHvWnPY5nhk1otTP0hDNDJFKViZCQAR1HUYrY0CzjurlrW4eKB2PDSn5cGpBMLu8guHRU89QP3a4Ckda19QsLayvop9rNbt8jFPmwMdceuaj23u+Z10cFbVapfkc1qGkW9vrRhlullSFsLIgyrVo6jbKVmiACFOmPQitPX9LjNk0iKQdu5HHcHsfesOwuWEkAugGyPlI74pKXM0mVKgqDcbbk+h3BlspbWePJHynHWs288PWrb33lZF6AH9K1bNBBrErSDaky5XHTNSzsEzIcHJwT61VKLtZnPiJQcbS1aPPDfvZXEtmWLRjgH3rFuSrTMVPB9sVseKLQxXxmjGAeSQO9YMgJIOeR6VtFOKt2PnarvKzI5UAyT19qzrjg8Y5q/LuweeB71l3BO4g9648ZNKGhdFPqMzxTeCeaG4O30pnQ14s523OseynGe3tTo8buOtM3Ae57UqPz0pxnBSTuJokdy2R1wc0ocKMkU0OrZ42k8Uxh8uC1bOo4rmjqSl0ZN52Rx/wDqp4Zj1NV1Xbx3qWPBGM4962pVJN+8TKKSLUfXjpVuMfL6VVgwBzVpRz6gCvUg9DlmSBjHgr16/WrlipuZAWYYHr1qixycj8q0rFGUBV/jP0NX1FFXQ6eLzMxxgkZ55qlcHcyxKvyrwR2zXTXEEdtYl/4iMk/1rNt7NfLaXvjceetO+hu6WpnsrwARB+XHzEdvarekW6NPtYnGcKc9++at22kmWAOXBlbpjsPWormB7KIrGSJG43jsO5q4WtzMidKUbXM/UXMl1tjJKodqjrmr0GmymCJREfOlOeR29TVnwzYLNK086hYo+jMK621sxPJ9olyiMCT/ALvoPSmp9eptSwvPuYkNgwihAwkSfKm7gsT1b6U6+0xvtCQWyqVHzSueFK+prQnvklaVyoaNeI1Xv/8AWrQ0aAraNcXc3yt+8Ynkkdh/9apnUsjspYOEnb8TE0hFkmntILbd9oUojsxwMenufWtizh05ZYbe2mYnrIqxkeWRx9T0q1Y26Tgi3ysagu7jgL3AFTHSR5S3IkG91OYkbDsAfvH2rFzVR6ndTw0sPFSirp9exny+WjSxxSTxwk4yyZMg69e1Z940pkcqrJuUYBHOBWvJfxTzPBGuApJhynX3YnvUc0m2dVVo2kxsaTsaqCa0kKvaSvB/cRWMb3hE8sbBE+RRnBx3NWLfT0Wcu2DuOFVecCrIg8u0KiQtK/AVRnA9aLJHtzsT5m6g/wBynFLdEzjJWjN6+RYhdbaFlQKqD5SzdM96z59TjisIxFMhaR2yB1UVpCIXNhMpkwuc/MvJPeuduNHMxf7PhETn5uM0oz5ncurQlSguVX0NW11HzIR8q+XnGDT7pbOSxkZUKTdB71kW0stoNuEkG3HTp71JPITLEcnyzyc9KuN7mE7OnpuZ0yNGmChz296oXUbNKS33gM8+ldTcRw3EAk+847ZrAZCLxZLiJpIlYbk3bSy9xntXStzya/w2NjS7K+/4RuzuNF0O1vWlklFzLPAsrZB+UAE8Lj071h+JYr/7XGup6fDYXHljbHFCIwy5PJA981rm80VRx4fnC+gv3/wrK1WSymuUeztXtYwuGjaYykn1yenHasaUZc7co9+3/wAk/wAjimklo/6+4047ZGa3t5FKSKp5P+FTSQFbwBGVmdSCOm01UurwSJHIAftB+6w9KuXMcwdbhQhRDy54zx0NczPrYuLTSRYSJYWt2nbbI42qQcYpwjRpHGYyhXkMehqpb2s15ch5gQAcgHpj2q0bdPtzOzYVRggd6bSLjdrbQS1OyzlCyAQjA6f0pfs0MXly8Mk331Bxj0qwbW3miaIu0fI2hRkkj1qwbWPyzKCilCBtI6g+lS2n5GqhKMdFew3TVhg1LczswHHHykjHTNUrmzLXQiL7d8hK5YbuOelXtkrWzSGNyFf7+MAZqrJabib9pFneNgACcMM9wPSs7XZrKK5EmvMdaeXK8qSYjkcFSqjqR6VetZE+wC2X54mYjDY3K3eqETwsyiRHSWRg3mA5x6j2rSiMcbSxwxKHiIO7Od5Pc+lS79TWlZaIy5Nlnbw+XuKxyDepxgHPb2rQkvHzI6xKySL/ABDv60mpRWsreVHlPMjDnIyM/wD66ZZyxy2wilzlSCMdPwqopX1RHM1eKdiY3jS2BCKUlKYZezHviudtoYJJ59yMksZ3YJwBWxbNsvbiBwWx8yk+lRy26C7Ergc8E+oq0vdOeq5Ta12Kl05AjnQ7kRgQCamu7iKVsKMFl5FVTIrpPBkBVJ28c1im+EY2McyKe3WuiC7Hk4iq1uR+J2jNkyqAGb1rjWGBzyRW5rM3n8KG5/lWI4JBBPStZHjTlzSbKc/Kds+tZs+N/qau3Xyqc+tZsmWkPNeJj6llY6qKEkGG65FMI5J5qQjrxSZOCMV5Ljdu5uMBx0oBwDSkZpCOa53zRKFRsNT3+bk1EamA+XnOa2pSck4iYA/L9KdESrc801Qehpy8NXZTeqZDL8JPboKtrjYMDn1qlEeOPSrSHoDkZr3Kb01OOpHUsWsYJy3055rc0m2aScMc4zxntWLC393r0rotOZ7e3AUctwBVy0Rph1eWpY1CMTL5QzjpioBbm5ZbeLLKOTirvl4tmkIyx7Hin6bA0CFhkSk5Ax2qItyO1wSdh8c6WYeBU+ZR6dBWcIhqGoMs5YRheVHpVi6gkllYqzBerk96u6RbmBWkdcqTkA9/QV0dUTHmk1GWyJ0szO8Vjajy0IyQKv60gSJbS2fjhXweTUlmohhFw5wz9QD29KktIVYPOfm8wnB64Hc1lKV3oejRo+449ynDaQwGJpAUReFIG4fXHcVf1FBcL5cTv5MjbTLt2hmHtVeW6guHeGBJCjLsiyPmB/8A10y28yKBhPiMr8iBh6dSal3eptDkj7i2L1pcR2ls6FSqDDMCeCo4/OoJZJZEa4Eb75vuuo4AHaqnmKyFJCXUctjv6fhV+CXyLJGRpHcngM3yoD6D8qm3U1jPnXL0sJZeaxjSRN8zfKu5Mk+tTWc0FvK0cmmRTFsKjlyNpzUyzGykW5DkuE3ElcEMahju44Ldl8sN53t0GatNy0M50YUrS6onu9SuBOYY7eMIykfuv55qO0l+yRb2RvMduFHp3q0jQeVtfKBwPurnAqvcu1uygZbcQCAOin+tJ7WNIxtJT6E11IIbBSqFWcnaD2+lUFxcLiUMXU8L2PFWXui968cIaXCjLMOQPSo1IihcxsS27g45oiuVFVG6krX0RmeWpm3SLjA+76UkoAdExkHtTp3XzCHBEnXp1qaLT5G09p3JGWyvrW6aR50k5XihtnAChBIDAknms3UMw3DZI2tyMVpFmiAyBu2/nWNO5Z2Mvb+VbU27nBjFFRVtyqZ2clRyT2FNuYLTyk8uS6N2BmWOWIKqnPQHOfTqO9dboV3ZW+mWc5mgEtj58ptimZJZ24iYHHKgflis3xLMJ5rMm6jvruO2VLm5XpK+SevfAIGfapjVlKfLay/ry/q55birXKMFtIYIYm2jIzuHNbKsPs8STMWU4Le4FSaXbM1vCkK7iyEA+9JfvHBPBHcqQ20qQo6Vwuo5aI+yp0PZR55M1ZmleIbUYxcEEDgD0qqyK1+oKsAAD6VpeG71oFkSHEgwE2SdGGe9V42MupzpJEqkA4ZeQnP8qhSaep6E4RlFNdSvMUgmkLxyo4+YNjk59qdFOZ4VVyoj6DBwM571uXpVrKzJkSWfyypYLwPQZrLXTYJEnS2ZmkTDsSuNp7/UVSlFq7RnKjNStB6E8lvKL1IXlGwgHg5AB71VvmBhkRIRGq4RgjZyR3x71cQqUiIG19uGkD53/wCFMt4WW5fC5jLY+YcE/jWd7PU1lG8OWPUyLOQQybf+WcibTv6D3q1E8a3cRVjtkUKxPAp99bQxWflyhRPHNz6lT2qGKYfZRas43hzjA5UjpWid7nLJOm0i1LFCWaOYlWQHy2H06Gq3liS2YRfKykHaT1q3DKJbPe4BaMgkVlfbAsxUFuCQO/vRqmOcoct+5O6vHeRu22P5SpPrUNy52IeSsbckcirOrSJJbQurdD8wI6Goz5TWj+W2UPGD61sveT7nFNuLt0MjXJEW4WRBt8xeoFYASJGMrYz/ALVat+6PbhZFIkRsD2rE1xxCBtXG4cjtWkVZnjYmV05FLVZFZx5eMAYrEkwQe1WpZC8YwTjtnpiqUrcMQckCrqSPMim3qULknPGSKqSLjBxg1NO5x1quWJU14eJlFyaZ6EFZCHrTCDk80AnBpC3NeXOorXNQDddxpD83OaaeaATiuX2l9HsOw4g9qNx6Zo3UvBHB5oWnwsY4NkDPanxuM8jOahAzTx1FddGpK+pDSL8R4HAHHrVqI/iKpREHaM/NVyM5B5x9K9+i7o5ZotR8nj8q6XTsSFSehAx7nvXNxngNg5rotBlL43qNqDr/AErplsPCv31c0bu4SJQMfKMdfWtTSYxMqytxkY47VUuraKePdgcDO09c1NpbtHCUbjbxQvhPRSaq+8W7mGKV/LB2jODjvV+VAUitlUeUvzORUFkqS3GXAwOaZqM0sLlRld/pQrnTaKTbEmjWY8gqucIvqK07iWFLSO3B2TnClVGAF+tUNMmzcJNcjKx8IDzzST3JmvNxyY+pIHvScWzSFSKjddSxYT29nPNJEm59vlRZ/hP9761WkBmlL3DklDxk5DHuSalnBa4his2Mj5zjgYFTFvNuvssCZSP72BgH1oty6lr31y3K84kjg2CJQ8vzbV9PSrenxlP9eQxTHB6ZPar32dfMUySIdn7xiOh9BT1AcFo0WRmB2BuMnHWkpcysbqnyyTuVL4+cN5AVFH4DNZ1l5c0jKG24woY9/atG6cSWgDpt8xgCo/XmnyWiQQQKQnmINwH+NNWRNSLnO62RYaRpJPMZVi4wNvIIqlNeRfajFbNkbfmY9AaszMVAiQ4crk98Z7VnyW+QscIJJ+ZuOuKUY63ZpVqvltB6kdp8s29mPllufRq03hjZGCRsXxkEdM1A0RMeAhJhUHn9act3LIhQZRmBwcU5K+qM6T5fdkY+oLL9oRwee7VPDcOYDCv3cYwetPuIHWJDLnrgemKz5cxTtJA24evpWsVzWRw1Zui3JdSG8uZRJsB9s+lVNrEnPSpXceeCSCp6ipHK+adoGCeK612PEqvmbZ1HhiGWTRjDpiRussFyt4qgGQyEfuuvO3HTHGetY/iNWE9jHN5Rv0tUW68rGN4zgccbgu0Gr4jtNP0Cxun0dL2ad5A0xdwFAOAp2nrVjULCxeyla20xtPmSyS8z5jEoS2PLcH16g8GuGMlCrzvZt9u9u+2vbsJ6xMe0l2RxeXI4X5gCpximPtlvrTzw0yp97d1xnmr1pagwRllCEZPscCpLYrM0b3A3BWwgH06Zrl5krI+xVNtWZbs7aJ4p7pJlSFX2+WThseopLVDMrMcLk/KUHJAq4unSw6Y0iQlk3HJPINO0lbU/upmeSCP5iF+U5/8ArUc3u3R1xp2koyW4+IxMqAl2ByG3kdexFWLSKETKJbgQ+YSgP+P40jQKl9Hb4ZZGkBwADkEVN9mjSY+fGWAUmNe5xnnIqWzZQ5XqZtxFHAJQjgSAAbF5BA7g1ajQyRHyyoJTzAM9CO9VkgU3cAk8ySORWUqrbST1HNStGbdrdVwzgb8DlkyMYNVa613MOezajsVXVZHk+0uFeRA+SMLn1zWHdRE3aTx7lZzjHqfWtp1eSZWQgmLIUMOCOtUkVbp4Elbynjk6+oNaRlZXOPEQ5ny9ehetmWBAJwAJME5PAzWJHG0GoSuCv7t9wX1FbWp20ZcW6uN0a4LAfexyDWNqCOju75YNhQwrRJO7OarKStF9DQ10JLGjQlPLfDEL2qFLZY4w3O1iGBzxmm6NHK8LxOgZBnBqvNdvErxHkLwoq0mznqON3KXUpXGxrmXcw9cfjXPaw6SptwDsBGR3q9fidbhGYsN/Gaxb47AwON/WtUjyK87xasYr9SF4P6VWm4Qnt09KtOOMMcKPSs+7bkjHTpWdV2TbOSCuzOuGy3HWoixPWpG5NRNw1fOV5O7fQ746IQk46Uw/rQxyRSV5dSfNoaJAaSg9KTGaxa1KFpwOKYaUHP1qouzAeCc08VH1IpyhsZFdVKTTJZbg78c1diz171RgJwKvIe3rX0OFfunLURegkKvlQPx5rqNHVZ2XagVVHb1rkoCAQMHjvXX+HBmIce/Fd1242Fh0vao3ZYPLjLDqPWqUQcMSO9aUz4hCkZ98VAkchkUAAZ60obanr1Yq+hZsAYMtISaWedbiYu/Kp2FWbuMmDCn5sVAlquwEgliapNNjlGSjyrYiaUzDbAmxWG3p096ktUMIG5wVB3E9RgdKkkjK42nn+7iliI82SKQHY5GR9OtU3dEqHvWe/clsxIZWuY49gIwuffvVmKW2twquweY/Nkjv2qzxKh+zq2xR34yfQVTl0wzKXB2nJ3Y6DHJrPR/EdSUoa09bF2NjPHGhYI0zHf6t6mppJFEjRRnIQ4DAdeOlZFnHcJN50m8sRgMP4R7Vs2Ue9Q5ATd0Ynp7/AFqZe69DopTdVXe4tvGhdHmU7AeCR2H9arJGkl3LNtZlzwoP5frUd7LKITH5hO58Bc4yPWpNO22yBpQXSM525zlu1PktrciVbmfKlsOW3lEC3UqFBG5DbiMs3YD2+tV1jkivIlt1czZ+YZxx6Zq9K5mTc5WMsxkdcZ2+2ahUqIppGZuvyqD1pRlYqpBOKtp1KTM6lw8oG8kADt7VNJKLdIYBksB82R3qgu+5vI1AGzcM8VdkQ+fJtOZH+UHritWkjlp1XJuwvmh7dvMjJYdB2FZcdpJtaEjBYk4NatzI9vlDGiOq7cKePrRbQGWNp9x+71AzVRdtTnrrnlyN7HOTWiK0rMfnBA20wJtztGT1qxcZM7OcEk9MYqUR7og38I64rpiePUSTsdH4XRLexgkN9qMNxdpNKsdswVNsfrnqxwax/EDqpiksbm9ls7+JblmuJNxlcEjJHtyK0bKRbLSbCS61RrVWlea1RLfzSMfKxJ7A9xWN4hvUu7tGguRcQpEEULb+SsYyflC+nfPvXJTi3Wct9+/d+Xp16Eyfu2NDR3kliSMAHcCoOO+KmtHS13phJApwR2PNXIY7eOysZBkYjy7L1z/jWa8e+CSRUA3ZcYP+cVwJKVmfeXlSXdm1brM9nMqyGJC3KZ4PPapdPjit4d0sAYmTLNnhRjgEe9UNCSWSxuJPmLRgMvruqzJIosJ1lbdJIRtUnDKc5yKXkdakrKo1qWLspPCbmCGY3YkBBB4XHTHtVqwMl9NeXN67JswAVGCCeMYqDTbSe5tCbeRkkjJY88AD/Grd5fQ3EUmyMLhgH3HB49u9J78qHze77SRkXm6O5cQsHEZBXIxu7His7Wnu7izurmxJj8he3B3CtEzbrxXlhxCRjA7+lLEfs/mRXAzHPk7SORkcGt1daLc86dqmrdt/+AY+hxXl1ZwSXLKjld4VwctT73McjmSMMQc4U461p+W9sYzyBjEbZ4we1Utej/fkoQysuQAeh9K0g7vU55xUYNrV+ZmPfyrGrJG25TtLMc1au5WudIAYFSDg8dTVBt6s8Up+V1DL7+tXLoPDABFOpVxu2+hraydjg55a3GaNcncqs7YJxjNV9chKSbh8pz+VUY7s20gkAJz1Haluppb8MV4UHOPWqjHqc06qceXqJdyAWId0+cVxd9N5lyzN+PNdVeXqxwGMja3TmuJ1EgXHy8k84HQ1d7K55uJkpSUbkM0oH8P0FZl22GPSrcjdyuD6E1QuSNx71x4ifusilErdTnvUbdM0O2KiY56V89XrJLlOtIaDk5obg4oPB+lK5DHgYrynZo0EBHSgH1pKKV2MKOlFFIBw5HNSKcAetR5xTx/KuujN30JZYtzlsdM1oRAHpWbF2z3rQibCDjP0r38G/d1OeoWkGG6Emut8MTLu2f3cYrkUwfpW1oDGO4GOnY16PTQmg+Womzu50Vl+UE4HU1U+0nzcR9cYq5GweHJU5xxRBaowaQ43GnCS6ns1YSk7xL2lwfaNqseSc8+laTeRacEAk8D2rJV2hiZ04YCn6b5k7gzYOalreTOmnKKtBLUtlFZ95CnjOP8ACrGnRJFbySyoHkkG2PPbnqKiuU5OMKoOBirqSlIETG5lXk4xj0FK+hryWltsPswuWV32OoLEH1pogEdsCzIZZjkoByBUKzrCJfMZTK52ge3enMA6lVcFpTjJ6gelQ073NoyioqK3LDqHhJRV+cbAG6Y7kUiwbFQSJ+7X5hz+lWTbs0m47lWPEaK3Umob64P2WQBFMjjlsdAKXMacttuhXka0luN2wsF5wDg59qivMmBBbqI2PzFhzuPapVjh+UTYEijt1H1pIJPNlCJEWkIOMjj0FaRaWxxVU27MjSZbEPOpDuCo3MuR78GnvHE1vmZ2QN8+AOopZZPtSosy/LDHwinA9j7069MbxKV+eZQBtI61XMwlBRi1czoFWKxluGwN/wAqE8H8KtRSoNPheNVExJY5HOKztQOWGVYgj5R2WrcQSC3jMi7/AJBkVpKN9zmhNpuMegJbm9myf4+c/wA6mRVt18qNmPOCpXtUsDqZkIG0MQPwq7fWscU6Su5JOSygYxx+tTza8pSjGK5upy2rCEPI6ZB6Ae9VGdVgURtlsc8dK0tdtk2RNCx2uM9KxoohHcr5gMkSsC6q20sO+D2rqg9Lo8PEp82p0+lC/k8N2v8AZmn2N0GkkMxugrEtnAKgkYGP1rD8Qi8ju0W+tLa0fy/lS3RVUjPU7Seas+d4eZv+QPeZ9Ptn/wBaqOoSWUtyG062kt4gMFZJd5J9c1lSi1Uu136f/bP8jnlqjrXVJtN+zpF8y4KsOoJ9aytstvG0cieU+WGT3IFWLSdkhuLjfIVzgMnUN+NEwa5hWaUNIzyHOR1P+Nefy8svI+8U1UhdbkVlOyAxwu4WQDcF4zxWksP2ZPKdk8wAHnqD2waypIZFKRRLsYrhTn0rQtIxJEnmSDO3AbknPpVyj16E05/Zlua2nyzRQwRzDypGkLK+ePxpbuJJLiWWVscMoA5z6/41FbRJJMUuJAWU7yAT8ufanNp8kzBkYSRq7DcDg4Pc1m7XuzrV+XlSuVmYptaMq5X5gMcD0+tRX6lyWYb3cYXnkEd62IbONYPvblIKsR1UdjWPNPBvgXCqkecsB1HTmnGSb0M6tH2cPe6leGYGFEb59yMo7jOcg0lz9mmhQs3lzDr1JHFDTD7NiIl0R/lx2HbFVD5t1BdPjLIee2K6IR6s82tO65XqUpYY+C75ftznihIXWBJOWReg61XyHuNuTuVcfiKtTSSogXBAZcjFa3exwWi9WjLvQjPLhMDBxgVFAfLjVk5B4NW4meYtlVOeDVHUJPs9o6x/eU8DGape9octW0FzsyNdT94HDH5hXOXcYDEFSCBkEc1s3dwZgoPJHIrPmTOTnOfWtnHQ8apNObkZU5wvPXFZlyc1pXanGT19PSsu4Vhz2BrysZdRdjopalZiCtRntQT1470ma+Xq1OZnYlYD0pCKWgdawUbsYEYFN6CnMc0gonZvQYLjHI5oxSMxzSk8Um0loAlTqwC9Bn3qEDNO6nB6VtRnyCauTxE596vQdO9Z8R+Y49a0LdsDgexr3cBO8TCoXYR3PFbOiqvnDPK5xWPEeMYyK2NLGZkxnd1J6c17MV7pyxlaaO5h5hCc8j0qRMRuADhc5zWdbTPHtB6njPpV6KMu2T936VlFWZ9FGXNFW3LkyiRURTweSPWpbRDG4ffkE9aptH95u+OKowy3CyfeJTOcVqo3WhE6ihJNo7CJSzxKxBVfmOe9N1GQRfIuCGIJxzTNNkElq0j8Ad/pRC3mKzSqPlORWFrPU9Ny54JJ7laWGN7gGNmIToTVy3UtceaiFVRcls8/UVNHbMZUWBcLgF8+lX0KSLtG0K53EY6//WonV7Do4a7vLQfYxCO28+6Zt7dGJrFgjeS+YByM/dyOMf55rovMMzcqnlQjapboTVS9ktYWkuG27Io9qqOrMaxhJtvQ68TTioxs9vxM+4UbUSGNiCSzN3x70kdsWm3SPsCEZGc/U+9WrSVTFG7EqpwzqeM4/pSWUbie4wd0lwfkTsoNbczirdjh9mpNSWtwey8xjPNtFvJg4U8gf0qPUPLmuS0QAhhGEAHX61cv/OtXZJYyzEBUPUKexFUrwfbJ44beJ4kAG/nlsdTRF9RNW0buZ91HPfXUaIoyF+4vA+lW7O2mmiVX+UZ78dKtW6zQwSyCP51IaORTjbjuaexNwkkr/KQo2gcVfO3p0IjSjB876kMVswjklYgupxjpUOo21w6JIgkAI2gnoa1tOtVmKjeQSemOv41Pq8629i6GQuY2GVPJ59PSpjUakktTCqoTi9duhyGo2zxWY3Sbihxgdqw4grXEQmZ1hz+82Y3bfbPetHUbh33KmcHr+dUUXbkldxI6Z4rvgmlqeDXlGUvcRs2mmabeKz2Vhr80anaXQRkA+mcVU1TTksrhBHBe24ZdxS8xvPOM8dq2NG1GOK101JLqWFYzNBPCoOCJAcScenHvxVPxDKu62jFx9rmhgEU9wAcOwJx154GBXPTc1Vs7217/APDf8OjGVraFHRpFkmMMjlYip3An2rZs4JGtY40bfGrkLxx+FczJcCG5YxBQcbR3/Gum0SZG0uJdzHLZI7ZNZ4iP2kfT5ZUX8N7oknWITlX3FWA27aZDLH5MnlxOMJg56A5qS+UW3kPY9TkPnnBNPuFdkcQp5qxlcyKP51zppRPTmr1LLQn0XUWuC0RChguGYcnHqK1pRsRvK+aEp8244JPpWDDZSG6Zinl5wq7OK3opvkjinUMzDBOcnj19KyqtXutj0MHzKNp79x1tJcSW8KE+SW+RsHJcY/SuYvYV+3PHtxzwAeDzzXYm3BKo6ADP3gcbffisK6slaV1dl8xeQwOBjnrSpVLO4sVRc0orVlKSCKJv7odMbQeD9KpKhijul2HbJyCT2rTljb7PGG3F/wCH2qhczpJGAQ6sFPOOprrp3PHr8qfYz5olhCTEA7uSBVUTNMpC9UPFWmkM620RVggzz/jS3No8d3hVC7l49q2Ttozhmr6x2Klyhhg8x/lHcCs2SaCSBwcZHbOM1LrsksOYWbcrelc3KSgGOOxraEG1c8fFYhRnboVLkEsypkc8c4qJ12Jhjzg5OOlWd4GSwwT1yao3UykHHQcc1s9NzyHq7GZfzDLHqfWsqScbiCOtWr5wXJHHrms52BzXhYyvJPRno0aaSHyIkmCuNxqu0bLzjIxmjdzwcelSrL68fSvIm6NZ6qzN0mtiselGasvGrjK5HpzUDRsD61xV8POm77otSTGUUvQ0HiuUoQjNFHPajrQAopabThVp9BD4z82K0bc571mrwwxV62bmvay2fQyqI1bdSSM9xWvpswgfoMY4x3rKtmAjwMAdavRjJAxyOB7V9JT2POlJqR11lP8AaGAXgVtWZJwoVj71z+huqoBxn09K6zSpIlGGBJB7CspLldj6LBSVSKdyIQs5IOMeh9apLbZuSh4zz71rXU6q6jnrkiqE7ZmEw+8oxTpttam+IhBNdbGnEiiIRK5CirCxGNcBt+RmqWmkSu2/AJHArbt4llfBwAOCfas5ysddCiqlrFq1Lw2e1iBLIMbiegqpbOFSUkfMx2qfRRUwhlB+U5Ungt6VLMm0t5QHlgbAfX1NYJ/id8o3t5BGrCCNFBVeTnPeoMQywC3aHfIH3NLn26VOxDxMrYVcZOT+VVlVN0K84Iy3UYOe9VHQyq8raTRLFFHLPGXYLCDtAHcDrxWh5sC3AmjXMfKIQuCzVRkdZLmRkjAB/dgk4CjHXFTGFEtoS1wkbxBiCSct3zRPXdmcGo6pC3tw9xfIrIrxxZGAOrevtTT5YumBAXy0+YH161DB5ggHlbm3EyNkd/f2pI4p2ZnmCkMOidqpQVjOVbXTuE0xlwUVlRsKy9d3/wBar8TBrQLHDl93GV429KNSMK3iCKNokaPOw9sD9KiiuStpBJghgwAHbFJaxVgnq3I2xphj8+ZyYY4lDqw6Me4H0riNWvhIJgjZMrZ3Hstburak9xbTKrOkWPkEjZPviuSmaJtuM4A5zxzWuEpS+KZ5OY17OyVmQKVAcY3HGBkdPeogmfvMOOnHWrLR7Y8kEux7UW7NDMs0ajMZ3DcMjI9RXobbHhtmnbqLzQ7S1tbq1glid3mhmkEZkYn5XDHrgcY7VX8TTpPLbKbmO6uY4VS4uI/uyOCe/fAwM98VrWDPFpMVxLeaTbRyyOVW4td7E5yT0PH8qz/EVjcSI12LvT7gxRLIVtYjHiMnhwMYYZ61xQmlV17v7352/Upq8dDnNVlFxckqipwBtHSprHUzY2ciLGMk7lbOcfhVVizSEqPlzyTTZIvnYdOOgrslTjJcpvSxNSE3NPVnSpqLai9qGaNnRNzYXac+9akV4Y5ZAxZzI4LgcA4Fcroass67F3EKcgjjmuj8rasWHLuQBsxnFcNaEYux9Fl9ec4c/UvSzRfaYiMqxZSUXqTVm4ulgkYK4837zZxkmqZtTBCxkAMmfxXPOahezaO5RgxlAUbgw5IrmUYt3PY9tUS5er6l6N5mtIjMTtkfGC3KjPeo5bNjevEkn7okEHGeK1ZfI/sqSTcPMROV9B61mpc+dAZsEKuF9xWcU9bI3lOEmoylcztQeba0ZYN5Y3KTWe7O74yBkE/pWlKGQ+ayghvl+Y1XvUgSNZZnAB7Dsa6qe1kjycU0nzSZmQE9Rn3FOvrhxMhAJz39KIbqBWwCrl8gY7Go75iYGLgK4HFdHK+Y4JVoKm+VnN+IJ3edDuwQfzrDlun27SVPOORmr2pszyhtxPOPpWdOncgccc4rsSaVj5bEVOebZE5DYLqOOOOKz7uPMZMR3jngdRVm5kKcHj6isyctkkNg+tZVJJIzgm2mZd0Tg555qi30wK0biRWVw/3uMH8aouRjAGe1fNY6KlK6Z6dN6EbAY4pue1PbPpUdeRV9xm0QVip44FSCXnDVEelJWUa04bMdkPc88UzrRkdKB0qJy5ncYo70gooqAA0oopcYFVFAHerlsecVUFWoCODmvSwLtMzma9s3OAMVq22NoJ+7061i2+04B5xWtbnjb2xX1VB3POrI17CbySCeg5weuK7PRZ0lRPm+ma4iziVjzjk9T1FbNkdnKkg+1dMocysbYTESou51s6KJQyHIXtVOeJ5CX6AelV9Pnlnm2Mcrit1LXMOFHHY1zNezZ71OpHExbSKmlSbH3EKW6AV0EZSZQgwvds+tc68MkU64UjHt1rdiGUUbACRyW6/hWVZLRno4KbScWaU7loFQqCqDJx0rPMm0JtLFcFj6CrEdwscpRlDFuOfT6VXcjzAg4TOTjpisY9md9V2ScWS2dxEtrIjoTLKQFY9hUtxF5UkYHzrnOBzVYiRQJEOB1yamW3wj3EjZYJnGf0quVRd0cbnKolG2xI05dBtiUMxwoAzmoZ3+zuQAMIvJbr/nNWzKPssRMeEAPBPQ+tZMrtNKDs5J2rjngd6cFfcdaajoicTTMcKHZ9gyo6Ed6nFw42YbcxGXXOMYP60+z2JI7On7xkG0g9TmrCwwJBIZMNPgjA5/Km5K9jNUtpDT/piGeRl46BuuewHrS3UcFnHGGcMZBtdfTn0qoLkIUSTaUQjHHamkJNe/6T93BwCdvanGL67HJiql4pRZDqjtbwhZmV5HO2Mddg65PqaxYI1lUhiFLHljxVu6KvdM+AQpyAf61UO4yu2CoPOB0FdtKNkfP1qrm7PoSvGOCTuK9PpUZXZnaSBjkU8PuA2jIPbtShTIAp5rReZzSNPSo01DS4hqNtCbWF2WCeS58g5Jyyjg7hn24qHV55rVp7N7KOFpIEhhKSblSDOflP8AEWPVqkEdjc2VtDfSzxSWpYRSRIHDKxzgr6570usMjGyWCGVLeODZCZcbpF3HLHHTnPFcaj+81Xfvb5a216/1enKy0OYEZAIToTTAmZzgj0PvVgkD5FGAT19KgkYxvxzjqQP0rvEjU0Qi3vcvwso28Gupv4bSxWBp5QLl13Ax/Nx61x9tlkL96mlJYBiTjHTOa5qlDnle56NDMJUafs0btjqBuTcLcHfxhAR0qdoTFdqQWZWAyPwrnbGdIbhTIpkQn5lzjNaN3qkhnAtv3aKMDvj2rCeHbl7p6mGzOEKX7zcmfUj5i2yKoiU4P+1z3rX221zFIqny1VR8vqRXENK7yszZAznPrWzeaxDJp0UUETLMPvvu61VXD3sokYXM1BzlU+Qy/wBQiiijQRhmB67uMVzk0j392ecKegHapZVVlbIPHNUvJ2v8rOGPOR1rqhSUVoeTVxc60ve2KcsL2d5IA2MHOR3qxd3ss0Sgnpz0xmpJot2GY5cep61QmjfcdvC9xWqjY5ZT3S2ZQu2IVsjIJ4x61nsXdiMD6ntWje5O0hcjoQapSOUyCOtNnJN3ZlXWdxJz35NZly3HB7cVpXrEsCeg/Ksi7YE54rhxDsmbUVcz52YuQfWokOKdIfmqPdgZFfL1qlql2ejFaWHsQQagNOLEimmuCvUU3oXFWA9KSiiudu5QUZoo79KQAKBnNA556UUAKKXOTTaOlNOwDwcVYtjk496rVJCcMPrXbhanLUREloa8ByM9vatGAnIHOPSsq2YbuvArVtx0DZPfivq8O7q6OCsrGxYyfdzwR0rXhcn7+0H61hW7CPGMDgE/StSCbcg79jXoxZzxdjb0qRvP2qcZFdbau0RU53E8HmuHsXKvlSM9c1tC+kDoew7ZqKkOY9LC4j2Z14t/MjDOBjIqCSQxybQc4HUdqoWesSXC+SD16Cp13RykSNkY6+tcEoNOzPpsLXVRc0S5aOuJCwyQMZNQj5pSzEKAMYzTTlgETjdyxzSRQqkoaRvepirHTOTdlYkunKlI0Usdw3VYjaWV4wNxGc47fjTYEa4YuCQR1NWkjYxyGNeQMZBqnJbGUIPWS2ZGs7xPJCVVznHrj1q3bR7pTEgHkKvGR0qraBnm2gLtA5Pc+tbV3LCojghj2vj5j69/wqJPWyRnz8q5myhaIpumto+XJwB6E9TUjWLLM5VHJVCjN0HPemQQz207XxkjVg2WRj+lXtR1CaDY2wujndIg6YI6ZqW25JRMalR025S27EGs6Rb2OnJLLKPNXA471i6nqEVzLCsSERxoAQwGSfwqpq+qy3dyhwAVGAMZ4quMSI3QMT1A6110aLik5u7PGxOM5rxhomBAkkI2jZnJHTPtUc6ksx2hFHAAFTsy5UomFbsCTimZLtycIOcV0Hm6vUiiVAvzJnpjsaswIgdFd9iM3L9cD1xURUOVUhiOvHpVhUclURSxY7UTuTTkyWy+tjphGf7XwM8H7M3+NQ61JbH7GlrOZUgh8sybCuTuJ6H61J/YurMMHT7gY6Db0qvfWc1iEhu4jGxG4K45OTXNDlck+e/3fogd+xy87OXHlgnnNSQgYyx5J5Bq2kQyrAdSf/1UsyqgHyjjPXnFdorkohCQ5DEN0xUDdQGYAYz0zTIbp5DjYcJwDVyHaxII+b2pbDvYSJMBQQMjnPtTSwZmG4D8Kc5KE5/yKryFWHQ59qSQ0+o2cgQlQeD3FRkYgwMknn6U9FBYBwQOuBUc7rk7fu+1WO5DNIRwEJzx9KWGdEQtJyegFRSSFnAA6UyX5iOwHTmqSJEmJkYMvAPOOtVyQGOathlVQR95eMVWugAcg5pgZ1/tVD2PsKxJ33sM5IB61sXaliwByT0rGuE2k9ufx/GpkznnuZl2xJYHjHesW7cEYyM+lbF63DYzx61hXJ+avKxsmoux14dFXkkntUZ61I/QCozxXydWVj0EH0pMAUE8ijrXM2mMSjvRR3qBhj5utLSfnmloATtiiiigAoooFACinx8N1pgpwzWtJ2kJmlakjBz+FbNsTwwPbnPasK3PSti3JIGD1719dg5XicFdF/d8vy8VbtcghRnGfXrWeh3dcEH2q5b/ACMePrXpxZxnUafECq4IGevFXGiIQNyQOKw7W88sjJHHStuK+R1A/pVu5205U5R1FtpjFPuXIP5V1GmXMd0qibH59TXNSuCFAUnFS2c5jIKnB9xUzpqaOjD4l0J6PQ6uWIB8xZ8vpye1V4drXQaRT5Y6fWtEzWqaUpDZlYd6zrJhPLsZeMc1wpOKbZ9LGrGrazNC2G2OTYWbzDtGO1aSsYLAxlcyyHaB0wPWqI3RTxpGAAvNaVu5mlQSKGB7k/drKWurNZ3UbRJLaxSCQENyyZYHp+dOuLSY7LgkoHOSR6CtlNPWdo1YkhsHIHFJ4kmsbW3iUTsSpI2DvXMqzc0lq2KVSi467I58+ZqEjpsbbjkqPvGmXtobLT1kmmBVgf3bN3q5b6pFFZSJDCFnYgdc8EdawNauPtE4jiLmOMYzXXSjNys9Ejx8XXj8cGZHlgTMQBnH15qfCiEjABznI6//AKqQrsAXPBP40rpsO1Twema9BnhSdxu05wykEDt2zTmCDKqCTjkmpoEZiWY9egA61KsLY3MhUHofalzIltFOFTKxKLgrxUjIzBcZJB6Yqy0m07lAyBj6+lNgmfcHQskqnIbGCD7Ursm/UszTXF4UaUPvRAhcZBbHQt71BHD+9/eZbAwCc/1ro5b7W7hY5o0vR8gEmxDtY/3gMcViajcXE0v+ltK0yjH7wYIHpiuelJvSyXo/+ATLUwPNXzcnAVug6Gql4wYuB8u7qc1cCLIpViMgcfWmTQKqhT0xzXcmrlIq2QWNBzu3cYzz9atA5KiPhunJ6VAkAaQbNoUd6tQIZJBl2AHBAGKAZDcnAG4FW6de9VTIQ2VILL29auXCpuc8nHOargRecCgIBHORTRS2FUs3O3jvUF0vDFRhv0NXApCEg4BOKjIHLSD86Lh1MlNyuWwxx19qkKFyWyCv0qefbjEZHJqElo1HQCrTAikJGcY3VSuJS2RtxUhlPmsGzj1qCdiXJxhSeaaJexTmZgGw3I54rOnLMSc9R1qzdbi2VbBzggdqz5JDnuc9qmRzSbZk3w255rElIya2r5s81iSspOD+deJj5W2Z6GGWhWfBc0wVI64PXimHrXylZSUveO9CUDilpKwGFFFFIAoBJ6CiigAXvSdBmlo7UAKOe9FIOmKKADOO1Ozx3ptO7VpF2YmW7dsc9xzWpbtwCAcYzisa3bFalseuDzX02Aqc0Ec1WKNWCTBHtxWjEASMkEZrHtzhlJHHXitWGQeWQQMdzjvXt0pXPOmrMtBdoyQOvatSyYBck5HtWTFhlx0Pp2q5ZqzSYHQfrW6CDNpJQylQPcVJACrZ689+1VofkOCMH1q3ESeBgc0zdM0YZHAUHlc4wa2ba7SJ1/djkflWEHLAcc+lTxHhc53VnOCludNLEzpfCzrXntpYQd2JTjvTLmRoLcyq+CxwAD2rnnZlXAbmpd7SRoGclR61zrDpO53SzOdSHLI6u28US/ZY7eVe/wAxHXFZmt6ib+4JICxqPlwKLLT98Pmu4XI4zzxVSK3ifzjNL5ZUZUZ61EKVKEnKK1Mqk6rilLZjbWd1kbazEnoaHkOGwSDVcOCg2K2R3p1q3mtlj87fwmui3U89tskTa+3c2T6VIq/vCDggHj2qSO2EeWK5PQe1W0UEcALkYx6VLZlzJEsUUYXCodue55qnfK4OQcL2rQXarKAQBtzz3qtOwYnOdv8A9es4vUyi9blBAxdVJJ75/lWjabLa4SWVN6q6sy+oBpgTLKF644qzBGn2iAXH+qZ13+y55pzasU3qrFq7xd3Mkq61Dh2yN7urKOwKj09qrazcJL5IEv2loYhG87LjzDnr6+1W7q4V76Wz1eKGKI8QSwoB5Q/hYEdV6ZzUWsRGFbKByrEW/LIQQfmPOa5aTtKN/lttbyRc9E7HFLI4kZNm1j0PYDvTm3sjIqtgdM1aWAspfd8g/lUkK5VtynjnJFenzILlaK3JiQ4xjrmnTFogoBB/HpTp3dVIUHPJwKp225gWl+bHIB7U1qC1IGYuQu0jnipIGDysoJz0HHSrcUI3biBubmnPboqmQEZ68cUcy2C9iK4BiTkncPTvVOeXzk2gEZGakuSWJCg++aZFGhP3ju6896a0GZwhYuQWOe3pVhosKBzj261LcR7Se2PaoWL9CBj61QFS4g2MGBGaq3DBUODyeMe9aZYE5bBz0BrL1EDHA6c1RLehj3Dk7snv17Gs84LncD6VNcSOCwJyOnSqLPg5A/A1EnbQ5tWylqW0A4xye1YMmC1amoPknk1kSnJzXzmaTueph1aIgYA4NRsRnrQTzSV87WrOeh2JWCiikxXOMWg8UnSg9M0AAJzSnpSA0hoAUGlptFADqKRaWgApR1NJz60VSYEsRw1admQSFz75rKTqKvW7AEc817eW1OhhWjobUYAIIrRt3UquSCenPpWPCTgEH2q5bn5wCT+FfTU5WPMnE11HJI49hWhayBUBGc+1Z0QQoc/TOf5VetUGV78da6UZxbua1vLvzuHJ/WrK7Awy2CaqQltvH6UpOB159Ko6E2aiDaA2fpU0ZJUt6VkxyOQNrYB9a0LeTjD8kc80mUmXIyxA3EAfzqZk2xH5sn2qpEcydCVq4GzxwARnmpYM2tPvVliVJX2BRz71SmkR5pGC7snikghGzHJJFTW6KE9T6CseVRd0b1MTKcVF9CFIizbRjHfmnKPKkX27ipD+7lx2Ixmp0HUgZP060NnNzFi3+ZC0pyMflRGN7kj5FHem23cMDuIyM9KlQEcNge1ZvQyYjRPuJ3Z9MVXeIhcnkntnpWj5ZjXHJY9aqyQgNkHJ9DSi7ijK5JCCNrNyT0NDqz5bjjj6URHJAIJAHTtV+xKLdW/mqNhkUtnp171M5cupDdmVJdNuHVA5giduQskgRiO3FQtbvbKyupRwdu09q271Qt9C0r2qmP8A14mIyST8xIP3gR0xVXVWRXhDKQ/l8qeqrk7M+4XFY060pNJ9TSS926OUBwWx3HarVk25Sp6Giiu97DkRjiRsgH61TnlyuAoB5/SiiqiUR7mEmQatMB5ZoooluOWxVmOI3PHGDVFXL5Jxk96KK0QxyruXkmmToqocD3oooAoSN85PesvUJDtb64ooq0TLY5+/bqMe1ZbsQfrRRXPUMKZk3ZOT9azmJoor5bMm+Y9ejsM70meaKK8FnQBpMmiikAGiiipYBRRRSQBRRRTkAUZNFFNAGTSjtRRTAUHk1cgP3aKK9TL/AIjKoa1ofl/DNXoxn+dFFfWUtjzaho2jliR2ANX4HYZYNjPpRRXXHY50asDHb+lSZw5wBz1ooqzojsW40XbwOPSpmAGMUUUFdC1ExQDFWIWy4ooqGBoA7UOPSn2ZJAPrRRWb2ILM4Hl7iMkUkTk4XsOKKKgXQsg7ULAfN0qVmPlg8c9QR7UUVmyOoKxOPwqaQDIAGBRRSe5L3CSNUKMM5xTyAVUnqKKKnoZvW1xDfXKAKJc7DhSyhio9iRkVl3cjNOdxJJ5LE5Jooq4QinojeDb3P//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Examination with a Wood's lamp reveals coral red fluorescence in this patient with erythrasma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38321=[""].join("\n");
var outline_f37_27_38321=null;
var title_f37_27_38322="Nicotinamide (niacinamide): Drug information";
var content_f37_27_38322=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nicotinamide (niacinamide): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/20/9540?source=see_link\">",
"    see \"Nicotinamide (niacinamide): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F201127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vitamin, Water Soluble",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F201108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Pellagra (unlabeled use):",
"     </b>",
"     Oral: 100 mg every 6 hours for several days (or until resolution of major signs and symptoms), followed by 50 mg every 8-12 hours until skin lesions heal (Hegyi, 2004)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F201119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Pellagra (unlabeled use):",
"     </b>",
"     Oral: 10-50 mg every 6 hours until resolution of signs and symptoms (Hegyi, 2004)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F201109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F201090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 100 mg, 250 mg, 500 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F201078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F201091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Dietary supplement",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F14394605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Prophylaxis and treatment of pellagra",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F201133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Niacinamide may be confused with niacin, niCARdipine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F201095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to niacin, niacinamide, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Niacinamide may enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14394606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Water-soluble vitamins cross the placenta (IOM, 1998).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Niacinamide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $2.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $4.37",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Nicomide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750-25-1.5-0.5 mg (60): $163.68",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F201098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bepella (CZ);",
"     </li>",
"     <li>",
"      Farmobion Pp (IT);",
"     </li>",
"     <li>",
"      Micril PP (PT);",
"     </li>",
"     <li>",
"      Nicobion (CH, DE, FR);",
"     </li>",
"     <li>",
"      Nicotinamide (IT);",
"     </li>",
"     <li>",
"      Nicotinsaureamid Jenapharm (DE);",
"     </li>",
"     <li>",
"      Nicovitol (AT);",
"     </li>",
"     <li>",
"      Papulex (GB);",
"     </li>",
"     <li>",
"      Ucemine PP (BE, LU);",
"     </li>",
"     <li>",
"      Vitamin B3 (AU);",
"     </li>",
"     <li>",
"      Vitamina PP Angelini (IT);",
"     </li>",
"     <li>",
"      Vitaminum PP (PL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F201081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Used by the body as a source of niacin; is a component of two coenzymes which is necessary for tissue respiration, lipid metabolism, and glycogenolysis; does not have hypolipidemia or vasodilating effects.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F201094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 45 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 20-70 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Gugler R, &ldquo;Clinical Pharmacokinetics of Hypolipidaemic Drugs,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1978, 3(6):425-39.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/27/38322/abstract-text/363332/pubmed\" id=\"363332\" target=\"_blank\">",
"        363332",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hegyi J, Schwartz RA, and Hegyi V, &ldquo;Pellagra: Dermatitis, Dementia, and Diarrhea,&rdquo;",
"      <i>",
"       Int J Dermatol",
"      </i>",
"      , 2004, 43(1):1-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/27/38322/abstract-text/14693013/pubmed\" id=\"14693013\" target=\"_blank\">",
"        14693013",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B",
"      </i>",
"      <sub>",
"       6",
"      </sub>",
"      <i>",
"       , Folate, Vitamin B",
"      </i>",
"      <sub>",
"       12",
"      </sub>",
"      <i>",
"       , Pantothenic Acid, Biotin and Choline",
"      </i>",
"      , Washington, DC: National Academy Press, 1998.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      LeWitt PA, &ldquo;The Neurotoxicity of the Rat Poison Vacor. A Clinical Study of 12 Cases,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1980, 302(2):73-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/27/38322/abstract-text/6243167/pubmed\" id=\"6243167\" target=\"_blank\">",
"        6243167",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ovesen L, &ldquo;Vitamin Therapy in the Absence of Obvious Deficiency: What Is the Evidence?&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1984, 27(2):148-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/27/38322/abstract-text/6230219/pubmed\" id=\"6230219\" target=\"_blank\">",
"        6230219",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9696 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-4A54400AA2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38322=[""].join("\n");
var outline_f37_27_38322=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201127\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201108\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201119\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201109\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201090\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201078\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201091\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14394605\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201133\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201095\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299760\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221897\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14394606\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323490\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201098\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201081\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201094\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9696\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9696|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/20/9540?source=related_link\">",
"      Nicotinamide (niacinamide): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_27_38323="Interferon alfa-n3: Drug information";
var content_f37_27_38323=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"8\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Interferon alfa-n3: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?29/54/30564?source=see_link\">",
"    see \"Interferon alfa-n3: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alferon&reg; N",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F183333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alferon&reg; N",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F183345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Interferon",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F183336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Condylomata acuminata: Intralesional:  Inject 250,000 units (0.05 mL) in each wart twice weekly for a maximum of 8 weeks; therapy should not be repeated for at least 3 months after the initial 8-week course of therapy",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F183337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F183321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alferon&reg; N: 5 million units (1 mL) [contains albumin (human), chicken egg protein, mouse protein]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F183307\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088613.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088613.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F183323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inject into base of wart with a small 30-gauge needle",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F183322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients &ge;18 years of age: Intralesional treatment of refractory or recurring genital or venereal warts (condylomata acuminata)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F183353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Alferon&reg; may be confused with Alkeran&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F183343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Flu-like reactions, consisting of headache, fever, and/or myalgia, were reported in 30% of patients, and abated with repeated dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills, fatigue, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Decreased WBC",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Depression, dizziness, insomnia, malaise, thirst",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, dyspepsia, taste disturbance, tongue hyperesthesia, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Groin lymph node swelling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, cramps, paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Visual disturbance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Nose bleed, pharyngitis, rhinitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Increased sweating, vasovagal reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Photosensitivity. Rare adverse reactions reported with other alfa-interferons include autoimmune disorders, depression, ophthalmic disorders, suicide.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F183325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to alpha interferon or any component of the formulation; anaphylactic sensitivity to mouse immunoglobulin, egg protein, or neomycin",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F183311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Flu-like symptoms: Flu-like symptoms are common; may aggravate debilitating conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone marrow suppression: Use with caution in patients with severe myelosuppression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with pre-existing cardiac disease, including unstable angina, uncontrolled HF, or arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Coagulation disorders: Use with caution in patients with coagulation disorders (such as thrombophlebitis, pulmonary embolism, hemophilia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes with ketoacidosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pulmonary disease: Use with caution in patients with severe pulmonary disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been not established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Albumin: Contains albumin, which may carry a remote risk of transmitting Creutzfeldt-Jakob or other viral diseases.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Product variability:",
"     <b>",
"      Due to differences in dosage, patients should not change brands of interferons.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F183316\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Interferons (Alfa) may enhance the adverse/toxic effect of Aldesleukin. In particular, risks of myocardial and renal toxicity may be increased by this combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Interferons (Alfa) may increase the serum concentration of Methadone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ribavirin: Interferons (Alfa) may enhance the adverse/toxic effect of Ribavirin. Hemolytic anemia has been observed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Interferons may decrease the metabolism of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zidovudine: Interferons may enhance the adverse/toxic effect of Zidovudine. Interferons may decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F183318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F183327\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety and efficacy for use during pregnancy have not been established. Interferon alpha has been shown to decrease serum estradiol and progesterone levels in humans. Menstrual irregularities and abortion have been reported in animals. Effective contraception is recommended during treatment.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F183338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Alferon N Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5000000 units/mL (1 mL): $722.89",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F183328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Alferon N (CA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F183310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Interferons interact with cells through high affinity cell surface receptors. Following activation, multiple effects can be detected including induction of gene transcription. Inhibits cellular growth, alters the state of cellular differentiation, interferes with oncogene expression, alters cell surface antigen expression, increases phagocytic activity of macrophages, and augments cytotoxicity of lymphocytes for target cells",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Vial T and Descotes J, &ldquo;Clinical Toxicity of the Interferons,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1994, 10(2):115-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/27/38323/abstract-text/7516663/pubmed\" id=\"7516663\" target=\"_blank\">",
"        7516663",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8564 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-33CB703E27-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38323=[""].join("\n");
var outline_f37_27_38323=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183332\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183333\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183345\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183336\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183337\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183321\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183307\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874827\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183323\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183322\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183353\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183343\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183325\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183311\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299522\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183316\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183318\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183327\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183338\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323198\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183328\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183310\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8564\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8564|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?29/54/30564?source=related_link\">",
"      Interferon alfa-n3: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_27_38324="Anatomy of the liver - posterior view";
var content_f37_27_38324=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Anatomy of the liver - posterior view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is the posterior view of the liver. The left triangular ligament is a fold of peritoneal tissue that attaches the liver to the diaphragm. Division of the peritoneal attachment allows for access to the esophageal hiatus and intra-abdominal esophagus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38324=[""].join("\n");
var outline_f37_27_38324=null;
var title_f37_27_38325="Facial features of a patient with acromegaly";
var content_f37_27_38325=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Facial features of a patient with acromegaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 407px; height: 558px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A, B) Facial aspect of a patient with acromegaly. The nose is widened and thickened, the cheekbones are obvious, the forehead bulges, the lips are thick and the facial lines are marked. The forehead and overlying skin is thickened, sometimes leading to frontal bossing.",
"    <br>",
"     (C, D) Mandibular overgrowth leads to prognathism, maxillary widening, teeth separation and jaw malocclusion.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Chanson P, Salenave S. Acromegaly. Orphanet J Rare Dis 2008; 3:17. Copyright &copy; 2008 BioMed Central Ltd.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38325=[""].join("\n");
var outline_f37_27_38325=null;
var title_f37_27_38326="Face and brow presentations in labor";
var content_f37_27_38326=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Face and brow presentations in labor",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38326/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38326/contributors\">",
"     Svena Julien, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38326/contributors\">",
"     France Galerneau, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38326/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38326/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38326/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38326/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/27/38326/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;At term, the fetal spine typically lies along the longitudinal axis of the uterus, as this lie best accommodates the relatively long torso of the fetus within the uterine cavity and positions the fetus for egress into the birth canal. The fetus usually maneuvers to accommodate the breech and flexed legs in the broad uterine fundus and the head in the narrower lower uterine segment. This seems to allow the best fit in the available intrauterine space. During labor, presentation is further defined by the part of the fetus that leads into the birth canal: vertex (occiput), face, brow, breech (frank, footling, complete), shoulder, or compound (a limb and head or breech). Fetuses in transverse or oblique lie have no presenting part descending into the birth canal.",
"   </p>",
"   <p>",
"    Determining fetal presentation is a crucial step in the evaluation of the laboring gravida. The fetal presentation is usually identified during the course of labor by internal examination through the dilating cervix. The occiput is smooth and hard, while the face, brow, breech, and fetal extremities tend to be soft",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    have a more irregular contour. Identification of malpresentations through the undilated cervix or myometrium prior to labor is possible, but challenging and less reliable because maternal tissues obscure the fetal landmarks denoting presentation.",
"   </p>",
"   <p>",
"    Diagnosis and management of face and brow presentations will be reviewed here. Breech and compound presentations and transverse lie are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13448?source=see_link\">",
"     \"Overview of breech presentation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/43/7858?source=see_link\">",
"     \"Management of the fetus with compound presentation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22662?source=see_link\">",
"     \"Management of the fetus in transverse lie\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20401540\">",
"    <span class=\"h1\">",
"     INCIDENCE OF MALPRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common fetal presentation in labor is vertex, which occurs in 96 percent of fetuses at term; 91.4 percent of fetuses present in vertex occiput anterior (OA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/1\">",
"     1",
"    </a>",
"    ]. Fetuses that are not in vertex OA presentation are considered to have a malpresentation. At term, the types and estimated incidences of malpresentations are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/1-7\">",
"     1-7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Breech",
"      <span class=\"nowrap\">",
"       (1/33",
"      </span>",
"      deliveries)",
"     </li>",
"     <li>",
"      Cephalic malpresentations",
"      <span class=\"nowrap\">",
"       (1/18",
"      </span>",
"      deliveries)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vertex occiput posterior",
"      <span class=\"nowrap\">",
"       (1/19",
"      </span>",
"      deliveries)",
"     </li>",
"     <li>",
"      Face",
"      <span class=\"nowrap\">",
"       (1/600",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       1/800",
"      </span>",
"      deliveries)",
"     </li>",
"     <li>",
"      Brow",
"      <span class=\"nowrap\">",
"       (1/500",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       1/4000",
"      </span>",
"      deliveries)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compound",
"      <span class=\"nowrap\">",
"       (1/1500",
"      </span>",
"      deliveries)",
"     </li>",
"     <li>",
"      Transverse lie",
"      <span class=\"nowrap\">",
"       (1/833",
"      </span>",
"      deliveries)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The incidence of face presentation at Parkland Memorial Hospital has decreased to",
"    <span class=\"nowrap\">",
"     1/2000",
"    </span>",
"    deliveries in recent years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/8\">",
"     8",
"    </a>",
"    ], possibly due to fewer deliveries of fetuses with anomalies such as anencephaly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]; however, others have not observed a decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20401860\">",
"    <span class=\"h1\">",
"     CONSEQUENCES OF MALPRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most efficient way for the fetus to negotiate the birth canal is in vertex presentation. With this presentation, the biparietal plane of the fetal head enters the pelvic inlet (called &lsquo;engagement&rsquo;) during labor, although sometimes this occurs antepartum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/8\">",
"     8",
"    </a>",
"    ]. As the head continues to descend beyond the pelvic inlet, pressure and resistance from maternal soft tissues cause the fetal neck to flex so that the chin comes into contact with the chest. Flexion allows the head to have room to descend the length of the birth canal whether the head is occiput anterior or occiput posterior. The remaining cardinal movements of labor follow: internal rotation and extension of the neck, external rotation (restitution), and finally complete expulsion of the fetus.",
"   </p>",
"   <p>",
"    By the comparison, the neck of the fetus in face or brow presentation is deflexed (extended backwards) (",
"    <a class=\"graphic graphic_figure graphicRef78180 \" href=\"mobipreview.htm?29/9/29840\">",
"     figure 1",
"    </a>",
"    ). The wider head diameters that present when the neck is deflexed inhibit head engagement and subsequent fetal descent (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Course and management of labor'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     FACE PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In face presentation the fetal neck is sharply deflexed, allowing the occiput to touch the back and the face (from forehead to chin) to present in the birth canal (",
"    <a class=\"graphic graphic_figure graphicRef77290 \" href=\"mobipreview.htm?25/16/25856\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Etiology and risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of face presentation is unknown. It is presumed to occur because of factors that favor extension or prevent flexion of the fetal neck. A common risk factor is an anomalous fetus, particularly one with anencephaly, massive hydrocephalus, or an anterior neck mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/7\">",
"     7",
"    </a>",
"    ]. Multiple nuchal cord loops may also prevent flexion of the head [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/2\">",
"     2",
"    </a>",
"    ], although the majority of fetuses with multiple loops of nuchal cord do not have a malpresentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. Other factors that have been associated with face presentation include cephalopelvic disproportion,",
"    <span class=\"nowrap\">",
"     prematurity/low",
"    </span>",
"    birth weight, macrosomia, contracted maternal pelvis, platypelloid pelvis (",
"    <a class=\"graphic graphic_figure graphicRef58301 \" href=\"mobipreview.htm?13/63/14324\">",
"     figure 3",
"    </a>",
"    ), polyhydramnios, previous cesarean delivery, black race, and multiparity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/9-12\">",
"     9-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extreme laxity of the anterior abdominal wall may predispose multiparous women to fetal malpresentation. Lack of muscle tone may permit the uterine fundus and fetal trunk to swing anteriorly, which may extend the cervical spine, leading to a face or brow presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/11\">",
"     11",
"    </a>",
"    ]. Others have suggested that the higher rate of face (and brow) presentation in multiparous women may be due, in part, to later engagement of the vertex in these women, often after the onset of labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/10\">",
"     10",
"    </a>",
"    ]. The association with polyhydramnios may be a secondary effect of impaired swallowing due to obstruction of the fetal trachea and esophagus from a hyperextended fetal neck [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. Polyhydramnios also occurs with fetal anomalies associated with face presentation, particularly anencephaly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/10\">",
"     10",
"    </a>",
"    ]. The increased frequency of prior cesarean delivery in pregnancies with face and brow presentation may be explained by a contracted maternal pelvis, which predisposes to both dystocia and malpresentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/10\">",
"     10",
"    </a>",
"    ]. Black race has also been associated with face presentation, possibly due to differences in pelvic shape and a higher rate of prematurity in black women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/11\">",
"     11",
"    </a>",
"    ]. Prematurity has been linked to face presentation, possibly because a very small fetus can descend with the neck partially extended; however, the association between prematurity and face presentation is weak [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of face presentation is usually made late in the first stage or in the second stage of labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. On digital examination, landmarks indicating a face presentation are the ability to palpate the orbital ridge and orbits, saddle of the nose, mouth, and chin (",
"    <a class=\"graphic graphic_figure graphicRef69905 \" href=\"mobipreview.htm?8/62/9187\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Sonography of a face presentation will show a hyperextended fetal neck. Although imaging studies can be performed to confirm the diagnosis if it is uncertain or internal examination cannot be done, imaging is not mandatory and results do not have prognostic value for predicting the outcome of labor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92676049\">",
"    <span class=\"h3\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A face may be mistaken for a breech on blind digital examination since the latter is more commonly encountered (and therefore expected) and both are comprised of soft tissues with an orifice. Careful palpation will reveal the bony facial structures and lead to the correct diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Course and management of labor",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the time of diagnosis, nearly 60 percent of face presentations will be in the mentum anterior position, 26 percent will be mentum posterior, and 15 percent will be mentum transverse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/9\">",
"     9",
"    </a>",
"    ]. Thirty to 50 percent of fetuses in mentum posterior and mentum transverse positions will spontaneously convert to the mentum anterior position during the course of labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/9\">",
"     9",
"    </a>",
"    ]. This is important since at term only mentum anterior face presentations are likely to deliver vaginally (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Mentum anterior'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H8\">",
"     'Mentum posterior'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    The management of face presentation requires close observation of the progress of labor because cephalopelvic disproportion is more likely than with vertex presentation. As noted above, during labor in the vertex presentation, flexion of the neck normally brings the chin to the chest, resulting in the relatively small suboccipitobregmatic diameter (average length 11.9 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/13\">",
"     13",
"    </a>",
"    ]) as the widest diameter negotiating the maternal pelvis. This diameter is able to traverse the obstetrical conjugate.",
"   </p>",
"   <p>",
"    By comparison, the widest diameter of the fetal head negotiating the pelvis in face presentation is the trachelo-bregmatic or trachelo-parietal diameter (also called trachelo- or submento-parietal; average length 12.6 cm), which is 0.7 cm greater than the suboccipito-bregmatic diameter (average length 11.9 cm) of a normally flexed vertex presentation (",
"    <a class=\"graphic graphic_figure graphicRef59887 \" href=\"mobipreview.htm?5/30/5600\">",
"     figure 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/13\">",
"     13",
"    </a>",
"    ]. Despite the increased diameter, over 75 percent of mentum anterior fetuses are delivered vaginally, whereas persistent mentum posterior and transverse fetuses require cesarean birth (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Mentum anterior'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H8\">",
"     'Mentum posterior'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/2,3,11,14,15\">",
"     2,3,11,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abnormalities of the fetal heart rate occur more frequently with face presentations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/4,14,16\">",
"     4,14,16",
"    </a>",
"    ]. In one series, for example, severe variable and late decelerations developed in 29 and 24 percent of labors, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/16\">",
"     16",
"    </a>",
"    ]. Only 14 percent of patients had normal tracings. Moreover, 13 percent of the infants had a low five-minute Apgar score. For this reason, these fetuses should be continuously monitored during labor, ideally with an external device. An internal device may cause facial or ophthalmic injuries if improperly placed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. If internal monitoring is needed, the electrode should be cautiously applied over a bony structure such as the forehead, mandible, or zygomatic bones to minimize the risk of trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Mentum anterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once engagement has occurred in a mentum anterior face presentation, the fetal neck extends even further backward such that the occiput touches the back. Internal rotation occurs between the level of the ischial spines and ischial tuberosities, making the chin the actual presenting part of the face [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. As the face descends onto the perineum, the fetal chin passes under the maternal symphysis pubis, slight flexion of the neck occurs, and delivery is possible via maternal expulsive forces.",
"   </p>",
"   <p>",
"    The parturient may begin pushing at full dilatation.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"     Oxytocin",
"    </a>",
"    augmentation may be given if indicated and the fetal heart rate pattern is reassuring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/14\">",
"     14",
"    </a>",
"    ]. Outlet forceps should only be used by experienced practitioners. Since engagement does not occur until the face is at +2 station, forceps should only be applied to the face that is bulging the perineum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. Attempts at version, extraction, or midforceps delivery should be avoided, as they are associated with unnecessary maternal trauma and neonatal injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Mentum posterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the mentum posterior position, the neck, head, and shoulders must enter the pelvis simultaneously; however, the pelvis is usually not large enough to accommodate the fetal trunk in this position. In addition, the fetal neck must extend the length of the maternal sacrum (average 12 cm) in order to reach the perineum, but the fetal neck is too short to accomplish this task. Lastly, an open fetal mouth may act as a fulcrum against the sacrum preventing further descent. Therefore, the mentum posterior face presentation will",
"    <strong>",
"     not",
"    </strong>",
"    deliver vaginally unless spontaneous rotation occurs or the fetus is very small (eg, very preterm) (",
"    <a class=\"graphic graphic_figure graphicRef59795 \" href=\"mobipreview.htm?22/59/23475\">",
"     figure 6",
"    </a>",
"    ). In one series, 11 of 12 fetuses in the mentum transverse position and 2 of 10 patients with mentum posterior delivered vaginally after spontaneous rotation to mentum anterior [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the past, manual conversion of the mentum posterior face to a vertex or mentum anterior position was attempted using internal and external manipulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Although some operators have been successful with no significant neonatal or maternal complications, others have described cases of maternal death from uterine rupture, neonatal asphyxia secondary to cord prolapse, and devastating neonatal neurologic sequelae from cervical spine trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/19\">",
"     19",
"    </a>",
"    ]. Given the safety and ready availability of cesarean delivery, there is little justification currently for use of internal version. This procedure should be reserved for occasions when an operative delivery is unable to be accomplished due to lack of surgical facilities and inability to arrange maternal transport, or absolute maternal refusal to allow a cesarean birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Neonatal outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to 1955, increased rates of intrapartum fetal death and perinatal mortality (approximately 10 percent) were reported with face presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. Perinatal mortality decreased to 2 to 3 percent by 1980, likely due to the increased use of cesarean delivery, as well as other advances in obstetrical and neonatal care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonates who were in face presentation often have significant facial edema and skull molding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/8\">",
"     8",
"    </a>",
"    ]. This usually resolves within the first 24 to 48 hours of life. Difficulty in ventilation during resuscitation has been reported and attributed to tracheal and laryngeal trauma and edema. Therefore, equipment and personnel to perform endotracheal intubation should be readily available at the time of delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Facial trauma and spinal cord injury have also been described in case reports, and often involve version, extraction and midforceps rotations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/2,16,18,22\">",
"     2,16,18,22",
"    </a>",
"    ]. Appropriate management of face presentation, as described above, typically does not result in increased serious maternal or neonatal morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     BROW PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetus in the brow presentation occupies a longitudinal axis with the fetal neck extended, but not to the degree in face presentation (",
"    <a class=\"graphic graphic_figure graphicRef77290 \" href=\"mobipreview.htm?25/16/25856\">",
"     figure 2",
"    </a>",
"    ). The area presenting in the birth canal typically extends from the anterior fontanelle to the brow (orbital ridge), but does not include the mouth and chin. The brow presentation is often a transitional state: further neck extension leads to a face presentation or neck flexion results in vertex presentation in 50 percent of cases. Persistent brow presentation is not compatible with vaginal birth unless the fetus is very small.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Etiology and risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of brow presentation is unclear. A contracted pelvis is the most consistent risk factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. It is possible that fetuses delivered from the occiput posterior position were brow presentations at the onset of labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of brow presentation is usually made late in the second stage of labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. On digital examination, landmarks indicating brow presentation are the ability to palpate the forehead, saddle of the nose, and orbits. Face presentation is excluded because the mouth and chin are not palpable. The brow may be anterior or posterior (",
"    <a class=\"graphic graphic_figure graphicRef55580 graphicRef69371 \" href=\"mobipreview.htm?43/14/44260\">",
"     figure 7A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If the diagnosis is uncertain after physical examination, ultrasound may be helpful. In a case report of suspected brow presentation, ultrasound showed that the fetal orbits were just below the symphysis pubis, which differs from a typical occipito-posterior presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Course and labor management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The head in brow presentation engages transversely at the pelvic brim. As the fetus descends into the birth canal, internal rotation to brow anterior occurs and causes the occiput to become wedged in the sacral hollow. Downward pressure from uterine contractions and maternal pushing force the mentum to extend further anteriorly, resulting in a mentum anterior face presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ]. Alternatively, internal rotation may rotate the face to under the symphysis pubis and the neck may flex to the vertex occiput posterior position. Conversion to occiput anterior is rare.",
"   </p>",
"   <p>",
"    If internal rotation does not occur, the mento-parietal diameter presents at the pelvic inlet and must pass through it for engagement to occur. The mento-parietal (or mento-bregmatic) diameter is the largest diameter of the fetal head (13.4 cm), 0.8 cm wider than the trachelo-parietal diameter (12.6 cm) of the face presentation and nearly 1.5 cm wider than the suboccipito-bregmatic diameter (11.9 cm) of the vertex presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/13\">",
"     13",
"    </a>",
"    ]. Therefore, the possibility of dysfunctional, prolonged labor and cephalopelvic disproportion is high if this presentation persists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5,13\">",
"     5,13",
"    </a>",
"    ]. Successful vaginal delivery of a persistent brow presentation is only possible in an extremely small or macerated infant, or with an unusually large maternal pelvis.",
"   </p>",
"   <p>",
"    Women with a clinically adequate or proven pelvis can be allowed to labor since a large proportion will deliver vaginally. In one review, when brow presentation was diagnosed early in labor, 67 to 75 percent of fetuses spontaneously converted and delivered vaginally; when diagnosed late in labor, 50 percent spontaneously converted (30 percent converted to a face presentation and 20 percent converted to vertex presentation) and delivered vaginally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. Labor should be monitored closely, with cesarean delivery if progress is protracted or arrested. Vaginal delivery is less likely when the pelvis is narrow or contracted, so cesarean delivery early in labor is a reasonable option for these women.",
"   </p>",
"   <p>",
"    Patients in spontaneous labor are followed with continuous fetal heart rate monitoring and frequent assessment of progress. The diagnosis of persistent brow presentation and protracted or arrested labor necessitates an abdominal delivery;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    augmentation is not recommended given the association between brow presentation and cephalopelvic disproportion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5,14,20\">",
"     5,14,20",
"    </a>",
"    ]. Version is not recommended, as the risk of perinatal mortality or uterine rupture is high [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92676529\">",
"    <span class=\"h2\">",
"     Neonatal outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recognition and appropriate management of brow presentation, as described above, typically do not result in increased serious maternal or neonatal morbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fetus in face or brow presentation has a deflexed (extended backward) neck, which inhibits head engagement and subsequent fetal descent. (See",
"      <a class=\"local\" href=\"#H20401860\">",
"       'Consequences of malpresentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Face and brow presentations are associated with multiparity, cephalopelvic disproportion, prematurity, polyhydramnios, and fetal anomalies (eg, anencephaly, anterior neck mass). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology and risk factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Etiology and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the face presentation with the mentum anterior or transverse, we suggest that labor be allowed to progress.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"       Oxytocin",
"      </a>",
"      augmentation may be used in the setting of a normal fetus with abnormally slow progress, as long as the fetal heart rate pattern remains reassuring. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Mentum anterior'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The face presentation in persistent mentum posterior will not deliver vaginally; therefore, abdominal delivery is indicated. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Mentum posterior'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is an increased risk for fetal trauma with face presentations. Maternal and perinatal mortality and morbidity associated with these abnormal presentations are probably not increased if there is liberal use of cesarean delivery. Internal manipulation can be traumatic and should be avoided. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Neonatal outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The brow presentation is often a transitional state. Fifty percent of brow presentations will spontaneously convert to a face or vertex presentation. Therefore, we suggest that spontaneous labor be allowed to progress, with close monitoring and delivery by cesarean when an arrest of progress is diagnosed. Persistent brow presentation is not compatible with vaginal birth unless the fetus is very small. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Course and labor management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest continuous intrapartum fetal heart rate monitoring using an external monitoring device for malpresenting fetuses, as there is an increased risk of nonreassuring patterns with malpresentations. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Course and management of labor'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/1\">",
"      Gardberg M, Leonova Y, Laakkonen E. Malpresentations--impact on mode of delivery. Acta Obstet Gynecol Scand 2011; 90:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/2\">",
"      Duff P. Diagnosis and management of face presentation. Obstet Gynecol 1981; 57:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/3\">",
"      Ducarme G, Ceccaldi PF, Chesnoy V, et al. [Face presentation: retrospective study of 32 cases at term]. Gynecol Obstet Fertil 2006; 34:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/4\">",
"      Bhal PS, Davies NJ, Chung T. A population study of face and brow presentation. J Obstet Gynaecol 1998; 18:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/5\">",
"      Cruikshank DP, Cruikshank JE. Face and brow presentation: a review. Clin Obstet Gynecol 1981; 24:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/6\">",
"      Weissberg SM, O'Leary JA. Compound presentation of the fetus. Obstet Gynecol 1973; 41:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/7\">",
"      Ing&oacute;lfsson A. Brow presentations. Acta Obstet Gynecol Scand 1969; 48:486.",
"     </a>",
"    </li>",
"    <li>",
"     Williams Obstetrics, 23rd Ed, Cunningham, FG, Leveno, KJ, Bloom, JC, et al (Eds), McGraw-Hill, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/9\">",
"      Cruikshank DP, White CA. Obstetric malpresentations: twenty years' experience. Am J Obstet Gynecol 1973; 116:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/10\">",
"      Bashiri A, Burstein E, Bar-David J, et al. Face and brow presentation: independent risk factors. J Matern Fetal Neonatal Med 2008; 21:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/11\">",
"      Shaffer BL, Cheng YW, Vargas JE, et al. Face presentation: predictors and delivery route. Am J Obstet Gynecol 2006; 194:e10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/12\">",
"      Zayed F, Amarin Z, Obeidat B, et al. Face and brow presentation in northern Jordan, over a decade of experience. Arch Gynecol Obstet 2008; 278:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/13\">",
"      BORELL U, FERNSTROM I. The mechanism of labour in face and brow presentation. A radiological study. Acta Obstet Gynecol Scand 1960; 39:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/14\">",
"      Schwartz Z, Dgani R, Lancet M, Kessler I. Face presentation. Aust N Z J Obstet Gynaecol 1986; 26:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/15\">",
"      Westgren M, Svenningsen NW. Face presentation in modern obstetrics--a study with special reference to fetal long term morbidity. Z Geburtshilfe Perinatol 1984; 188:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/16\">",
"      Benedetti TJ, Lowensohn RI, Truscott AM. Face presentation at term. Obstet Gynecol 1980; 55:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/17\">",
"      Lauer AK, Rimmer SO. Eyelid laceration in a neonate by fetal monitoring spiral electrode. Am J Ophthalmol 1998; 125:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/18\">",
"      Miyashiro MJ, Mintz-Hittner HA. Penetrating ocular injury with a fetal scalp monitoring spiral electrode. Am J Ophthalmol 1999; 128:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/19\">",
"      Vialle R, Pi&eacute;tin-Vialle C, Ilharreborde B, et al. Spinal cord injuries at birth: a multicenter review of nine cases. J Matern Fetal Neonatal Med 2007; 20:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/20\">",
"      Levy DL. Persistent brow presentation: a new approach to management. South Med J 1976; 69:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/21\">",
"      Neuman M, Beller U, Lavie O, et al. Intrapartum bimanual tocolytic-assisted reversal of face presentation: preliminary report. Obstet Gynecol 1994; 84:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/22\">",
"      Vialle R, Pi&eacute;tin-Vialle C, Vinchon M, et al. Birth-related spinal cord injuries: a multicentric review of nine cases. Childs Nerv Syst 2008; 24:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/23\">",
"      Jennings PN. Brow presentation with vaginal delivery. Aust N Z J Obstet Gynaecol 1968; 8:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38326/abstract/24\">",
"      Lau WL, Leung WC, Chin R. Intrapartum translabial ultrasound demonstrating brow presentation during the second stage of labor. Int J Gynaecol Obstet 2009; 107:62.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4442 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-D201336892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38326=[""].join("\n");
var outline_f37_27_38326=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20401540\">",
"      INCIDENCE OF MALPRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20401860\">",
"      CONSEQUENCES OF MALPRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      FACE PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Etiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H92676049\">",
"      - Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Course and management of labor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Mentum anterior",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Mentum posterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Neonatal outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      BROW PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Etiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Course and labor management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92676529\">",
"      Neonatal outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/4442\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/4442|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/9/29840\" title=\"figure 1\">",
"      Longitudinal lie cephalic presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/16/25856\" title=\"figure 2\">",
"      Brow presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/63/14324\" title=\"figure 3\">",
"      Maternal pelvic types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/62/9187\" title=\"figure 4\">",
"      Left right face positions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/30/5600\" title=\"figure 5\">",
"      Diameters of the vertex brow and face presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/59/23475\" title=\"figure 6\">",
"      Rotation mentum posterior to anterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/6/16480\" title=\"figure 7A\">",
"      Brow anterior presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/38/7776\" title=\"figure 7B\">",
"      Brow posterior presentation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22662?source=related_link\">",
"      Management of the fetus in transverse lie",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/43/7858?source=related_link\">",
"      Management of the fetus with compound presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13448?source=related_link\">",
"      Overview of breech presentation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_27_38327="Respiratory syncytial virus infection: Treatment";
var content_f37_27_38327=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Respiratory syncytial virus infection: Treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     Frederick E Barr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     Barney S Graham, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38327/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/27/38327/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) causes acute respiratory tract illness in persons of all ages. Almost all children are infected by two years of age, and reinfection is common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/1\">",
"     1",
"    </a>",
"    ]. The clinical manifestations vary with age, health status, and whether the infection is primary or secondary.",
"   </p>",
"   <p>",
"    The treatment of respiratory syncytial virus infection will be discussed here. The epidemiology, microbiology, clinical manifestations, diagnosis, and prevention of RSV infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7050?source=see_link\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/17/15640?source=see_link\">",
"     \"Respiratory syncytial virus infection: Prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The discussion that follows assumes that the patient's illness is severe enough to require hospital admission or to pursue an etiologic diagnosis since specific etiologic diagnosis is usually not sought in otherwise healthy patients with mild respiratory tract infections who are treated symptomatically as outpatients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7050?source=see_link&amp;anchor=H25#H25\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Outpatient treatment for patients with upper respiratory tract infections, bronchiolitis, or pneumonia who do not have a specific microbiologic diagnosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=see_link\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=see_link&amp;anchor=H3#H3\">",
"     \"Outpatient treatment of community-acquired pneumonia in children\", section on 'Empiric therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13146?source=see_link&amp;anchor=H199065563#H199065563\">",
"     \"The common cold in children: Treatment and prevention\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Therapy for respiratory syncytial virus infection of the lower respiratory tract is primarily supportive. Bronchodilators may help to relieve lower airway obstruction in some patients but should not be continued in patients who fail to demonstrate rapid improvement. Antiviral agents are available, but their use is not indicated in most patients. More aggressive therapy, including immunotherapy, or antiviral and immunotherapy with or without corticosteroids may be warranted for immunocompromised patients, as described below. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Ribavirin'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H14\">",
"     'Passive immunotherapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H15\">",
"     'Combination therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SUPPORTIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supportive care for children with respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) may include hospitalization and fluid and respiratory support. The supportive care and inpatient treatment for bronchiolitis and pneumonia are discussed in detail separately. Important aspects of care and those specific to children with RSV will be summarized below. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=see_link&amp;anchor=H5#H5\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Supportive care'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H6#H6\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Supportive care'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Respiratory support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with RSV bronchiolitis and pneumonia frequently have arterial oxygen saturations of &le;90 percent. Infants whose oxygen saturation is consistently &le;90 percent should be treated with supplemental oxygen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/24/27014?source=see_link\">",
"     \"Continuous oxygen delivery systems for infants, children, and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The frequency of mechanical ventilation required for respiratory failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    apnea in patients infected with RSV varies according to their age and underlying health status, as illustrated below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Mechanical ventilation is required in:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 5 percent of infants hospitalized with RSV",
"     </li>",
"     <li>",
"      Twenty percent of children with underlying congenital heart disease, bronchopulmonary dysplasia (BPD, also called chronic lung disease [CLD]), or immunosuppression",
"     </li>",
"     <li>",
"      Ten percent of elderly institutionalized patients hospitalized because of RSV",
"     </li>",
"     <li>",
"      Twenty percent of patients infected after lung transplant",
"     </li>",
"     <li>",
"      Fifty percent of patients with leukemia who are myelosuppressed at the time of infection",
"     </li>",
"     <li>",
"      Up to 70 percent of persons infected in the period immediately after bone marrow transplantation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PHARMACOTHERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Bronchodilators",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest a trial (single administration) of therapy with a beta-agonist (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    or epinephrine) if lower airway obstruction is clinically apparent (ie, in patients who are wheezing). Therapy should be discontinued in patients who fail to demonstrate rapid improvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/5\">",
"     5",
"    </a>",
"    ]. For patients who improve with inhaled albuterol or epinephrine, bronchodilator therapy can be administered every four to six hours and continued until the signs and symptoms of respiratory distress improve. Patients who continue to require inhalation therapy after discharge from the hospital should be treated with albuterol.",
"   </p>",
"   <p>",
"    Many patients with or without underlying asthma or other lung disease associated with airway reactivity develop clinical signs of airway obstruction during respiratory syncytial virus (RSV) infection. Wheezing occurs in as many as 80 percent of children hospitalized with RSV bronchiolitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/6\">",
"     6",
"    </a>",
"    ], 50 percent children of with outpatient bronchiolitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/6\">",
"     6",
"    </a>",
"    ], and approximately 35 percent of elderly patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 50 percent of infants with RSV-induced lower airway obstruction and respiratory failure respond to inhaled beta-agonists (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    or epinephrine), but there is no reliable method for predicting which patients will respond [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/7\">",
"     7",
"    </a>",
"    ]. The efficacy of bronchodilators among patients with less severe bronchiolitis is uncertain. Evidence from large randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/8\">",
"     8",
"    </a>",
"    ], meta-analyses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], and systematic reviews [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/11-13\">",
"     11-13",
"    </a>",
"    ] does not support benefit from bronchodilator therapy in infants with bronchiolitis. Nonetheless, because individual patients may respond, a trial of beta agonist therapy is warranted if lower airway obstruction is clinically apparent.",
"   </p>",
"   <p>",
"    The use of bronchodilators in children with bronchiolitis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=see_link&amp;anchor=H14#H14\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Inhaled bronchodilators'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend against the use of corticosteroids in infants with RSV bronchiolitis or pneumonia. In older children and adults, corticosteroids may be beneficial in the management of RSV-associated bronchial reactivity, particularly in those with asthma, in whom RSV reinfection may have triggered an exacerbation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/16/33034?source=see_link\">",
"     \"Acute asthma exacerbations in children: Outpatient management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Corticosteroids have the potential to decrease bronchiolar swelling and airway obstruction through their antiinflammatory effects. However, in randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], meta-analyses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/16\">",
"     16",
"    </a>",
"    ], and systematic reviews [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/11,12\">",
"     11,12",
"    </a>",
"    ], they have not been shown to be beneficial for the treatment of bronchiolitis. Data are limited on the use of corticosteroids in patients with bronchiolitis who require mechanical ventilation.",
"   </p>",
"   <p>",
"    The use of corticosteroids in the treatment of bronchiolitis in children is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=see_link&amp;anchor=H19511330#H19511330\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Systemic glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ongoing studies are evaluating the value of corticosteroid therapy in combination with passively administered antiviral immunoglobulin, particularly in immune-compromised patients, as discussed below. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Combination therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Bronchodilators plus corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combination therapy with bronchodilators and corticosteroids in infants with bronchiolitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=see_link&amp;anchor=H403690435#H403690435\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Bronchodilators plus glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H655542266\">",
"    <span class=\"h2\">",
"     Hypertonic saline",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of hypertonic saline in the treatment of RSV bronchiolitis in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=see_link&amp;anchor=H403690771#H403690771\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Hypertonic saline'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ribavirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     Ribavirin",
"    </a>",
"    is a nucleoside analog with good in vitro activity against RSV. Ribavirin is approved by the United States Food and Drug Administration (FDA) for the treatment of RSV infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     In children",
"    </span>",
"    &nbsp;&mdash;&nbsp;The routine use of nebulized",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    in infants and children with RSV lower respiratory tract infection (LRTI) is not recommended. The efficacy of ribavirin in this population has not been clearly proven [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. In addition, ribavirin is expensive and must be given early in the course to be effective, and there are concerns regarding occupational exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Randomized controlled trials comparing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    with placebo in children with RSV LRTI have yielded mixed results. Some studies have demonstrated decreased severity of illness, decreased duration of mechanical ventilation, oxygen therapy and hospital stay, and decreased viral shedding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/19-22\">",
"     19-22",
"    </a>",
"    ], whereas other studies have not demonstrated these benefits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. A 2004 systematic review of randomized trials comparing ribavirin with placebo in infants and children with RSV infection and LRTI found that trials of ribavirin lack sufficient power to provide reliable estimates of the effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics recommends against the routine use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/26\">",
"     26",
"    </a>",
"    ]. Ribavirin should be reserved for immunosuppressed patients with severe RSV infection. Consultation with an expert in infectious diseases is recommended before its use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     In adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the routine use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    is not recommended for infants and children with RSV LRTI, ribavirin may be beneficial for certain adults. Early use of inhaled ribavirin has been shown to reduce morbidity and mortality in adult bone marrow transplant recipients who develop RSV infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/27\">",
"     27",
"    </a>",
"    ]. The efficacy of ribavirin for patients with solid-organ transplants is unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     Ribavirin",
"    </a>",
"    is considered to be contraindicated in pregnant women, and a negative pregnancy test should precede its use in women of child-bearing age. Ribavirin is a known teratogen in rodent species. However, it has not been shown to be teratogenic in primates, and no adverse effects have been found in the human fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse effects related to occupational exposure to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    have not been reported. However, the National Institute of Occupational Safety and Health has published recommendations to reduce the ambient air concentrations of ribavirin and limit occupational exposure to hospital personnel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Passive immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a 2006 systematic review, neither intravenous immunoglobulin with a high neutralizing activity against RSV (RSVIG) nor monoclonal antibody proved beneficial in the treatment of RSV in hospitalized infants and young children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/31\">",
"     31",
"    </a>",
"    ]. RSVIG is no longer available.",
"   </p>",
"   <p>",
"    A pilot study of treatment with RSVIG demonstrated decreased viral shedding and improvement in oxygenation in children with RSV LRTI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/32\">",
"     32",
"    </a>",
"    ]. However, subsequent randomized studies found no benefit in reducing hospital stay, intensive care unit stay, mechanical ventilation, or the need for supplemental oxygen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Similarly, a study using an RSV-specific humanized monoclonal antibody (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/27/40371?source=see_link\">",
"     palivizumab",
"    </a>",
"    ) also found no benefit when used as therapy (rather than prophylaxis, which is discussed separately) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/17/15640?source=see_link&amp;anchor=H104278863#H104278863\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Palivizumab'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Combination therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Ribavirin and immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combined antiviral therapy and immunotherapy may be warranted in severely ill immunocompromised patients with RSV LRTI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Combination therapy with RSVIG and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    appeared to be more efficacious than either drug alone in a cotton rat model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/37\">",
"     37",
"    </a>",
"    ]. This finding suggested a possible intervention for adult bone marrow transplant patients with RSV pneumonia (who have a mortality of approximately 70 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/38\">",
"     38",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    In uncontrolled studies in such patients, combination therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    and intravenous immunoglobulin has been associated with improved survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/39-43\">",
"     39-43",
"    </a>",
"    ]. Additional studies in RSV-infected lung transplant recipients have suggested that combined ribavirin (nebulized or intravenous) with intravenous immunoglobulin",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    corticosteroids can reduce mortality, length of mechanical ventilation, and incidence of bronchiolitis obliterans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although combined",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    and intravenous immunoglobulin has not been supported by a prospective, randomized study, this expensive treatment is now sometimes used in selected patients.",
"   </p>",
"   <p>",
"    Similarly, the combination of intravenous immunoglobulin and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/27/40371?source=see_link\">",
"     palivizumab",
"    </a>",
"    is sometimes used in severely ill immunocompromised patients but has not been well studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Ribavirin and corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combined treatment with intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    and oral corticosteroids in an uncontrolled study of 18 adult lung transplant recipients was well tolerated and cleared RSV infection by immunofluorescent antibody testing. There was no mortality, and only one patient developed bronchiolitis obliterans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38327/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/19/27958?source=see_link\">",
"       \"Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Therapy for respiratory syncytial virus (RSV) infection of the lower respiratory tract is primarily supportive. Supportive care may include hospitalization and fluid and respiratory support. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Supportive care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest a trial (single administration) of therapy with a beta-agonist (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/61/16344?source=see_link\">",
"       albuterol",
"      </a>",
"      or epinephrine) if lower airway obstruction is clinically apparent (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Therapy should be discontinued in patients who fail to demonstrate rapid improvement. For patients who improve with bronchodilator therapy, it can be administered every four to six hours and continued until the signs and symptoms of respiratory distress improve. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Bronchodilators'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not using corticosteroids in infants with RSV bronchiolitis or pneumonia (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). However, corticosteroids may be beneficial in the management of lower airway obstruction in older children and adults. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Corticosteroids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not using",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"       ribavirin",
"      </a>",
"      routinely in the management of infants and children with RSV lower respiratory tract infection (LRTI) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). However, ribavirin may be beneficial in infants and children at risk for severe RSV LRTI. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Ribavirin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"       ribavirin",
"      </a>",
"      in combination with passive immunotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      corticosteroids for immune-compromised adults with severe RSV LRTI (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Ribavirin'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Combination therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neither intravenous immunoglobulin with a high neutralizing activity against RSV nor monoclonal antibody has as yet proven beneficial in the treatment of RSV in hospitalized infants and young children. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Passive immunotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/1\">",
"      Committee on Infectious Diseases. From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009; 124:1694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/2\">",
"      Wald TG, Miller BA, Shult P, et al. Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons? J Am Geriatr Soc 1995; 43:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/3\">",
"      Henderson FW, Collier AM, Clyde WA Jr, Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 1979; 300:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/4\">",
"      Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995; 21:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/5\">",
"      Langley JM, Smith MB, LeBlanc JC, et al. Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076]. BMC Pediatr 2005; 5:7.",
"     </a>",
"    </li>",
"    <li>",
"     Hall CB. Walsh EE. Respiratory syncytial virus and human metapneumovirus. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.2462.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/7\">",
"      Hammer J, Numa A, Newth CJ. Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection. J Pediatr 1995; 127:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/8\">",
"      Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/9\">",
"      Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2006; :CD001266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/10\">",
"      Hartling L, Wiebe N, Russell K, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004; :CD003123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/11\">",
"      Lozano JM. Bronchiolitis. Clin Evid 2004; :370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/12\">",
"      King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med 2004; 158:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/13\">",
"      Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997; 100:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/14\">",
"      Cade A, Brownlee KG, Conway SP, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000; 82:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/15\">",
"      van Woensel JB, Vyas H, STAR Trial Group. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. Crit Care Med 2011; 39:1779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/16\">",
"      Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004; :CD004878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/17\">",
"      Ventre K, Randolph A. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2004; :CD000181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/18\">",
"      Ottolini MG, Hemming VG. Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery. Drugs 1997; 54:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/19\">",
"      Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med 1983; 308:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/20\">",
"      Taber LH, Knight V, Gilbert BE, et al. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 1983; 72:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/21\">",
"      Rodriguez WJ, Kim HW, Brandt CD, et al. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J 1987; 6:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/22\">",
"      Smith DW, Frankel LR, Mathers LH, et al. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991; 325:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/23\">",
"      Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit Care Med 1994; 22:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/24\">",
"      Moler FW, Steinhart CM, Ohmit SE, Stidham GL. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. J Pediatr 1996; 128:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/25\">",
"      Guerguerian AM, Gauthier M, Lebel MH, et al. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160:829.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Respiratory syncytial virus. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.609.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/27\">",
"      McColl MD, Corser RB, Bremner J, Chopra R. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin. Bone Marrow Transplant 1998; 21:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/28\">",
"      Krinzman S, Basgoz N, Kradin R, et al. Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants. J Heart Lung Transplant 1998; 17:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/29\">",
"      Doud JR, Hinkamp T, Garrity ER Jr. Respiratory syncytial virus pneumonia in a lung transplant recipient: case report. J Heart Lung Transplant 1992; 11:77.",
"     </a>",
"    </li>",
"    <li>",
"     Hospital investigations: Health Hazards. In: OSHA Technical Manual (OTM), U.S. Department of Labor, Occupational Safety and Health Administration, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/31\">",
"      Fuller H, Del Mar C. Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev 2006; :CD004883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/32\">",
"      Hemming VG, Rodriguez W, Kim HW, et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987; 31:1882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/33\">",
"      Rodriguez WJ, Gruber WC, Welliver RC, et al. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics 1997; 99:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/34\">",
"      Rodriguez WJ, Gruber WC, Groothuis JR, et al. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics 1997; 100:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/35\">",
"      S&aacute;ez-Llorens X, Moreno MT, Ramilo O, et al. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J 2004; 23:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/36\">",
"      Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/37\">",
"      Gruber WC, Wilson SZ, Throop BJ, Wyde PR. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat. Pediatr Res 1987; 21:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/38\">",
"      Hertz MI, Englund JA, Snover D, et al. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) 1989; 68:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/39\">",
"      Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/40\">",
"      Ghosh S, Champlin RE, Englund J, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/41\">",
"      DeVincenzo JP, Hirsch RL, Fuentes RJ, Top FH Jr. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience. Bone Marrow Transplant 2000; 25:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/42\">",
"      De Vincenzo JP, Leombruno D, Soiffer RJ, Siber GR. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation. Bone Marrow Transplant 1996; 17:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/43\">",
"      Flynn JD, Akers WS, Jones M, et al. Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature. Pharmacotherapy 2004; 24:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/44\">",
"      Schmidt AC, Johnson TR, Openshaw PJ, et al. Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. Virus Res 2004; 106:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38327/abstract/45\">",
"      Glanville AR, Scott AI, Morton JM, et al. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2005; 24:2114.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6001 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-629A639819-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38327=[""].join("\n");
var outline_f37_27_38327=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SUPPORTIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Respiratory support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PHARMACOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Bronchodilators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Bronchodilators plus corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H655542266\">",
"      Hypertonic saline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ribavirin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - In children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - In adults",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Contraindications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Passive immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Combination therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Ribavirin and immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Ribavirin and corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/16/33034?source=related_link\">",
"      Acute asthma exacerbations in children: Outpatient management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/19/27962?source=related_link\">",
"      Bronchiolitis in infants and children: Treatment; outcome; and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/24/27014?source=related_link\">",
"      Continuous oxygen delivery systems for infants, children, and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=related_link\">",
"      Inpatient treatment of pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=related_link\">",
"      Outpatient treatment of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/19/27958?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/17/15640?source=related_link\">",
"      Respiratory syncytial virus infection: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13146?source=related_link\">",
"      The common cold in children: Treatment and prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_27_38328="Transient global amnesia";
var content_f37_27_38328=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transient global amnesia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38328/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38328/contributors\">",
"     Patricia H Davis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38328/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38328/contributors\">",
"     Mario F Mendez, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38328/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38328/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/27/38328/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient global amnesia (TGA) is a clinical syndrome of reversible anterograde amnesia accompanied by repetitive questioning that occurs in middle-aged and elderly individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The etiology of TGA remains obscure. While the prognosis for TGA is generally benign, other diseases in the differential diagnosis carry potential for serious long-term sequelae, making it important for clinicians to be familiar with the diagnosis and evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population, the incidence of transient global amnesia (TGA) has been estimated as 5.2 to 10 per 100,000 per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. Among those 50 years and older, it is 23.5 to 32 per 100,000 per year.",
"   </p>",
"   <p>",
"    The majority of episodes occur in individuals between the ages of 50 and 80 years, with a mean age of onset between 60 and 65 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The incidence of TGA does not differ according to gender [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atherosclerotic risk factors (eg, hypertension, diabetes, hypercholesterolemia) are not believed to be associated with TGA. While common in this aged population, case-control studies find no difference in the prevalence of these risk factors between TGA patients and age and gender-matched controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,7-13\">",
"     2,7-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Migraine has been found to be strongly associated with TGA in some, but not all, case-control studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,9,10,14,15\">",
"     2,9,10,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical neuroanatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical symptoms of TGA suggest that the primary site of neurologic involvement is the mediobasal temporal lobe and hippocampus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6,16,17\">",
"     6,16,17",
"    </a>",
"    ]. Functional neuroimaging studies provide evidence that this area is involved in the formation and retrieval of new episodic memories, the primary neurologic deficit in TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuroimaging studies demonstrate that this area is pathologically affected in TGA. Diffusion-weighted magnetic resonance imaging (DWI-MRI) studies in acute and subacute stages of TGA have demonstrated lesions in the hippocampus; high resolution imaging studies have specifically implicated the CA-1, Sommer sector [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8,18-20\">",
"     8,18-20",
"    </a>",
"    ]. Lesions are most often unilateral and left-sided, but right-sided and bilateral lesions also occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In patients who had acute neuroimaging and neuropsychological evaluation, evidence of lateralization is congruent in both tests; that is, prominent verbal memory loss was associated with dominant-side hippocampal lesions, while more prominent visuospatial memory deficits were associated with nondominant hippocampal lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8,16\">",
"     8,16",
"    </a>",
"    ]. Cases of TGA have also been described in patients who have previously had a hippocampal resection for treatment of epilepsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neurons in the CA-1 area of the hippocampus are known to be selectively vulnerable to cellular metabolic stress, specifically in the setting of hypoxia and ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8,19,22\">",
"     8,19,22",
"    </a>",
"    ]. This vulnerability may relate to sensitivity to cytotoxic glutamanergic release and uptake, or to the vascular anatomy of the hippocampus, as this area may represent a watershed between two major arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no consensus regarding an underlying cause of TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6,23-29\">",
"     6,23-29",
"    </a>",
"    ]. Hypotheses include a vascular etiology (either arterial or venous), a migrainous phenomenon or cortical spreading depression, epilepsy, and a psychogenic disorder. None of these hypotheses clearly and consistently explains the clinical features of TGA. Unfortunately, the results of neuroimaging studies, while demonstrating a consistent locus of pathologic involvement, do not clearly delineate the underlying etiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Arterial ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;TGA shares some features with transient ischemic attack (TIA), specifically a duration of less than 24 hours and occurrence in older adults. Some episodes of TGA have occurred in settings associated with acute cerebrovascular thromboembolism, such as vertebral artery angioplasty and stenting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/30\">",
"     30",
"    </a>",
"    ], basilar artery thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/31\">",
"     31",
"    </a>",
"    ], aortic dissection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/32\">",
"     32",
"    </a>",
"    ] and hypercoagulable conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. There have also been well-described stroke syndromes that produce acute amnesia, similar to that seen in TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/36-40\">",
"     36-40",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, other clinical observations argue against arterial thromboembolism as a cause for most cases of TGA:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      TGA episodes are longer in duration than typical TIAs.",
"     </li>",
"     <li>",
"      TGA patients have a lower atherosclerotic risk burden than patients with TIA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,10,11,14,41-43\">",
"       2,10,11,14,41-43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In follow-up studies, patients with TGA have a risk of future stroke and death that is lower than TIA patients and resembles that of an age-matched population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/3,10,41\">",
"       3,10,41",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment and prognosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      In many patients, TGA appears to be precipitated by events that are not associated with TIA. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical features'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Others have speculated that less common causes of TIA and stroke may underlie TGA, explaining the lower atherosclerotic risk burden and more benign prognosis. As an example, the frequent association of TGA with a Valsalva maneuver at onset led to the suggestion that paradoxical embolism from a patent foramen ovale may cause TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/44\">",
"     44",
"    </a>",
"    ]. However, while one case-control study found that patent foramen ovale was more prevalent in patients with TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/44\">",
"     44",
"    </a>",
"    ], this was not confirmed in a follow-up study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/11\">",
"     11",
"    </a>",
"    ]. Arterial vasospasm has also been proposed as a mechanism for TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings on neuroimaging studies, positron emission tomography (PET), single photon emission computed tomography (SPECT), as well as DWI-MRI have provided data that both support and refute arterial ischemia as a pathogenesis for TGA.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      DWI-MRI &mdash; Punctate areas of signal abnormality on DWI-MRI in the hippocampus are often described in patients with TGA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Neuroimaging findings'",
"      </a>",
"      below.) In TGA, these lesions resolve and do not evolve into permanent T2 lesions. While most often associated with acute ischemia, DWI lesions are not specific to TIA or stroke [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2\">",
"       2",
"      </a>",
"      ]. In one study, DWI lesions were no more common in 86 TGA patients than in 172 age- and sex-matched controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/13\">",
"       13",
"      </a>",
"      ]. However, the prevalence of DWI findings (11.5 percent) in TGA patients was somewhat lower in this series than others.",
"      <br/>",
"      <br/>",
"      In fact, some note that the lesions seen in TGA are somewhat atypical of those seen in TIA; the latter are larger, are more likely to be observed in the first few hours of the onset of symptoms, and are more likely to evolve into a permanent T2 abnormality [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6,8,29,42,47\">",
"       6,8,29,42,47",
"      </a>",
"      ]. One investigation observed that the lesions observed in TGA have higher apparent diffusion coefficient (ADC) values than are usual for TIA-associated lesions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/7\">",
"       7",
"      </a>",
"      ]. Another study found that the lesions in TGA were not associated with perfusion deficits, as would be expected for an ischemic etiology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/45\">",
"       45",
"      </a>",
"      ]. MR spectroscopy demonstrates a lactate peak in these lesions, consistent with, but not specific for, an arterial ischemic etiology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      SPECT &mdash; SPECT scanning in cases of TGA have shown variable results, usually hypoperfusion in one or both temporal lobes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,25\">",
"       2,25",
"      </a>",
"      ]. Hyperperfusion or involvement of other brain areas is uncommonly reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/48,49\">",
"       48,49",
"      </a>",
"      ]. These findings do not indicate whether the alteration in cerebral blood flow is a primary event or a secondary phenomenon related to changes in cerebral metabolism from another etiology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      PET &mdash; During the TGA attack, PET scans have shown abnormalities in several brain regions including the hippocampus, amygdala, lentiform nucleus, and the frontal lobe [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,16,23,50\">",
"       2,16,23,50",
"      </a>",
"      ]. However, findings appear to be consistent with stable cerebral blood flow and a reduction in regional oxygen uptake, suggesting altered neuronal activity rather than a vascular event [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other laboratory studies &mdash; In one study, measures of platelet activation were seen in patients with TIA and acute stroke, but not in patients with TGA or normal controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Venous congestion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous congestion was proposed as an alternative pathogenesis to arterial ischemia for TGA, in part based on the observation that specific events appeared to frequently trigger TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/28\">",
"     28",
"    </a>",
"    ]. These include Valsalva maneuver, vigorous activity of the arms, sympathetic activation from acute emotional events, and cold water immersion (diving reflex). In this paradigm, increases in either intrathoracic pressure or venous return could lead to central venous congestion affecting the deep venous system that drains the dorsomedial thalamus and hippocampus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/19,28\">",
"     19,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The basal veins of Rosenthal provide venous drainage from the mesial temporal lobes to the vein of Galen. This vein drains to the inferior sagittal sinus and then to the straight sinus, which most commonly becomes the left transverse sinus. This pattern of venous drainage has been used to explain how venous reflux into the left internal jugular vein could affect both mesial temporal lobes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some feel that venous congestion better explains the appearance of the MRI-DWI lesions than does the arterial ischemia, particularly the time course and reversibility of the lesions, as well as the higher ADC coefficient than is typical for acute ischemia of arterial origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8,47\">",
"     8,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Support for this theory came from a series Doppler ultrasound studies that demonstrated inducible venous reflux in at least one internal jugular vein in a higher prevalence of TGA patients compared with controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6,9,11,28,52,53\">",
"     6,9,11,28,52,53",
"    </a>",
"    ]. The largest of these series included 142 patients with TGA and 40 controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/52\">",
"     52",
"    </a>",
"    ]. Valvular insufficiency was found in 80 percent of the TGA patients and 25 percent of the controls. This presumably reflects a premorbid condition of internal jugular valvular insufficiency that then predisposes patients to TGA. MRI studies have also found abnormal venous signals suggesting retrograde venous flow in a higher percentage of TGA patients than controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/51,54\">",
"     51,54",
"    </a>",
"    ]. These findings seemed particularly relevant in that the demonstration of retrograde flow was more common in TGA patients who reported an antecedent Valsalva maneuver, compared with those who did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/9,51\">",
"     9,51",
"    </a>",
"    ]. Inconsistencies in these studies include that the side of apparent valvular insufficiency did not always correlate with the dominant side of venous blood flow or with the lateralization of DWI lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8,25,55\">",
"     8,25,55",
"    </a>",
"    ]. Also, one study found no Doppler evidence of intracranial venous reflux in TGA patients compared with controls despite the higher prevalence of internal jugular valve insufficiency in the patient group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some of the questions not answered by the venous congestion hypothesis include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Why the venous congestion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ischemia is selective to the anatomic structures related to memory",
"     </li>",
"     <li>",
"      Why TGA isn't seen more frequently with venous sinus thrombosis",
"     </li>",
"     <li>",
"      Why recurrence is so infrequent if the abnormality can be induced by a Valsalva maneuver",
"     </li>",
"     <li>",
"      Why it only occurs in older adults",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Migrainous phenomenon",
"    </span>",
"    &nbsp;&mdash;&nbsp;Migraine can cause transient neurologic symptoms (eg, migraine aura and migraine equivalents) and has been proposed as a cause of TGA. The mechanism of migraine aura is understood to be a self-propagating wave of neuronal and glial depolarization, so-called cortical spreading depression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/4/26698?source=see_link\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In support of this theory is that some, although not all, case-control studies find that a migraine history is associated with TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/9,10,14,15\">",
"     9,10,14,15",
"    </a>",
"    ]. Some believe that the observed changes on DWI-MRI and PET are most compatible with migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/25,56\">",
"     25,56",
"    </a>",
"    ], while others disagree [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/28\">",
"     28",
"    </a>",
"    ]. However, migraines tend to present in younger, not older patients and are also a recurring phenomenon, unlike TGA, which usually occurs in older persons as a single event. A single case-report of an atypical TGA patient with recurrent episodes documents cessation of episodes with beta-blocker medication, a treatment often used in the prophylaxis of migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One unsubstantiated theory is that TGA shares the underlying mechanism of migraine aura, that of a cerebral spreading depression. It is hypothesized that TGA is precipitated by an emotional experience that could trigger the release of glutamate in the hippocampus and trigger cerebral spreading depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Epileptic phenomenon",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient amnesia is a documented manifestation of some epileptic seizures. However, epilepsy is not believed to cause TGA. Seizures are recurring, not isolated phenomena, and cases of EEG monitoring during a TGA episode have not shown epileptic discharges [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6,59\">",
"     6,59",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Psychogenic disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the disorder was first described, a psychogenic origin was postulated; however, most clinicians now believe that TGA is an organic disorder, but that psychogenic stressors and psychogenic predisposition may play a contributing role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/23\">",
"     23",
"    </a>",
"    ]. Evidence for this is slight and circumstantial:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one case series, a high prevalence of phobic personality traits in TGA patients was observed compared to a control patient group with TIA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/60\">",
"       60",
"      </a>",
"      ]. A subsequent analysis also revealed that TGA patients had more frequent history of psychiatric disease (OR = 2.9), alcohol abuse (OR = 3.3), and a family history of psychiatric disease (OR = 3.0) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another case series, a subgroup of women with TGA appeared to have associated psychological disorders such as personality disorders or a history of anxiety or depression and to have the acute event triggered by an emotional stimulus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2\">",
"       2",
"      </a>",
"      ]. However, as a group, the TGA patients in this series did not have a higher prevalence of anxiety and depression history compared with controls.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is postulated that emotional upset might induce hyperventilation leading to vasoconstriction, reducing cerebral blood flow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/23\">",
"     23",
"    </a>",
"    ]. In susceptible older patients with small vessel disease, this might lead to focal ischemic symptoms. Alternatively, emotional events could trigger neurotransmitter release in the temporal lobe, affecting hippocampal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8,23,47\">",
"     8,23,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Multiple causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because no one theory of its pathogenesis clearly appears to apply to all patients with TGA, some speculate that, despite its relatively consistent clinical presentation, TGA is a syndrome that has multiple different etiologies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,26\">",
"     2,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one case series, two different potential etiologic groups were identified: arterial ischemia in patients with associated DWI-MRI abnormalities, vascular risk factors, and comorbid carotid arterial plaques; and venous congestion in those whose episodes were initiated with Valsalva [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/42\">",
"     42",
"    </a>",
"    ]. A hierarchical cluster analysis employed in another case series of 142 TGA patients, suggested three distinct subgroups: younger patients (less than 56 years old) with a history of migraine; women with a history of anxiety, depression, and recent emotional stress; and men without medical history and a preceding physical event-trigger [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2\">",
"     2",
"    </a>",
"    ]. However, a comparison of clinical event features among 15 TGA patients with migraine and 42 without revealed no differences between the two groups in regard to mean age, presence of identifiable triggers, associated headache, nausea, or vomiting, event duration, or recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodes of TGA are distinct events, usually with a fairly well defined time of onset.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prominent anterograde amnesia, an inability to form new memories, is the defining clinical feature. Patients are disoriented in time and often repetitively ask questions about the date or their environment, the so-called \"broken-record\" phenomenon. Immediate recall (eg, digit-span) is intact, but delayed recall is impaired [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6\">",
"       6",
"      </a>",
"      ]. Retrograde amnesia is common, but more variable and can extend back hours to days, weeks, and rarely years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8\">",
"       8",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Other cognitive functions are spared. In particular, a loss of self-awareness excludes TGA. Patients are able to perform complex motor tasks such as driving, cooking, lecturing, and playing a musical instrument [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/1,6,61\">",
"       1,6,61",
"      </a>",
"      ]. The neurologic exam is otherwise normal.",
"     </li>",
"     <li>",
"      The mean duration of episodes is approximately six hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,3,8\">",
"       2,3,8",
"      </a>",
"      ]. Most last between 1 and 10 hours. As the spell resolves, the retrograde amnesia usually completely resolves or is isolated to a brief time immediately preceding the event. Patients are left with an amnesic gap for the main episode.",
"     </li>",
"     <li>",
"      Associated symptoms may be reported. Between 10 to 40 percent of patients complain of headache during the spell [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,8,10,14\">",
"       2,8,10,14",
"      </a>",
"      ]. Nausea, undefined dizziness, anxiety, paresthesias, and other symptoms are variably reported.",
"     </li>",
"     <li>",
"      A past history of a similar episode is unusual (less than 5 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,8\">",
"       2,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antecedent, presumably triggering events are reported to occur in 33 to 89 percent of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,3,8-10,12,14,44,61\">",
"       2,3,8-10,12,14,44,61",
"      </a>",
"      ]. The variable proportion of those with TGA who have apparent event-triggers is probably due to how systematically such events were solicited and what types of events were included as potential triggers. Reported event triggers have included acute emotional events, physical events (eg, strenuous activity, sexual intercourse, Valsalva maneuver), postural changes, medical procedures, high altitude, contact with water,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      changes in body temperature, as well as more chronic emotional stress [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,8,62,63\">",
"       2,8,62,63",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      These observations have not been confirmed with case-control analysis. However, the relevance of Valsalva maneuver as a triggering event is supported by the fact that inducible retrograde flow in the internal jugular vein is more common in patients who reported a preceding Valsalva maneuver than in those who did not [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Several studies suggest that more than half of TGA attacks begin in the morning, after the patient has arisen without symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,15,41\">",
"       2,15,41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for transient global amnesia (TGA) includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seizure, epileptic amnesia &mdash; Features that suggest this diagnosis include a short duration of the attack (less than one hour, usually a few to several minutes), occurrence on awakening from sleep, and multiple attacks at the time of presentation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/10,61,64-67\">",
"       10,61,64-67",
"      </a>",
"      ]. Rare cases of transient epileptic amnesia have been reported to last hours or days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/64\">",
"       64",
"      </a>",
"      ]. Common accompanying symptoms, which may not be volunteered by patients, include olfactory hallucinations and motor automatisms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/65\">",
"       65",
"      </a>",
"      ]. Amnestic seizures are less likely than TGA to be accompanied by anxiety and repetitive questioning, and retrograde amnesia is more prominent than anterograde [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/67,68\">",
"       67,68",
"      </a>",
"      ]. These seizures are believed to arise from the mesial temporal lobe; some patients with epileptic amnesia also have interictal memory deficits [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/66\">",
"       66",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Normal or nonspecific changes on electroencephalography (EEG) do not exclude the diagnosis, as abnormalities may only be evident during sleep or with sleep-deprivation. Prolonged EEG monitoring may be helpful, and some patients are diagnosed when recurrent events cease during an antiepileptic drug trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/69\">",
"       69",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/1/23578?source=see_link&amp;anchor=H8#H8\">",
"       \"Localization-related (partial) epilepsy: Causes and clinical features\", section on 'Mesial temporal lobe epilepsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Transient ischemic attack (TIA) or stroke &mdash; Isolated amnesia without other focal neurologic deficits is a rare manifestation of TIA or stroke. However, the presence of vascular risk factors should raise concern for this diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/10\">",
"       10",
"      </a>",
"      ]. There are case reports of patients with a clinical syndrome compatible with TGA who had evidence of ischemic stroke on imaging studies with lesions in the mesial temporal lobe [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/36,39\">",
"       36,39",
"      </a>",
"      ], caudate nucleus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/37\">",
"       37",
"      </a>",
"      ], cingulate gyrus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/40\">",
"       40",
"      </a>",
"      ], and splenium of the corpus callosum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/38\">",
"       38",
"      </a>",
"      ]. While the neurologic examination is often reported to be otherwise normal in these cases, visual field abnormalities are common in strokes involving the temporal lobe [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other possibilities &mdash; Head injury, anoxic event (carbon monoxide exposure), hypoglycemia, intoxication, drug or alcohol withdrawal, herpes simplex encephalitis, and other causes of toxic-metabolic encephalopathy and delirium (",
"      <a class=\"graphic graphic_table graphicRef59893 \" href=\"mobipreview.htm?3/43/3773\">",
"       table 1",
"      </a>",
"      ) can be confused with TGA. In such cases, however, patients will demonstrate a more global confusion and inattention. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link\">",
"       \"Diagnosis of delirium and confusional states\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/1/36889?source=see_link\">",
"       \"Acute toxic-metabolic encephalopathy in adults\"",
"      </a>",
"      .) One exception might be Wernicke's encephalopathy, in which amnesia may dominate. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/62/10217?source=see_link\">",
"       \"Wernicke's encephalopathy\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Psychogenic amnesia may also be confused with TGA. However, it is common for these patients to have specific deficits in autobiographical data and even report that they don't remember their name; this very specific feature for psychogenic amnesia excludes TGA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of TGA is made on the basis of its clinical features. Diagnostic criteria have been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/1,61\">",
"     1,61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Information about the beginning of the attack is available from a capable observer. This is to exclude head trauma or loss of consciousness at the onset. Clouding of consciousness or loss of personal identity should be absent.",
"     </li>",
"     <li>",
"      Patient should be examined during the attack to be certain that there are no accompanying neurologic signs or symptoms besides antegrade amnesia.",
"     </li>",
"     <li>",
"      The memory loss should resolve within 24 hours.",
"     </li>",
"     <li>",
"      Epileptic features must be absent. Patients with active epilepsy are excluded.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no confirmatory diagnostic tests. The initial evaluation and management of patients with TGA focuses on excluding other diagnoses and should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the patient is symptomatic on presentation, the patient should be observed in the hospital until the amnesia resolves.",
"     </li>",
"     <li>",
"      Diagnostic testing includes oxygenation status, serum electrolytes, glucose, and a toxicology screen.",
"     </li>",
"     <li>",
"      Patients should receive thiamine 100 mg IV.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The need for further testing varies depending on the circumstances, such as how typical the event is for TGA, the presence of vascular risk factors, and whether the ictus was observed. Patients with recurrent or brief episodes, or activity suggesting motor automatisms should be evaluated with EEG for possible epilepsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32425?source=see_link\">",
"     \"Electroencephalography (EEG) in the diagnosis of seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We also suggest a neuroimaging study in all patients, preferably a brain MRI with DWI, to exclude acute ischemia, head trauma, and other causes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Neuroimaging findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;A computed tomography (CT) scan of the brain is likely to be performed in the emergency department setting and is usually normal or may show incidental findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A brain MRI is also often normal or shows only incidental findings. Several case series report finding one or more punctate lesions in the hippocampus on DWI-MRI, with an incidence that ranges from zero to 84 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,6-8,13,42,46,56,70-72\">",
"     2,6-8,13,42,46,56,70-72",
"    </a>",
"    ]. These lesions are associated with small reductions in the apparent diffusion coefficient (ADC) values and may be located in the left, right, or bilateral hippocampi. The timing of MRI may impact the likelihood of demonstrating these lesions; they are less common in the hyperacute phase and become more prevalent after 12 hours, with a peak incidence between 12 and 72 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/7,45,46,71\">",
"     7,45,46,71",
"    </a>",
"    ]. These lesions resolve on follow-up imaging performed one to six months after the event [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/7,8,42,56,72\">",
"     7,8,42,56,72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is not required for TGA. The condition usually does not recur, and the patient does not need to be restricted from driving unless events are recurrent.",
"   </p>",
"   <p>",
"    Recurrence rates range from 2.9 to 26.3 percent with variable follow-up; the annual rate is estimated to be 2.5 to 5.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2,3,10,12,14,23,41,61,73\">",
"     2,3,10,12,14,23,41,61,73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no increased risk of mortality, epilepsy, or stroke following TGA as compared with age-matched control subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/3,10,41\">",
"     3,10,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies suggest that TGA may not be as benign as previously thought.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study using high-resolution T2-reversed MRI of the hippocampus showed a significantly higher frequency of cavities in the hippocampus than controls, suggesting that neuronal loss in the Sommer or CA1 sector was a permanent sequelae in patients with TGA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/19\">",
"       19",
"      </a>",
"      ]. The pattern of pathology was distinct from incidental findings seen in normal control subjects or in those with Alzheimer disease or hypertension.",
"     </li>",
"     <li>",
"      Follow-up neuropsychologic testing in some case series of TGA patients suggest that subclinical residual deficits may be common one or more years later, while others have found no significant deficits [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8,74,75\">",
"       8,74,75",
"      </a>",
"      ]. One case series documents a subsequent diagnosis of primary progressive aphasia in three patients who had had one or more episodes of TGA between 1 and 10 years previously [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/76\">",
"       76",
"      </a>",
"      ]. Case-control studies have also had mixed results. One study showed that 55 patients, one year after an episode of TGA, had worse performance on tests evaluating memory and attention compared with a group of 80 age-matched controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/77\">",
"       77",
"      </a>",
"      ]. One-third of the TGA patients met criteria for amnestic mild cognitive impairment. However, another smaller, case-control study reported no significant difference in neuropsychological test results between patients and controls at a mean of three years after the TGA event [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/78\">",
"       78",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A meta-analysis of effect sizes from 25 studies found that impairments in antegrade memory and other cognitive spheres persisted up to 5 days but had completely resolved in the long-term phase (5 to 30 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38328/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient global amnesia (TGA) is a benign, self-limited selective disturbance of antegrade amnesia that occurs in middle-aged and elderly subjects.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Older age is the only consistently identified risk factor. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary site of neurologic functional disturbance is the medial temporal lobe. The pathogenesis of this transient disruption is unknown. Current theories include arterial ischemia, venous congestion, and migraine, but no theory explains all of the clinical features. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The event is characterized by a profound disruption in anterograde memory; patients are typically disoriented to place and will repeatedly ask where they are and why they are there. Retrograde amnesia is variably present. Other cognitive and executive functions are intact. Patients do not lose self-awareness. Resolution typically occurs after several hours. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical features of TGA are generally distinct from other considerations in the differential diagnosis including stroke, seizure, toxic metabolic encephalopathy, and delirium. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with TGA should be observed until the episode resolves. Investigations should include laboratory tests to exclude intoxication, infection, and metabolic derangements. Brain MRI with DWI is recommended to exclude stroke or other structural causes. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis and management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis after TGA is felt to be benign, and the risk of recurrence is low. No treatment or driving restriction is required. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Caplan, LR. Transient global amnesia. In: Handbook of Clinical Neurology, Vol. 1 (45), Vinken, PJ, Bruyn, GW, Klawans, HL, (Eds), Elsevier Science Publishers, Amsterdam 1985. p.205.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/2\">",
"      Quinette P, Guillery-Girard B, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 2006; 129:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/3\">",
"      Miller JW, Petersen RC, Metter EJ, et al. Transient global amnesia: clinical characteristics and prognosis. Neurology 1987; 37:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/4\">",
"      Lauria G, Gentile M, Fassetta G, et al. Incidence of transient global amnesia in the Belluno province, Italy: 1985 through 1995. Results of a community-based study. Acta Neurol Scand 1997; 95:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/5\">",
"      Koski KJ, Marttila RJ. Transient global amnesia: incidence in an urban population. Acta Neurol Scand 1990; 81:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/6\">",
"      Sander K, Sander D. New insights into transient global amnesia: recent imaging and clinical findings. Lancet Neurol 2005; 4:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/7\">",
"      Sedlaczek O, Hirsch JG, Grips E, et al. Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology 2004; 62:2165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/8\">",
"      Bartsch T, Alfke K, Stingele R, et al. Selective affection of hippocampal CA-1 neurons in patients with transient global amnesia without long-term sequelae. Brain 2006; 129:2874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/9\">",
"      Sander D, Winbeck K, Etgen T, et al. Disturbance of venous flow patterns in patients with transient global amnesia. Lancet 2000; 356:1982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/10\">",
"      Zorzon M, Antonutti L, Mas&egrave; G, et al. Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. Stroke 1995; 26:1536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/11\">",
"      Maalikjy Akkawi N, Agosti C, Anzola GP, et al. Transient global amnesia: a clinical and sonographic study. Eur Neurol 2003; 49:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/12\">",
"      Chen ST, Tang LM, Hsu WC, et al. Clinical features, vascular risk factors, and prognosis for transient global amnesia in Chinese patients. J Stroke Cerebrovasc Dis 1999; 8:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/13\">",
"      Enzinger C, Thimary F, Kapeller P, et al. Transient global amnesia: diffusion-weighted imaging lesions and cerebrovascular disease. Stroke 2008; 39:2219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/14\">",
"      Melo TP, Ferro JM, Ferro H. Transient global amnesia. A case control study. Brain 1992; 115 Pt 1:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/15\">",
"      Schmidtke K, Ehmsen L. Transient global amnesia and migraine. A case control study. Eur Neurol 1998; 40:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/16\">",
"      Guillery B, Desgranges B, de la Sayette V, et al. Transient global amnesia: concomitant episodic memory and positron emission tomography assessment in two additional patients. Neurosci Lett 2002; 325:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/17\">",
"      Markowitsch HJ, Staniloiu A. Amnesic disorders. Lancet 2012; 380:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/18\">",
"      Westmacott R, Silver FL, McAndrews MP. Understanding medial temporal activation in memory tasks: evidence from fMRI of encoding and recognition in a case of transient global amnesia. Hippocampus 2008; 18:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/19\">",
"      Nakada T, Kwee IL, Fujii Y, Knight RT. High-field, T2 reversed MRI of the hippocampus in transient global amnesia. Neurology 2005; 64:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/20\">",
"      Lee HY, Kim JH, Weon YC, et al. Diffusion-weighted imaging in transient global amnesia exposes the CA1 region of the hippocampus. Neuroradiology 2007; 49:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/21\">",
"      Dupont S, Samson S, Baulac M. Is anterior temporal lobectomy a precipitating factor for transient global amnesia? J Neurol Neurosurg Psychiatry 2008; 79:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/22\">",
"      Bartsch T, Alfke K, Wolff S, et al. Focal MR spectroscopy of hippocampal CA-1 lesions in transient global amnesia. Neurology 2008; 70:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/23\">",
"      Pantoni L, Lamassa M, Inzitari D. Transient global amnesia: a review emphasizing pathogenic aspects. Acta Neurol Scand 2000; 102:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/24\">",
"      Men&eacute;ndez Gonz&aacute;lez M, Rivera MM. Transient global amnesia: increasing evidence of a venous etiology. Arch Neurol 2006; 63:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/25\">",
"      Bettermann K. Transient global amnesia: the continuing quest for a source. Arch Neurol 2006; 63:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/26\">",
"      Roach ES. Transient global amnesia: look at mechanisms not causes. Arch Neurol 2006; 63:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/27\">",
"      Solheim O, Skeidsvoll T. Transient global amnesia may be caused by cerebral vein thrombosis. Med Hypotheses 2005; 65:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/28\">",
"      Lewis SL. Aetiology of transient global amnesia. Lancet 1998; 352:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/29\">",
"      Tong DC, Grossman M. What causes transient global amnesia? New insights from DWI. Neurology 2004; 62:2154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/30\">",
"      Kim HY, Kang HS, Roh HG, et al. Transient global amnesia following vertebral artery angioplasty and stenting. Eur Neurol 2006; 56:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/31\">",
"      Taylor RA, Wu GF, Hurst RW, et al. Transient global amnesia heralding basilar artery thrombosis. Clin Neurol Neurosurg 2005; 108:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/32\">",
"      Mondon K, Blechet C, Gochard A, et al. Transient global amnesia caused by painless aortic dissection. Emerg Med J 2007; 24:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/33\">",
"      Semmler A, Klein A, Moskau S, Linnebank M. Transient global amnesia-like episode in a patient with severe hyperhomocysteinemia. Eur J Neurol 2007; 14:e5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/34\">",
"      Montalb&aacute;n J, Arboix A, Staub H, et al. Transient global amnesia and antiphospholipid antibodies. Clin Exp Rheumatol 1989; 7:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/35\">",
"      Warkentin TE, Hirte HW, Anderson DR, et al. Transient global amnesia associated with acute heparin-induced thrombocytopenia. Am J Med 1994; 97:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/36\">",
"      Greer DM, Schaefer PW, Schwamm LH. Unilateral temporal lobe stroke causing ischemic transient global amnesia: role for diffusion-weighted imaging in the initial evaluation. J Neuroimaging 2001; 11:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/37\">",
"      Ravindran V, Jain S, Ming A, Bartlett RJ. Transient global amnesia in a patient with acute unilateral caudate nucleus ischemia. J Clin Neurosci 2004; 11:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/38\">",
"      Saito K, Kimura K, Minematsu K, et al. Transient global amnesia associated with an acute infarction in the retrosplenium of the corpus callosum. J Neurol Sci 2003; 210:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/39\">",
"      Ott BR, Saver JL. Unilateral amnesic stroke. Six new cases and a review of the literature. Stroke 1993; 24:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/40\">",
"      Yoon B, Yoo JY, Shim YS, et al. Transient global amnesia associated with acute intracerebral hemorrhage at the cingulate gyrus. Eur Neurol 2006; 56:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/41\">",
"      Pantoni L, Bertini E, Lamassa M, et al. Clinical features, risk factors, and prognosis in transient global amnesia: a follow-up study. Eur J Neurol 2005; 12:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/42\">",
"      Winbeck K, Etgen T, von Einsiedel HG, et al. DWI in transient global amnesia and TIA: proposal for an ischaemic origin of TGA. J Neurol Neurosurg Psychiatry 2005; 76:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/43\">",
"      Hirabayashi H, Shimizu M, Kohara S, Shinohara Y. Activated platelets in transient global amnesia and TIA. Neurology 2004; 63:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/44\">",
"      Kl&ouml;tzsch C, Sliwka U, Berlit P, Noth J. An increased frequency of patent foramen ovale in patients with transient global amnesia. Analysis of 53 consecutive patients. Arch Neurol 1996; 53:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/45\">",
"      Toledo M, Pujadas F, Griv&eacute; E, et al. Lack of evidence for arterial ischemia in transient global amnesia. Stroke 2008; 39:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/46\">",
"      Weon YC, Kim JH, Lee JS, Kim SY. Optimal diffusion-weighted imaging protocol for lesion detection in transient global amnesia. AJNR Am J Neuroradiol 2008; 29:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/47\">",
"      Bartsch T, Alfke K, Deuschl G, Jansen O. Evolution of hippocampal CA-1 diffusion lesions in transient global amnesia. Ann Neurol 2007; 62:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/48\">",
"      Yang Y, Kim JS, Kim S, et al. Cerebellar Hypoperfusion during Transient Global Amnesia: An MRI and Oculographic Study. J Clin Neurol 2009; 5:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/49\">",
"      Chung YA, Jeong J, Yang DW, et al. A Tc-99m SPECT study of regional cerebral blood flow in patients with transient global amnesia. Neuroimage 2009; 47:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/50\">",
"      Eustache F, Desgranges B, Petit-Tabou&eacute; MC, et al. Transient global amnesia: implicit/explicit memory dissociation and PET assessment of brain perfusion and oxygen metabolism in the acute stage. J Neurol Neurosurg Psychiatry 1997; 63:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/51\">",
"      Chung CP, Hsu HY, Chao AC, et al. Detection of intracranial venous reflux in patients of transient global amnesia. Neurology 2006; 66:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/52\">",
"      Cejas C, Cisneros LF, Lagos R, et al. Internal jugular vein valve incompetence is highly prevalent in transient global amnesia. Stroke 2010; 41:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/53\">",
"      Baracchini C, Tonello S, Farina F, et al. Jugular veins in transient global amnesia: innocent bystanders. Stroke 2012; 43:2289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/54\">",
"      Chung CP, Hsu HY, Chao AC, et al. Transient global amnesia: cerebral venous outflow impairment-insight from the abnormal flow patterns of the internal jugular vein. Ultrasound Med Biol 2007; 33:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/55\">",
"      Schreiber SJ, Doepp F, Klingebiel R, Valdueza JM. Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia. J Neurol Neurosurg Psychiatry 2005; 76:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/56\">",
"      Strupp M, Br&uuml;ning R, Wu RH, et al. Diffusion-weighted MRI in transient global amnesia: elevated signal intensity in the left mesial temporal lobe in 7 of 10 patients. Ann Neurol 1998; 43:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/57\">",
"      Berlit P. Successful prophylaxis of recurrent transient global amnesia with metoprolol. Neurology 2000; 55:1937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/58\">",
"      Teive HA, Kowacs PA, Maranh&atilde;o Filho P, et al. Leao's cortical spreading depression: from experimental \"artifact\" to physiological principle. Neurology 2005; 65:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/59\">",
"      Jacome DE. EEG features in transient global amnesia. Clin Electroencephalogr 1989; 20:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/60\">",
"      Inzitari D, Pantoni L, Lamassa M, et al. Emotional arousal and phobia in transient global amnesia. Arch Neurol 1997; 54:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/61\">",
"      Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry 1990; 53:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/62\">",
"      Hiraga A, Matsunaga T. Transient global amnesia after gastroscopy. J Neurol Neurosurg Psychiatry 2006; 77:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/63\">",
"      Agosti C, Borroni B, Akkawi NM, et al. Acute myocardial infarction presenting with transient global amnesia. J Am Geriatr Soc 2006; 54:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/64\">",
"      Zeman AZ, Boniface SJ, Hodges JR. Transient epileptic amnesia: a description of the clinical and neuropsychological features in 10 cases and a review of the literature. J Neurol Neurosurg Psychiatry 1998; 64:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/65\">",
"      Butler CR, Zeman AZ. Recent insights into the impairment of memory in epilepsy: transient epileptic amnesia, accelerated long-term forgetting and remote memory impairment. Brain 2008; 131:2243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/66\">",
"      Butler CR, Bhaduri A, Acosta-Cabronero J, et al. Transient epileptic amnesia: regional brain atrophy and its relationship to memory deficits. Brain 2009; 132:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/67\">",
"      Bilo L, Meo R, Ruosi P, et al. Transient epileptic amnesia: an emerging late-onset epileptic syndrome. Epilepsia 2009; 50 Suppl 5:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/68\">",
"      Milton F, Muhlert N, Pindus DM, et al. Remote memory deficits in transient epileptic amnesia. Brain 2010; 133:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/69\">",
"      Gallassi R. Epileptic amnesic syndrome: an update and further considerations. Epilepsia 2006; 47 Suppl 2:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/70\">",
"      Huber R, Aschoff AJ, Ludolph AC, Riepe MW. Transient Global Amnesia. Evidence against vascular ischemic etiology from diffusion weighted imaging. J Neurol 2002; 249:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/71\">",
"      Gass A, Gaa J, Hirsch J, et al. Lack of evidence of acute ischemic tissue change in transient global amnesia on single-shot echo-planar diffusion-weighted MRI. Stroke 1999; 30:2070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/72\">",
"      Matsui M, Imamura T, Sakamoto S, et al. Transient global amnesia: increased signal intensity in the right hippocampus on diffusion-weighted magnetic resonance imaging. Neuroradiology 2002; 44:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/73\">",
"      Agosti C, Akkawi NM, Borroni B, Padovani A. Recurrency in transient global amnesia: a retrospective study. Eur J Neurol 2006; 13:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/74\">",
"      Guillery-Girard B, Quinette P, Desgranges B, et al. Long-term memory following transient global amnesia: an investigation of episodic and semantic memory. Acta Neurol Scand 2006; 114:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/75\">",
"      Le Pira F, Giuffrida S, Maci T, et al. Cognitive findings after transient global amnesia: role of prefrontal cortex. Appl Neuropsychol 2005; 12:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/76\">",
"      Graff-Radford J, Josephs KA. Primary progressive aphasia and transient global amnesia. Arch Neurol 2012; 69:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/77\">",
"      Borroni B, Agosti C, Brambilla C, et al. Is transient global amnesia a risk factor for amnestic mild cognitive impairment? J Neurol 2004; 251:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/78\">",
"      Uttner I, Weber S, Freund W, et al. Transient global amnesia--full recovery without persistent cognitive impairment. Eur Neurol 2007; 58:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38328/abstract/79\">",
"      J&auml;ger T, B&auml;zner H, Kliegel M, et al. The transience and nature of cognitive impairments in transient global amnesia: a meta-analysis. J Clin Exp Neuropsychol 2009; 31:8.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4822 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-6CC31590FA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38328=[""].join("\n");
var outline_f37_27_38328=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical neuroanatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Arterial ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Venous congestion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Migrainous phenomenon",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Epileptic phenomenon",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Psychogenic disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Multiple causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Neuroimaging findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/4822\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4822|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/43/3773\" title=\"table 1\">",
"      Causes of delirium and confusion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/1/36889?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32425?source=related_link\">",
"      Electroencephalography (EEG) in the diagnosis of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/1/23578?source=related_link\">",
"      Localization-related (partial) epilepsy: Causes and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/4/26698?source=related_link\">",
"      Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/62/10217?source=related_link\">",
"      Wernicke's encephalopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_27_38329="Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma";
var content_f37_27_38329=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Jennifer R Brown, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Jon C Aster, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Andrew Lister, MD, FRCP, FRCPath, FRCR",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/27/38329/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/27/38329/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse large B cell lymphoma (DLBCL) is the most common histologic subtype of non-Hodgkin lymphoma (NHL) accounting for approximately 25 percent of adult NHL cases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21337?source=see_link\">",
"     \"Classification of the hematopoietic neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The molecular pathogenesis of DLBCL is a complex, multistep process leading to the replication of a malignant clone of germinal or post-germinal B cell origin. While some steps in this pathway have been elucidated, many remain unknown. There are both genetic lesions (eg, rearrangements of BCL-6) and molecular alterations, some of which are also seen in other NHL variants. This may reflect in part the not uncommon evolution of low-grade lymphoma into DLBCL. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=see_link\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/19/5433?source=see_link\">",
"     \"Pathobiology and treatment of histologic transformation in the indolent non-Hodgkin lymphomas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3609?source=see_link\">",
"     \"Pathobiology and treatment of Richter's transformation in chronic lymphocytic leukemia/small lymphocytic lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following sections will describe genetic changes, aberrant gene and protein expression, and other mechanisms that are thought to play a role in the development of DLBCL. It is increasingly appreciated that the diagnostic category of \"DLBCL\" is heterogeneous in terms of morphology, genetics, and biologic behavior. A number of clinicopathologic entities are recognized that are sufficiently distinct to be considered separate diagnostic and therapeutic categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      T cell rich large B cell lymphoma. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=see_link\">",
"       \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/45/26330?source=see_link\">",
"       \"Initial treatment of advanced stage diffuse large B cell lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Primary diffuse large B cell lymphoma of the mediastinum, also called primary mediastinal large B cell lymphoma. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9238?source=see_link\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intravascular large B cell lymphoma. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13511?source=see_link\">",
"       \"Intravascular large cell lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphomatoid granulomatosis, an Epstein-Barr virus (EBV) positive large B cell lymphoma. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/20/41287?source=see_link\">",
"       \"Pulmonary lymphomatoid granulomatosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the pathobiology underlying the most common genetic lesions seen in DLBCL and primary mediastinal large B cell lymphoma. General discussions of the pathobiology and specific chromosomal abnormalities seen in NHL subtypes can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/5/41049?source=see_link\">",
"     \"Genetic abnormalities in hematologic and lymphoid malignancies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/21/6489?source=see_link\">",
"     \"General aspects of cytogenetic analysis in hematologic malignancies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29529?source=see_link\">",
"     \"Overview of the pathobiology of the non-Hodgkin lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CELL OF ORIGIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;DLBCL is a heterogeneous clinicopathologic entity that includes tumors derived from germinal center B cells or post-germinal center B cells (also called activated B cells). The germinal or post-germinal ancestry of these cells is principally supported by the identification of somatic mutations in the variable region of the immunoglobulin genes (IgVH), which serves as a marker of germinal center transit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/1\">",
"     1",
"    </a>",
"    ]. The majority of cases also demonstrate ongoing somatic mutations, which reflect the pressure of antigen selection associated with post-germinal center lymphocytes (",
"    <a class=\"graphic graphic_figure graphicRef80736 \" href=\"mobipreview.htm?2/54/2920\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31098?source=see_link\">",
"     \"Normal B and T lymphocyte development\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional information regarding the cell of origin is derived from gene expression profile analyses described in more detail below. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Gene expression heterogeneity of DLBCL'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ABERRANT BCL-6 EXPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of DLBCL tumors demonstrate increased expression of the B cell lymphoma 6 (BCL-6) gene. The increase in expression is the result either of mutations (often near the gene transcription initiation site) or of translocations that place the gene under the control of a new promoter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/4\">",
"     4",
"    </a>",
"    ]. Overexpression of BCL-6 in B cell lymphoma cell lines leads to downregulation of target genes, including the p53 tumor suppressor gene, which prevents the cells from undergoing apoptosis in response to DNA damage (",
"    <a class=\"graphic graphic_figure graphicRef62109 \" href=\"mobipreview.htm?0/1/30\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The combined frequency of BCL-6 mutations and rearrangements approaches 100 percent in DLBCL cases, suggesting that structural alterations of the 5' noncoding region of the BCL-6 gene are necessary for the development of these tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     BCL-6 action",
"    </span>",
"    &nbsp;&mdash;&nbsp;The B cell lymphoma 6 (BCL-6) gene, located at band 3q27, encodes a 95 kD nuclear phosphoprotein of the BTB-POZ transcription factor family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/6\">",
"     6",
"    </a>",
"    ]. BCL-6 contains six zinc-finger motifs, which bind to its DNA recognition sequence, a POZ transrepression domain, and a second repression domain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/7\">",
"     7",
"    </a>",
"    ]. The net effect is that BCL-6 is a potent repressor of transcription [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/8\">",
"     8",
"    </a>",
"    ], and can mediate repression of genes that lack BCL-6 binding sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     BCL-6 in normal cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;BCL-6 is expressed in mature germinal center B cells, but not in their differentiated cell progeny (plasma cells and memory B cells). It acts as a transcription repressor for many proteins, including itself, thereby creating a negative autoregulatory loop.",
"   </p>",
"   <p>",
"    Overexpression of BCL-6 in B cell lymphoma cell lines prevents the cells from undergoing apoptosis in response to DNA damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. It is hypothesized that BCL-6 expression permits the DNA strand breaks that are required for normal somatic hypermutation and class switching to proceed in the germinal center without triggering apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/12\">",
"     12",
"    </a>",
"    ]. BCL-6 expression must then be downregulated before the cell can progress into the post-germinal center phase of development where damaged DNA must be minimized. Signals that induce lymphocyte differentiation downregulate BCL-6, a process that is probably required for normal B cells to exit the germinal center [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disruption of BCL-6 in mice by homologous recombination leads to the absence of germinal centers and impaired T-cell-dependent antibody responses, indicating that BCL-6 is required for germinal center formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/16\">",
"     16",
"    </a>",
"    ]. Transgenic mice have been engineered to overexpress BCL-6 from the immunoglobulin heavy chain promoter, thereby mimicking the (3;14) translocation seen in human DLBCL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/17\">",
"     17",
"    </a>",
"    ]. These mice show increased germinal center formation and 75 to 90 percent develop a lymphoproliferative disorder that frequently progresses to a DLBCL-like lymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     BCL-6 in lymphomagenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the BCL-6 gene is overexpressed in most cases of DLBCL. This overexpression can result from a translocation that places the gene under the control of a new promoter or from a BCL-6 mutation that interferes with the negative autoregulatory loop for this gene. Overexpression of BCL-6 results in downregulation of several other genes, including the p53 tumor suppressor gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/12\">",
"     12",
"    </a>",
"    ], which allows cells with DNA damage to escape from the normal pathway to apoptosis.",
"   </p>",
"   <p>",
"    The best mechanistic data suggesting a role for BCL-6 in lymphomagenesis come from a structure-function analysis of 55 mutant BCL-6 alleles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of 32 DLBCLs screened, BCL-6 mutations resulting in overexpression of BCL-6 were found in four, all of which lacked translocations involving BCL-6.",
"     </li>",
"     <li>",
"      Four of 12 alleles derived from DLBCLs were associated with marked overexpression of BCL-6. The mutations in these alleles, located in the first exon, blocked the ability of BCL-6 to bind to its two cognate binding sites, thereby disrupting the negative autoregulatory loop by which BCL-6 normally represses its own transcription [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/19\">",
"       19",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      This has led to the hypothesis that cells unable to downregulate BCL-6 (either due to a mutation or translocation) may be unable to exit the germinal center and undergo normal differentiation; this block in differentiation could promote lymphomagenesis. It remains to be determined whether disruption of this negative autoregulatory loop is the functional mechanism of all BCL-6 mutations and rearrangements.",
"     </li>",
"     <li>",
"      Normal levels of BCL-6 expression (comparable to wild-type alleles) were produced by alleles derived from normal germinal center B cells, Burkitt lymphoma, follicular lymphoma, or chronic lymphocytic leukemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Genetic alterations to BCL-6",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     BCL-6 mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 70 percent of DLBCLs have a BCL-6 gene that contains multiple, often biallelic, mutations clustering in its 5' non-coding region, within 2 kb of the transcription initiation site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/5,20\">",
"     5,20",
"    </a>",
"    ]. These mutations occur frequently in systemic nodal DLBCL, primary extranodal DLBCL, CD5(+) DLBCL, CD30(+) DLBCL, and primary splenic DLBCL, but generally not in primary mediastinal DLBCL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Mediastinal large B cell lymphoma'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    These mutations also occur in a small proportion of normal germinal center B cells, 30 percent of follicular lymphomas, and varying percentages of chronic lymphocytic",
"    <span class=\"nowrap\">",
"     leukemia/small",
"    </span>",
"    lymphocytic lymphoma, Burkitt lymphoma, and MALT lymphoma. They are frequently independent of translocation to immunoglobulin (Ig) loci, occurring in the absence of any recognizable chromosomal abnormality affecting band 3q27 or rearrangement of the BCL-6 locus. The mutations are often single base substitutions, most commonly transitions, with a targeting motif similar to that of somatic hypermutation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In tumors with BCL-6 translocation, they occur more commonly on the der(14q32) translocated allele [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The genomic sequences most frequently involved in these mutations are adjacent to the BCL-6 promoter region, and overlap with the major cluster of chromosomal breakpoints, suggesting that mutations and rearrangements may both be selected for their ability to alter that region, which appears to be important for the negative auto-regulation of BCL-6 by itself [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/5,10,11\">",
"     5,10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Translocations involving the BCL-6 gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 40 percent of DLBCL of the immunocompetent host and 20 percent of AIDS-related cases display rearrangement of the BCL-6 gene on chromosome 3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/6,22-24\">",
"     6,22-24",
"    </a>",
"    ]. Reciprocal translocations juxtapose 3q27 to one of several chromosomal sites, including 14q32 (IgH), 2p11 (Ig kappa), 22q11 (Ig lambda), as well as at least 10 other chromosomal sites unrelated to antigen receptor loci. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\", section on 'Genetic features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chromosomal translocations involving band 3q27 truncate the BCL-6 gene within its 5' flanking region, usually within the noncoding first exon or first intron [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/6,25\">",
"     6,25",
"    </a>",
"    ]. In a minority of cases, the chromosomal breakpoint is not located in the immediate proximity of the BCL-6 gene, suggesting that more distant breakpoint clusters may exist. In all cases displaying direct involvement of BCL-6, the coding domain is left intact, whereas the 5' regulatory region, containing the promoter sequences, is either completely removed (in case of truncation within the first exon or intron) or truncated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/25\">",
"     25",
"    </a>",
"    ]. As a result, all of the coding exons of the BCL-6 gene are linked downstream of heterologous sequences, which, based on cytogenetic analysis, can originate from different chromosomes in different cases.",
"   </p>",
"   <p>",
"    The common consequence of these alterations is the juxtaposition of heterologous promoters to the BCL-6 coding domain, leading to increased BCL-6 expression by a mechanism called promoter substitution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Dysregulated expression of the translocation partner gene, now regulated by the BCL-6 promoter, may also occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     P53 DOWNREGULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to 20 percent of DLBCL demonstrate mutations or deletions of the p53 tumor suppressor gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. In addition, p53 transcription is at least partially controlled by the BCL-6 gene product known to be overexpressed in DLBCL. Downregulation of p53 expression or expression of mutant p53 products results in a loss of the normal growth-limiting activities of this gene.",
"   </p>",
"   <p>",
"    The normal \"wild type\" p53 gene, located at 17p13.1, produces a DNA-binding protein that acts as a transcriptional activator of growth inhibitory genes. Normally, activated p53 induces a variety of growth-limiting responses, including cell cycle arrest (in order to facilitate DNA repair), apoptosis, senescence, and differentiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Effect of BCL-6 on p53",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the B cell leukemia 6 (BCL-6) gene product is a transcription repressor that decreases the expression of many genes including itself and the tumor suppressor gene p53. Mutations in the p53 gene of DLBCL are seen almost exclusively in cases without BCL-6 translocations, suggesting that the aberrant expression of BCL-6 circumvents the need for p53 mutations in such cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'BCL-6 in lymphomagenesis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     p53 mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 20 percent of patients with DLBCL exhibit p53 mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Mutations are seen in sequences of the p53 gene that encode the non-DNA binding domain regions (39 percent) or different DNA-binding domain regions including Loop-L3 (23 percent), Loop-Sheet-Helix (20 percent), and Loop-L2 (19 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/29\">",
"     29",
"    </a>",
"    ]. The region involved may have prognostic implications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, a multicenter study demonstrated p53 mutations in 102 of 477 (21 percent) cases of DLBCL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/29\">",
"     29",
"    </a>",
"    ]. The presence of a mutation was associated with worse overall survival. Furthermore, the location of the mutation within the p53 protein appeared to be important, with DNA binding domain mutations associated with the worst outcome, followed by mutations of the Loop-Sheet-Helix and Loop-L3. Mutations in Loop-L2 did not affect survival. The presence of a DNA binding domain mutation in p53 was an independent predictor of survival, along with the International Prognostic Index (IPI), suggesting that these mutations are important either in the pathogenesis or in susceptibility to chemotherapy.",
"   </p>",
"   <p>",
"    P53 activates the p21 cyclin dependent kinase inhibitor. Expression of p21 appears to be an independent predictor of failure-free and overall survival in DLBCL treated with R-CHOP. As an example, a prospective intergroup trial demonstrated that the addition of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    to standard chemotherapy had no effect on the clinical outcomes of patients with p21 negative tumors, but significantly improved the failure-free survival of patients with p21 positive tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1088482\">",
"    <span class=\"h1\">",
"     INSIGHTS FROM DEEP SEQUENCING OF DLBCL GENOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep sequencing of DNA isolated from DLBCL and PMBL genomes have identified over 100 new recurrent mutations in DLBCL, virtually all of which remain to be functionally characterized. Of note, some of the most frequent mutations in DLBCL involve genes that regulate histone modifications, such as MLL2, MEF2B, EZH2, and CREBBP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/31,32\">",
"     31,32",
"    </a>",
"    ], suggesting that epigenetic alterations play an important role in the pathobiology of DLBCL. Because many epigenetic regulators are enzymes that can be targeted with drugs, these insights may provide a rationale for new therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OTHER MECHANISMS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Aberrant somatic hypermutation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Somatic hypermutation is the introduction of point mutations and small deletions or insertions, usually affecting the variable regions of immunoglobulin heavy chain genes of germinal center B cells. Somatic hypermutation is a key component to the affinity maturation of the humoral immune response. In normal germinal center cells, somatic hypermutation also targets the 5' regions of a selection of non-immunoglobulin genes, including BCL-6 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/11,33,34\">",
"     11,33,34",
"    </a>",
"    ]. Approximately half of DLBCL cases demonstrate aberrant somatic hypermutation targeting proto-oncogenes involved in cell proliferation, differentiation, and signal transduction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29529?source=see_link&amp;anchor=H38689713#H38689713\">",
"     \"Overview of the pathobiology of the non-Hodgkin lymphomas\", section on 'B cell germinal center reaction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, aberrant somatic hypermutation was found to target multiple loci, including proto-oncogenes in more than 50 percent of cases of DLBCL, suggesting a malfunction of somatic hypermutation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study reported that approximately 25 percent of DLBCLs demonstrate somatic hypermutation resulting in the inactivation of SOCS1 (an inhibitor of",
"      <span class=\"nowrap\">",
"       JAK/STAT",
"      </span>",
"      signaling), resulting in deregulated STAT activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of interest, some of the hypermutable genes are also susceptible to chromosomal translocations in the same regions, consistent with a role for hypermutation in generating translocations by DNA double-strand breaks. By mutating multiple genes, and possibly by favoring chromosomal translocations, aberrant hypermutation may be a major contributor to lymphomagenesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     BCL-2 activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;B cell",
"    <span class=\"nowrap\">",
"     leukemia/lymphoma",
"    </span>",
"    2 (BCL-2) is an oncogene that blocks programmed cell death (apoptosis), leading to prolonged cell survival. BCL-2 overexpression is often the result of a (14;18) translocation that places the BCL-2 gene under the control of an immunoglobulin promoter. This translocation is common in follicular lymphoma, but is also seen in up to 30 percent of DLBCL, especially germinal center-like DLBCL. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Gene expression heterogeneity of DLBCL'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/41/24215?source=see_link&amp;anchor=H26243875#H26243875\">",
"     \"Pathobiology of follicular lymphoma\", section on 'Translocations involving BCL-2'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     c-MYC overexpression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     c-MYC/Ig",
"    </span>",
"    fusion characteristic of Burkitt lymphoma has also been reported in 5 to 15 percent of patients with DLBCL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/37\">",
"     37",
"    </a>",
"    ]. This translocation has the same molecular features as seen in Burkitt lymphoma. Moreover, the prognosis of these patients is particularly poor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Amplification",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    overexpression of the c-MYC gene, without translocation to an immunoglobulin locus, has also been described in DLBCL and is associated with poor prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/37,39-41\">",
"     37,39-41",
"    </a>",
"    ]. As an example, one study reported that 38 percent of DLBCL tumors demonstrated an increase in the c-MYC gene copy number, which was also associated with increased mRNA levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/56/35720?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma\", section on 'Translocations involving the c-MYC oncogene'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     HETEROGENEITY OF DLBCL",
"    </span>",
"    &nbsp;&mdash;&nbsp;As described above, the diagnostic category of \"DLBCL\" is heterogeneous in terms of morphology, genetics, and biologic behavior. While a number of clinicopathologic entities that are sufficiently distinct to be considered separate diagnostic categories (eg, intravascular lymphoma) are now recognized, it is difficult to reliably subclassify DLBCL into morphologic variants (ie, diffuse centroblastic lymphoma, diffuse immunoblastic lymphoma, and diffuse mixed lymphoma) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/42\">",
"     42",
"    </a>",
"    ]. Most likely, DLBCL heterogeneity does not depend upon cytologic features, but rather upon the tumor genotype. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\", section on 'Morphology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Molecular heterogeneity of DLBCL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biologic diversity of DLBCL has been validated by the identification of at least three distinct genetic types, which may have different prognostic effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/43\">",
"     43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      BCL-6 positive DLBCL (40 percent): Rearrangements of BCL-6 in the absence of other known genetic lesions. BCL-6 positive DLBCL are de novo lymphomas, presenting without a previous history of follicular lymphoma (FL). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Aberrant BCL-6 expression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      BCL-2 positive DLBCL: B cell",
"      <span class=\"nowrap\">",
"       leukemia/lymphoma",
"      </span>",
"      2 (BCL-2) can be activated either alone or in combination with p53 mutations. BCL-2 positive DLBCL carrying p53 mutations derive from the histologic transformation of a previous FL, whereas the histogenesis of BCL-2",
"      <span class=\"nowrap\">",
"       positive/p53",
"      </span>",
"      negative DLBCL is controversial. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'BCL-2 activation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cases with germline BCL-2 and BCL-6 genes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one study, cases associated with BCL-6 rearrangements displayed the most favorable prognosis, whereas cases carrying BCL-2 translocations had the poorest outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/43\">",
"     43",
"    </a>",
"    ]. The third group (ie, cases without rearrangements of BCL-6 and BCL-2) displayed an intermediate prognosis. Of interest, grade IIIB follicular lymphoma, which has an aggressive clinical course similar to DLBCL demonstrated a similar pattern of cytogenetic changes, suggesting a close relationship to DLBCL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/46/25322?source=see_link&amp;anchor=H30#H30\">",
"     \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\", section on 'Tumor grade'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Gene expression heterogeneity of DLBCL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gene expression has been extensively studied in DLBCL using microarray technology. One line of investigation that has come to dominate the field uses supervised clustering to sort DLBCLs based on likely cell of origin. This work has characterized three types of DLBCL: germinal center B cell-like (GCB), activated B cell-like (ABC), and a not-otherwise-specified type 3 (",
"    <a class=\"graphic graphic_figure graphicRef80736 \" href=\"mobipreview.htm?2/54/2920\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/45-48\">",
"     45-48",
"    </a>",
"    ]. The optimal combination of immunohistochemical markers that can reliably separate GCB from ABC type DLBCL is controversial and remains in flux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\", section on 'Lymphoma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29127?source=see_link&amp;anchor=H17219010#H17219010\">",
"     \"Prognosis of diffuse large B cell lymphoma\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Germinal center B cell like &mdash; The germinal center B cell like (GCB) DLBCL has a gene expression profile characteristic of normal germinal center B cells. The immunoglobulin gene demonstrates intraclonal heterogeneity and ongoing somatic hypermutation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/50\">",
"       50",
"      </a>",
"      ]. These cells contain the (14;18) translocation",
"      <span class=\"nowrap\">",
"       (IgH/BCL-2",
"      </span>",
"      fusion gene) typical of follicular lymphoma and amplifications of the locus on chromosome 2 which codes for the c-Rel oncogene. GCB has also been associated with gains of chromosome 12q12 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/51\">",
"       51",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'BCL-2 activation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Activated B cell like &mdash; The activated B cell like (ABC) DLBCL demonstrates a gene expression profile similar to that of post-germinal center activated B cells. The immunoglobulin gene demonstrates intraclonal homogeneity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/50\">",
"       50",
"      </a>",
"      ]. ABC is associated with loss of 6q21, trisomy 3, gains of 3q and 18q21-22, and mutations of EZH2 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]. This locus on 6q encodes the tumor suppressor gene PRDM1 (Blimp-1), which is a master regulator in the differentiation of mature B lymphocytes to plasma cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/53\">",
"       53",
"      </a>",
"      ], loss of which may lead to inhibition of terminal differentiation as a pathogenetic pathway in DLBCL. ABC DLBCL also have high expression of PDE4B, which prevents cAMP from triggering apoptosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/54\">",
"       54",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In addition, ABC DLBCL have high expression and constitutive activity of the nuclear factor kappa B (NF-KB) complex involved in the B cell receptor (BCR) signaling pathway [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/4,46,55\">",
"       4,46,55",
"      </a>",
"      ]. ABC DLBCLs carry somatic mutations in multiple genes that are positive regulators of NF-kappaB, including CARD11, TRAF2, and TRAF5 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/56\">",
"       56",
"      </a>",
"      ]. The survival of ABC DLBCLs without CARD11 mutations appears to be dependent upon the expression of another BCR signaling component known as Bruton's tyrosine kinase (BTK) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=see_link\">",
"       \"Toll-like receptors: Roles in disease and therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Type III &mdash; Type III DLBCL is a heterogeneous group of tumors that have gene expression profiles that do not resemble either germinal center or post-germinal center B cells. The mechanism of its pathobiology is unknown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An alternative molecular classification scheme generated by the unsupervised clustering of gene expression profiles divides DLBCL into three groups characterized by the expression of genes involved in B cell signaling (BCR), oxidative phosphorylation, or the host immune response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/57\">",
"     57",
"    </a>",
"    ]. Of note, the tyrosine kinase SYK, which participates in BCR signaling and is selectively active in BCR-type, is a promising therapeutic target in DLBCL and certain other B cell neoplasms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Supervised analysis of DLBCL expression profiles from the same group identified expression of PKC-beta as a marker of poor outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/60\">",
"     60",
"    </a>",
"    ], a finding also noted by others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/61\">",
"     61",
"    </a>",
"    ]. This association has led to trials of PKC-beta inhibitors (eg, enzastaurin) in DLBCL .",
"   </p>",
"   <p>",
"    The role that gene expression profiling plays in the diagnosis and treatment of DLBCL is a matter of ongoing research. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29127?source=see_link&amp;anchor=H17219010#H17219010\">",
"     \"Prognosis of diffuse large B cell lymphoma\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     MEDIASTINAL LARGE B CELL LYMPHOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary large B cell lymphoma of the mediastinum (PMBL) is a variant of DLBCL arising in the mediastinum from the thymic (medullary) B cell. Although long-suspected on clinical grounds, emerging biological data suggest that PMBL should be separated from DLBCL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/62\">",
"     62",
"    </a>",
"    ]. The gene expression profile of these lymphomas is more similar to that of classical Hodgkin lymphoma than that of DLBCL, with decreased expression of B cell receptor signaling components and increased expression of cytokines and extracellular matrix components [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Of particular interest, PMBL often has genetic lesions that are predicted to increase signaling through the",
"    <span class=\"nowrap\">",
"     JAK/STAT",
"    </span>",
"    and NF-KB signaling pathways, as well as to enable PMBL cells to escape from T cell-mediated immune surveillance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9238?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional features of PMBL include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although PMBLs have rearranged immunoglobulin genes and express B cell markers, they do not express surface immunoglobulin, despite expressing CD79a, a component of the B cell receptor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Characteristic cytogenetic abnormalities of PMBL include gains of 9p with the JAK2 gene and gains of 2p with the REL gene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/66,67\">",
"       66,67",
"      </a>",
"      ], which encodes one form of NF-KB. In addition, the combined expression of c-Rel in the nucleus and tumor necrosis factor receptor-associated factor-1 (TRAF-1) in the cytoplasm has been reported in 53 percent of PML, compared with 2 percent of other subtypes, providing a histologic means of identification [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bcl-2 translocations are uncommon, but may be seen in up to 17 percent of tumors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/69\">",
"       69",
"      </a>",
"      ]. Bcl 6 translocations were previously thought to be rare but have been reported in approximately 30 percent of PMBL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Genetic analysis of PMBL has revealed frequent amplification of PDL1 and PDL2, genes that encode proteins that down-regulate T cell responses, as well as frequent disruptive rearrangements in the CIITA gene, which encodes a factor that is needed for expression of HLA class II proteins [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/27/38329/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/60/27588?source=see_link\">",
"       \"Patient information: Diffuse large B-cell lymphoma in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse large B cell lymphoma (DLBCL) is the most common histologic subtype of non-Hodgkin lymphoma. The molecular pathogenesis of DLBCL is a complex, multistep process leading to the replication of a malignant clone of germinal or post-germinal B cell origin. While some steps in this pathway have been elucidated, many remain unknown.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      DLBCL is a heterogeneous clinicopathologic entity that includes tumors derived from germinal center B cells or post-germinal center B cells (also called activated B cells) (",
"      <a class=\"graphic graphic_figure graphicRef80736 \" href=\"mobipreview.htm?2/54/2920\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Cell of Origin'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Heterogeneity of DLBCL'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of DLBCL tumors demonstrate translocations or mutations that result in the increased expression of the B cell lymphoma 6 (BCL-6) gene. Overexpression of BCL-6 leads to downregulation of target genes, including the p53 tumor suppressor gene, which prevents the cells from undergoing apoptosis in response to DNA damage (",
"      <a class=\"graphic graphic_figure graphicRef62109 \" href=\"mobipreview.htm?0/1/30\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Aberrant BCL-6 expression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Up to 20 percent of DLBCL demonstrate mutations or deletions of the p53 tumor suppressor gene. In addition, p53 transcription is at least partially controlled by the BCL-6 gene. Downregulation of p53 expression or expression of mutant p53 products results in a loss of the normal growth-limiting activities of this gene. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'P53 downregulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other mechanisms important in the pathogenesis of a minority of DLBCL include aberrant somatic hypermutation, BCL-2 activation, and c-myc overexpression. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Other mechanisms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary large B cell lymphoma of the mediastinum (PMBL) is a variant of DLBCL arising in the mediastinum from the thymic (medullary) B cell. The pathogenesis of PMBL is largely unknown, but may be more similar to that of classical Hodgkin lymphoma than that of DLBCL, and appears to involve activation of JAK-STAT and NF-KB signaling as well as acquisition of genetic lesions that allow the tumor cells to escape from immune surveillance. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Mediastinal large B cell lymphoma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/1\">",
"      Stevenson F, Sahota S, Zhu D, et al. Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes. Immunol Rev 1998; 162:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/2\">",
"      Lossos IS, Okada CY, Tibshirani R, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood 2000; 95:1797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/3\">",
"      Ottensmeier CH, Thompsett AR, Zhu D, et al. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998; 91:4292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/4\">",
"      Davis RE, Ngo VN, Lenz G, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010; 463:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/5\">",
"      Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A 1995; 92:12520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/6\">",
"      Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993; 262:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/7\">",
"      Chang CC, Ye BH, Chaganti RS, Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci U S A 1996; 93:6947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/8\">",
"      Parekh S, Polo JM, Shaknovich R, et al. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood 2007; 110:2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/9\">",
"      Phan RT, Saito M, Basso K, et al. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 2005; 6:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/10\">",
"      Shen HM, Peters A, Baron B, et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998; 280:1750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/11\">",
"      Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A 1998; 95:11816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/12\">",
"      Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/13\">",
"      Cattoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995; 86:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/14\">",
"      Tunyaplin C, Shaffer AL, Angelin-Duclos CD, et al. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004; 173:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/15\">",
"      Fearon DT, Manders PM, Wagner SD. Bcl-6 uncouples B lymphocyte proliferation from differentiation. Adv Exp Med Biol 2002; 512:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/16\">",
"      Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997; 16:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/17\">",
"      Cattoretti G, Pasqualucci L, Ballon G, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 2005; 7:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/18\">",
"      Pasqualucci L, Migliazza A, Basso K, et al. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003; 101:2914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/19\">",
"      Wang X, Li Z, Naganuma A, Ye BH. Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci U S A 2002; 99:15018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/20\">",
"      Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000; 95:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/21\">",
"      Jardin F, Bastard C, Contentin N, et al. Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma. Blood 2003; 102:1872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/22\">",
"      Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994; 83:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/23\">",
"      Gaidano G, Lo Coco F, Ye BH, et al. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 1994; 84:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/24\">",
"      Dalla-Favera R, Migliazza A, Chang CC, et al. Molecular pathogenesis of B cell malignancy: the role of BCL-6. Curr Top Microbiol Immunol 1999; 246:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/25\">",
"      Ye BH, Chaganti S, Chang CC, et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 1995; 14:6209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/26\">",
"      Kaneita Y, Yoshida S, Ishiguro N, et al. Detection of reciprocal fusion 5'-BCL6/partner-3' transcripts in lymphomas exhibiting reciprocal BCL6 translocations. Br J Haematol 2001; 113:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/27\">",
"      Koduru PR, Raju K, Vadmal V, et al. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 1997; 90:4078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/28\">",
"      Ichikawa A, Kinoshita T, Watanabe T, et al. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 1997; 337:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/29\">",
"      Young KH, Leroy K, M&oslash;ller MB, et al. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood 2008; 112:3088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/30\">",
"      Winter JN, Li S, Aurora V, et al. Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494. Clin Cancer Res 2010; 16:2435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/31\">",
"      Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/32\">",
"      Pasqualucci L, Dominguez-Sola D, Chiarenza A, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011; 471:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/33\">",
"      M&uuml;schen M, Re D, Jungnickel B, et al. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med 2000; 192:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/34\">",
"      Gordon MS, Kanegai CM, Doerr JR, Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc Natl Acad Sci U S A 2003; 100:4126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/35\">",
"      Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/36\">",
"      Mottok A, Renn&eacute; C, Seifert M, et al. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood 2009; 114:4503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/37\">",
"      Barrans S, Crouch S, Smith A, et al. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 2010; 28:3360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/38\">",
"      Akasaka T, Akasaka H, Ueda C, et al. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J Clin Oncol 2000; 18:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/39\">",
"      Kawasaki C, Ohshim K, Suzumiya J, et al. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas. Leuk Lymphoma 2001; 42:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/40\">",
"      S&aacute;ez AI, Artiga MJ, Romero C, et al. Development of a real-time reverse transcription polymerase chain reaction assay for c-myc expression that allows the identification of a subset of c-myc+ diffuse large B-cell lymphoma. Lab Invest 2003; 83:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/41\">",
"      Stasik CJ, Nitta H, Zhang W, et al. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica 2010; 95:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/42\">",
"      Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/43\">",
"      Offit K, Lo Coco F, Louie DC, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994; 331:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/44\">",
"      Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003; 101:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/45\">",
"      Morgensztern D, Martin MG, Lossos IS. Gene expression profiling in diffuse large B-cell lymphoma. Leuk Lymphoma 2007; 48:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/46\">",
"      Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/47\">",
"      Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:1937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/48\">",
"      Klapper W, Kreuz M, Kohler CW, et al. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood 2012; 119:1882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/49\">",
"      Choi WW, Weisenburger DD, Greiner TC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 2009; 15:5494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/50\">",
"      Lossos IS, Alizadeh AA, Eisen MB, et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A 2000; 97:10209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/51\">",
"      Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005; 106:3183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/52\">",
"      Morin RD, Johnson NA, Severson TM, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010; 42:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/53\">",
"      Tam W, Gomez M, Chadburn A, et al. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 2006; 107:4090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/54\">",
"      Smith PG, Wang F, Wilkinson KN, et al. The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood 2005; 105:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/55\">",
"      Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/56\">",
"      Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009; 459:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/57\">",
"      Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105:1851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/58\">",
"      Chen L, Monti S, Juszczynski P, et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 2008; 111:2230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/59\">",
"      Friedberg JW, Sharman J, Sweetenham J, et al. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 2010; 115:2578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/60\">",
"      Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/61\">",
"      Hans CP, Weisenburger DD, Greiner TC, et al. Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol 2005; 18:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/62\">",
"      Steidl C, Gascoyne RD. The molecular pathogenesis of primary mediastinal large B-cell lymphoma. Blood 2011; 118:2659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/63\">",
"      Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102:3871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/64\">",
"      Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/65\">",
"      Kanavaros P, Gaulard P, Charlotte F, et al. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. Am J Pathol 1995; 146:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/66\">",
"      Bentz M, Barth TF, Br&uuml;derlein S, et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 2001; 30:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/67\">",
"      Joos S, Ota&ntilde;o-Joos MI, Ziegler S, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/68\">",
"      Rodig SJ, Savage KJ, LaCasce AS, et al. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma. Am J Surg Pathol 2007; 31:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/69\">",
"      Dunphy CH, O'Malley DP, Cheng L, et al. Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISH. J Hematop 2008; 1:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/27/38329/abstract/70\">",
"      Iqbal J, Greiner TC, Patel K, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007; 21:2332.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4722 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-01FC61200C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38329=[""].join("\n");
var outline_f37_27_38329=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CELL OF ORIGIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ABERRANT BCL-6 EXPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      BCL-6 action",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - BCL-6 in normal cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - BCL-6 in lymphomagenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Genetic alterations to BCL-6",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - BCL-6 mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Translocations involving the BCL-6 gene",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      P53 DOWNREGULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Effect of BCL-6 on p53",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      p53 mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1088482\">",
"      INSIGHTS FROM DEEP SEQUENCING OF DLBCL GENOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OTHER MECHANISMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Aberrant somatic hypermutation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      BCL-2 activation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      c-MYC overexpression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      HETEROGENEITY OF DLBCL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Molecular heterogeneity of DLBCL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Gene expression heterogeneity of DLBCL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      MEDIASTINAL LARGE B CELL LYMPHOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4722\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4722|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/54/2920\" title=\"figure 1\">",
"      DLBCL pathogenesis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/1/30\" title=\"figure 2\">",
"      DLBCL pathogenesis II",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21337?source=related_link\">",
"      Classification of the hematopoietic neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9238?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/46/25322?source=related_link\">",
"      Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/56/35720?source=related_link\">",
"      Epidemiology, clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=related_link\">",
"      Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/21/6489?source=related_link\">",
"      General aspects of cytogenetic analysis in hematologic malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/5/41049?source=related_link\">",
"      Genetic abnormalities in hematologic and lymphoid malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/45/26330?source=related_link\">",
"      Initial treatment of advanced stage diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13511?source=related_link\">",
"      Intravascular large cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31098?source=related_link\">",
"      Normal B and T lymphocyte development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=related_link\">",
"      Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29529?source=related_link\">",
"      Overview of the pathobiology of the non-Hodgkin lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3609?source=related_link\">",
"      Pathobiology and treatment of Richter's transformation in chronic lymphocytic leukemia/small lymphocytic lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/19/5433?source=related_link\">",
"      Pathobiology and treatment of histologic transformation in the indolent non-Hodgkin lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/41/24215?source=related_link\">",
"      Pathobiology of follicular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/60/27588?source=related_link\">",
"      Patient information: Diffuse large B-cell lymphoma in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29127?source=related_link\">",
"      Prognosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/20/41287?source=related_link\">",
"      Pulmonary lymphomatoid granulomatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=related_link\">",
"      Toll-like receptors: Roles in disease and therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_27_38330="Serous cystadenoma Light I";
var content_f37_27_38330=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73288%7EGAST%2F82546%7EGAST%2F71673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73288%7EGAST%2F82546%7EGAST%2F71673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Serous cystadenoma of the pancreas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low and high power light micrographs of a serous cystadenoma of the pancreas. Left panel: Low power reveals multiple microcystic spaces within the lesion. Right panel: High power shows that the lining of the cystadenoma is comprised of flat cubboidal glycogen-rich cells (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD and Michael L Steer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pancreatic serous cystadenoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light microscopic appearance of a pancreatic serous cystadenoma (H&amp;E stain). Note cuboidal cells lining cystic spaces and amorphous stroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael L Steer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pancreatic serous cystadenoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Periodic Acid Schiff (PAS) staining of pancreatic serous cystadenoma. Note positive staining identifying glycogen-rich cells lining cystic spaces.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mike Steer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38330=[""].join("\n");
var outline_f37_27_38330=null;
var title_f37_27_38331="Past obstetrical history";
var content_f37_27_38331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Past obstetrical history",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        <strong>",
"         Number of pregnancies:",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fullterm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Preterm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Miscarriage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Abortion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ectopic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Living children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Multiple gestation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         For each pregnancy, indicate:",
"        </strong>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Date of delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Infant gestational age at delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Location of delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Sex of child",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Birth weight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Mode of delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Type of anesthesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Length of labor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Outcome (miscarriage, stillbirth, ectopic, etc)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Details (eg, type of cesarean section scar, forceps, etc)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp; Complications (maternal, fetal, child)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38331=[""].join("\n");
var outline_f37_27_38331=null;
var title_f37_27_38332="Vocal cord palsy flow volume";
var content_f37_27_38332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cricoarytenoid disease in rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 182px; height: 237px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inspiratory and expiratory flow volume loop in a patient with bilateral vocal cord palsy secondary to cricoarytenoid disease. Both forced inspiratory and forced expiratory flow are decreased, but there is more marked reduction in inspiratory flow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38332=[""].join("\n");
var outline_f37_27_38332=null;
var title_f37_27_38333="PA pressure and survival COPD";
var content_f37_27_38333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary artery pressure and survival in COPD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 226px; background-image: url(data:image/gif;base64,R0lGODlhrwHiAOYAAP///4CAgAAAAAAzmSBzOf8AAEBAQMDAwBAQEGBgYPDw8LCwsDAwMKCgoNDQ0HBwcCAgIODg4C58RZC5nP8QEP9gYP+wsNbl2//AwMjczlBQUJ7Cqf+AgPL382afd5CQkMDN5v9AQEBms4CZzFiWa0qNXqzLtf8wMP/g4P/w8HSohOTu5/9QUP9wcP8gIP+goP+QkDyFUoKwkP/Q0LrUwuDm89DZ7GCAv/Dz+aCz2SBNpjBZrLDA31BzuXCNxpCm0xBAnxMOBwYVCh5rNWVPJz8mckk6VGEjWasrFYFAIEl9TY6ymI95XA8vj18fX9Te178MJrkjETtkMX8ZTHR+dzFNRtUVCtMRENVlWnNHIxQeF0ldLp0yGOMOBwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACvAeIAAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6ckHDoQLAR8Rg+/x6vb32w4BAgaDDwIMECCQ9y/gQHwIE0YzIICfIAUCEAD4IOABRIkUHyR6okAhoxoeQ8Y64BAAyX4nT5osaTKAS5dBglQxcqRIkwE4c+rcybOnz59AgwodSrTogB4/bIhcmkrlSpT8VDpt+ZJKEAFChhAgwuUKlClOihgdS7as2bM+gSAFybQtKKcO/wACWCBAQ1wGc+sm2odVKwECW5JYKVDgBAsOFmbgs/GjBxCdOm7kYOu2siUHFBkc6AhBwAINAhoA6Pw59F4NCARoWeLh718pWaIQnh2iAgcMKOwxdgxZMmXLwBsxbCjgAAAHDCJqPJ4cwXJELh2kZqCggwkVElxvRdJl9mwKIVrAwKDOxggROyNPDs6+lMvj0zsKyiAjhnYlTLBUCOF9tosQHLyg2DkgnJeeZDi0p2An78EHkHyDrLABCdrFoAINKFjAAQsn9EeYYYjlVk6B6Om0gw88JLjgipQ06CB1h1iHnXYemNCBIDO8wEEILnhYQG3jpUAOiTudmCKLSDbi4v+LEB5Cn32ulbDBBYSkgAEMLYRAgYfgtfACeeLw4MMORaKoYpJoDrIkk4xcsEEJFcpAwyEoYMDBfj7+h9iA3uAgJpkmopgmmmuy2Yh1HmT3lwQ13ojIDBqy0KOHJ9iGAZjc+DnmTiKMAMKgCxZq6CM01KedlFQugoGOWvpYgQXfaApoTp1+Cqploo4KiZtwuhaDDBk4YiWW/H33Kjg45HCDDpx6eitTueoaCaLaSaCCjZBYUMGWhFFwLDg1KMusTp0q9Swk5o2QgyA4gOAuCOaG8oBoEwWgSrTSTkKDClD+RcIGK2S7rbGwhhPusjqpldS5iNRgrk4+AAACuaEocAD/AwkccIAG/aSCr4MdZ3LBBL3+9Wuwj2jLbQHeFmywuAkjFe+zINwwwAiCrGsDThIPsIO7M3dCEnENJXDKAS4ZYO8i0glgNCcrmNCaa9Zi64jKBJNTQ2OPoeX115yKIPbYZJc9wtlop622p++27fa7kiTL7A22DlLDADr0DIQIN/zWSQQBQKA0PE2OgnQASjfS9NOe7NsvAR4AnPLA3X47zm5gZ6755l4n8pgPfgvSwwA8AGDDDQbuMIoD8rTy8SBDM/7JBTKUTEAJwDrKCNaVuzxO6L+0+/bwIPCw9vFn+1D28mTPylMiI+gARN+E4IDeuoXwLIoDHBtgwHOnvD5I/wNFkyLh1IuaIPDKLTM8Tg7oifBpDWR2OkINI/RgoAijdEZcyOFbmiPI5zRTdGBfivJAwNaXNfeB6wY/6JlOijeuHpwJFHpxnQAHWL5TdGACi9rAJHjHMss58IQaAN+9NsjBAqLiAhS6HcokQcL2ndB9CUCA9763wkkQUHam2ICiZKA7GlKuhL67YZqG0xAAmkJ8h/ihKjqggkXNyRI1NKEStwgKKEaxg6nIAJRIsEAsHtGGXFQQcooDgQ/0sBJSXAUI/zIBTWQxiWl0i0EO8AAnuoeFkoijKlYQwxjMEBN3zGNlPGMApPmRFF5MhCBVQQNFqaCIiDyjFhWZEAR8wP8AC4AAECHxjgC0bi7wOOUhIilJME5RBiH0RCI5mRC+NMQ4k0gAQFJjnIIIRJWFYGUrXciKDPSKBKnqxCxpaY9PamABlWiIAvYRgItMpCJ7ASQcG6JNVAiRjpjcxDKZWY53AABw7cilACDAAOpIhSWHe0niNkFAerViBVOLwRVBUcMWiIic4oDA0gygAUpkJiIOeGfI4pm0bm7TNK+gAZQUOAoSnuAFQgLoN4ojCMRNIi79oIgB7pKXgkLHoZXgiz1b8cFYksICLDAWpjSqDVEqQAEYm0QEIrIAXRqNNKBZaTBRWgldQvQVMPxLCQ4ZihTAoEOEcQEH/klTa9iSoz7/7AwCEtCRNTpHEcJ0hFGF2opvEoCIppjBEVnwgqpeowEEheYbPzFWWVDRiqh4QUwrxye3PqMBZEVFWB9RV1mI0V9lLAUKODCpwsAgo35lBsdcMVjCNiSwrZgjAeqYCgysFY+RLUYDIKAxdsw1FIWVBSFNxtRSpOAFUC2AC/wZ2mMwkSUBLEVqZVHJv1xyFShoQWMvCtnaAqMBLwkAZkVR2UjsNhYdgCUBJCBCVsBUpsYNxjvQedpRPDcWxvRXMlXh1NhKlarZxcU/iqOBUUKSqJ34bizMOoFwokKtK2NrenOxVc141GPwje9lb4FPk+2zFXo1Vl/3G4viNDIBjxxF/3MpId9YSPQvFH3FYof7WAbHwgAMgABo3AjgVRgVl7Zo6XSrCwvP5he0Hj5F0x50tIayQpcISOctkipDWbzWvLSN8SpMi4rDzdPECNWFWdEqi+AOF6NCNoUC+vjMVUz4EgzJsS7uOt0Dx+K6lZtplD9xW7kKNsAVa46OcXFYApCxFuX1z1TH/AkB2AunEWYumtOc5F1olrO1wO9s9EvnTVQZAAEw6ZlhgdM+62K1BDAkLhLM10JjIgGCMwAEBKdCCe9ZFI3WMi96S4Df3mLDszlBhy09ids2cdGxCPWacxFdl+LCxYOGMatzceVNyNoX4XXzeG3xY+/UZk+71kWvff+t5l/Q1760CK6PCnOYLyV7FstmtqN5UeBFkYAEHpiAuDNAbmiv4lLEWpl3/iMeDBT32rmtxa9/QQPt2PveJfi2CsRtAnIPu7Osamx/jo2bKBcu3vJu9i86sIIVkNsE4pbBt21373t/mwTingANyn0KSG2oWJQ6jAXEHNkDCPTgjyhl6+gBzKHiYt7MIHcGNiBuD3z7cRWv0LfDPYENyDwUdeJAltTtHwAFya0RyLKZH9HodvZylwc5aS5gbg2HZ4AGGb94znN+cRnwm9wNz8SwdiTw74TnNujlpMYkoUsSA8CaGcmmLkKNcm9cgNw0n4AKJr71e1/L3JPAQKRiO3D/kS/4VqVN/KwfkRqGMCACCoVdchH36VU0GgLLPUcHZJ71bysqShP4dyaCjqc8AcjagyLa/yhxS59GXhAMpTwvIuC/NtbdIyOzXdUAf4lhZans3QrPeNIOnMm7JPOKSM1TSEoXRRsi26AebUMQUE3gyOjztwt9KVa1IcIbO0S01GUAxD8azwRV7r+QfkSqH5zcV+vvHddQ6b0DHvC7pQGpefUkFAAabDJHOWBVebGgftR3e0txfaeifamQIVnCJQBiAe+GEJvGD1vVXennPwW4IO5HNfCnCjnSgP3hAofhbgjhGQIAAA/gXp5mDATIfgqCgKAnemn1AiC4biMYgeNQ/xwMkGh5FgrQxwotaICVsYGL0oGs8IHeJ1s3SA4Ywxed9l7KsADDkYFIAoNKpYCucCUVkISVMh7j8AFuB2vKcABTmAAtp4Ek835W8wpayIUV4IXa8AFLZ4HIQIbEYYaDYoXZJ4PnBgNbSClvSHLQwBAQ8ABnCIXPYIdFc4grQoTTZYSwYCUbAnwn4CWHtwwO8ADJQUwIl4hMhIe3ooclgIU+ZieS4iHhISDNoABwhVtPJIDCoIhOw4hI4oi7R2ymCHypeInAsF51gWKdKA2yCIrnIoqkSAspoCGtMnAtYAHENwgoAAMcsGqXUo2HMAPSCGWCoCEw8IyRAGINIIQ+CP+LxTCMtIgmtgiJtZAhO0J0FICDAAByJyAI/XEIxiYILVAYFEAB3sh0r/CDvRABRjWLN2SMfNhkyriPiQCBKdAj5EEY1mgIbYUChAEAKcAyAAADBdACljBSfbRDT/gWNrYNAvk/wOhAthg5B+ljjNAjuUEYIcACgggAGJCPHECTP4KTIWAJDkY0PSg0I8kNJdlEJ+lAesgoU0IMGsmRAHAYFcAydTIbNwkAL8AfHIkBOYmVO3kMACkMQxkVeeQmiVItKvkL+VgBhsAf7laNVKWWM1AYAGABBcACl2aIGiQOX9lInCSW2IeUK/kKMSVVt4EBJ3AnLPNuhCl0hJEbPXL/XW2FZQ3BAOFIh92Ql0XJRXxJlklZC/0xVVB1AoeHAlDlAgUzAx1CAUyJCQvwAJ3xk5/QlcdgmQCVmVRTlurQU61JmeAgkPmnlxpFm4tim+QwHAzwAeLoCbCpDNPUm3NITsA5XcL5DQlgl6yQnMuwnA2BeZH1nH7pDYBFWeSoDdi5TshHS9wZndYwWXeZEOOpncZ1nptJDaNVWouHiArRnuU5mxswlrUZn89wW66JnOH5DfjpYfD5l8KAXC+Rn4kAeTrGcgHYFgUaYwdaDo3WMb4Udas0oOKgAB9Qey5ooPvZl+gZDABaCevVD3DnfxsaHB86faZEZxWaCG4yAVZj/x02am53t0B3J3O81wgfyRAhyQgksQ9QcaSSl1xHBhzqR5CFxp2JRQjaQQKCACcUUgKIcAHZwVkx9BetZQk7uH+FGHlTEXtLGhyyqAGXKWR8KQGJoD4r8BcAUG8eAACt4WVVSkeCQCE+lwE/ynSCMwlD8z/Ml0EtuiIHMJCgdG1RWgj0sVkAAEJ1JKmGMAESAEtcejskoD6YcFsquAgWcwCZ0Q5AdVTPx6H38JXuCW+GYAIUIgORCqmSmgGuEXoEgHWQCgBeJwPZgaeSEKRcZQlw0RxDimioig/tGaKsuqcEMHNnpasEsAGbB3aapaeDQKmX4ADt8AEMyiDHihAeiv+B1HltxjQB0tVwkXZYUWp1VaQCAfMrvNqsmMAAD8AXzWmfoNKkxMhqK9Ar+iQIJmAfMcCph4Ct+USwPEmGDKABzveK7iOLvrmssmCC9Rqg3npCDqCo3SqxotB/DcCwugkqvJmdG8uxnhABKaQAi1piWzSeVGiy2GCdIcGK4nqOMMsMMrsUDbCJTlOfN9sMOcsUELumP5sMQdsWGUscklm0njBPD9Cwf1RVEfAA+Yd5x8m0iwA4guMSDGCxmWBk35omLqusWAsJg0ocYUukQelXBLivZesIFoMxGuOzK2hcrVg0dPu2uHC0iMpEEau3i4B/q8ey+6WqJVu0jec9xdr/RWl7QlNbtcYJuIjwVespZNOEgWQLuCkInpamrzZ7sydKuIUmhXdItD8bpDwkupa2MSYpuRbzuiEbZYb7tgR0MYv7mo0LUICTf1t1rxLLTqT1X2K4rOMZEQngu9fmYHzktYXAii5xShCKfjDbU/lnvMhraaK0g5QrCbZ0EBnKiHzLTNRLHL3LqnQxfZ97CAcgD6BRTRFxTUMavgA1vtN3vNemD/VwCbrUAK9HFfKUuwxGv9YruYdAUv1rpgAcYwJcvjHWk4PrQwgAI4UKtWqSwFG2wPa7Xx65Q6krCRThHMpVfqWxXPKbXhh8vTTFOoKgwq3mk/+3vYdKwIpwwsY1/0/CG4wynAg0XFUOYAAIkGk6FLs5XAg7TE5ny1NCPMSGUMS0NC+cq8STwMR5lFBzm8RQrMM5RL4ZzEW+6IpRe8WXIMXuo0N2VohWDMaMIMa3UhwCME0UXLdorAlqjCaMpAFde8ZxnHJZXL8o3B71er6HiwklTMBzvCLaamUWnMeCUMiVIYVqqgpgq8ilIMCRCZIvsQCldbXjEBfEkb6bEMmSbAo9pXqkXMoAYckugckao8nSEAAIsAALQH3VmcihXMChegClFABByrOm3Mtdq7iXnMmmsMpvp3g+2DFnisO1PAu3nMu73MvQfMrAnMrCrAibgQi1uxIPjJykzLyaMP/Iy9wJzfwSzxzNpZwIPjyughAB+WccJKEZRPaa3YzH4XwM4+wS5XyCksQQKwsAO8RRJKFDbusM4FzPxtDDevEBA8EQxpGxiCMXrUzLBt0MrMsA0ORqwNgQ01DQE31cnZExg0DFyWGcifbQ3iwMHN3RvpAAmevPHBVKDaEBrDwMKa3S2VXTNl1bOJ3TkbXTPH1CzjuZEfrTTJscjrcIPk3U59J8AAAa15vUSn0r1IRodkYIZjo4xpfVWr3VXN3VXv3VYB3WYj3WZF3WZn3WaJ3War3WL2G6VlXVU52k8oTVbF3Xxuc9dp3XSkrXel3XeN3Xev3XgM3WyRyH2PQPYXj/qr4A1VLHC4zd2Mom0bO3TiYnALT42DEc2b2A2Yq9C5yNCtK3qpDt2ZItyKV9CZ9NCKltrB6x2h112pbg2q7N2qTd2rAd27fdIrk9CbO92rM9C2vXC8G9C8OtC8Vt3G49Eskd1czd3M793NAd3dI93dRd3dZ93SIR1DM9ZHkbCxHwAYSjC5ihXNu9CgnlyZCceAlh1BCNC/rgxbXARHiRCy68C02z246gegjB1E6dC8Nx0qmwADfVGcsNhOek0buwifjdCLd03Okw1XGNC1OxC52B3pD8DwvuCK6M4fTND4+MDxBe1bkw4bkQd7rQirfrCnHxDiJ+CxowfhFh4dwQ/3eIbdzwXQv/8KnxjVW3cFUtjgsMjQ87RVoVnguYARDXjAugIVABUOCQvIPrJeOnAHmJ6qS1cDEwjgDlvQ2hHcincFtOrgqql+GKEAGbCAF9HAsRXgtmHpndjd1wHudyPud0Xud2fud4nudupTGtc956XmhG+nYCseV/Tk4KQBr74EbTFFeC8JEJ0A5I4wD8OxGKK+WFjiR00RnzHRABkBykqss/TNWpAeP1qhmXrkjD0Q4gBeP2srzKtw9yBRovHuanniZOcRJt3XwLkBxUjUsKkACbmOa1PihTIRD8y63UBNO9LggJ8AF8JACJPewONBXck50CnhwTuOyIlhowLB7t3v7t4B7u4j7u5F7u5n7u6J7u6r7u7N7u7h5jgQAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The relationship between baseline mean pulmonary artery pressure (from less than 25 to more than 45 mmHg) and survival in patients with chronic obstructive pulmonary disease. Increasing pulmonary artery pressure was associated with a progressive decline in survival.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Bishop, JM, Prog Respir Res 1975; 5:9.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38333=[""].join("\n");
var outline_f37_27_38333=null;
var title_f37_27_38334="Extensor nodules in scleroderma";
var content_f37_27_38334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extensor nodules in scleroderma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nodules at the elbows in a child with a variant of localized scleroderma. Similar nodules may be present in the extensor and/or flexor tendons in the hands, and at the knees or ankle joints.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD, FRCP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38334=[""].join("\n");
var outline_f37_27_38334=null;
var title_f37_27_38335="Ink stains at polypectomy";
var content_f37_27_38335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F77062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F77062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    India ink at polypectomy scar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 312px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    India ink staining is visible at the site of a polypectomy scar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jerome D Waye, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_27_38335=[""].join("\n");
var outline_f37_27_38335=null;
